Mycobacterium kansasii G133 Bostrom is an obligate aerobe, mesophilic, rod-shaped human pathogen that was isolated from fatal case.
rod-shaped obligate aerobe mesophilic human pathogen genome sequence 16S sequence
SI-ID 44426
| @ref 20215 |
|
Last LPSN update
2026-02-09 11:19:42 |
| Domain Bacteria |
| Phylum Actinomycetota |
| Class Actinomycetes |
| Order Mycobacteriales |
| Family Mycobacteriaceae |
| Genus Mycobacterium |
| Species Mycobacterium kansasii |
| Full scientific name Mycobacterium kansasii Hauduroy 1955 (Approved Lists 1980) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 11560 | MIDDLEBROOK MEDIUM (DSMZ Medium 645) | Medium recipe at MediaDive  | Name: MIDDLEBROOK MEDIUM (DSMZ Medium 645) Composition: Bacto Middlebrook 7H10 agar 20.9945 g/l Glycerol Distilled water | ||
| 36241 | MEDIUM 55 - for Mycobacterium | ||||
| 120378 | CIP Medium 55 | Medium recipe at CIP |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 120378 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 120378 | amylase | - | ||
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 120378 | beta-galactosidase | - | 3.2.1.23 | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 120378 | caseinase | - | 3.4.21.50 | |
| 120378 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | + | 3.4.11.3 | from API zym |
| 120378 | DNase | - | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 120378 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 120378 | gelatinase | - | ||
| 120378 | lecithinase | - | ||
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 120378 | lipase | - | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 120378 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 120378 | ornithine decarboxylase | - | 4.1.1.17 | |
| 120378 | oxidase | - | ||
| 120378 | protease | - | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 120378 | tryptophan deaminase | - | ||
| 120378 | tween esterase | - | ||
| 120378 | urease | - | 3.5.1.5 | |
| 68382 | valine arylamidase | - | from API zym |
Global distribution of 16S sequence AJ536035 (>99% sequence identity) for Mycobacterium from Microbeatlas 
 Aquatic Samples |
382 |
 Soil Samples |
881 |
 Animal Samples |
203 |
 Plant Samples |
54 |
| Total Samples | 1520 |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM15789v2 assembly for Mycobacterium kansasii ATCC 12478 | complete | GCA_000157895   | 557599.62  | 2563366550  | 557599 | 98.81 | |
| 124043 | HU_Myco_2024.1 assembly for Mycobacterium kansasii ATCC 12478 | chromosome | GCA_040687845 | 557599 | 87.98 | | ||
| 66792 | Mycobacterium kansasii ATCC 12478 | contig | 557599.3 | 557599 | 73.2 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 20218 | Mycobacterium kansasii strain ATCC12478 16S ribosomal RNA (rrs) gene, partial sequence | AF059848 | 113 | | 557599 | |
| 20218 | Mycobacterium kansasii 16S ribosomal RNA gene, partial sequence | AF480601 | 1469 |  | 557599 | |
| 20218 | Mycobacterium kansasii 16S ribosomal RNA (16S rRNA) gene and 23S ribosomal RNA (23S rRNA) gene | L42262 | 432 | | 1768 | |
| 20218 | M.kansasii 16S ribosomal RNA | M29575 | 1369 | | 1768 | |
| 20218 | Mycobacterium kansasii strain CIP 104589 16S ribosomal RNA gene, partial sequence | AF547940 | 554 | | 1768 | |
| 20218 | Mycobacterium kansasii DNA for 16S rRNA, internal transcribed spacer, 23S rRNA | AB026695 | 432 | | 1768 | |
| 11560 | Mycobacterium kansasii 16S rRNA gene | AJ536035 | 1470 | | 1768 | |
| 124043 | Mycobacterium kansasii strain CECT 3030 16S ribosomal RNA gene, partial sequence. | OK538981 | 833 | | 1768 | |
| 124043 | Mycobacterium kansasii ATCC 12478 16S ribosomal RNA gene, partial sequence. | KY934282 | 1536 | | 557599 | |
| @ref | GC-content (mol%) | Method | |
|---|---|---|---|
| 67770 | 66.2 | genome sequence analysis |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Critical view on antimicrobial, antibiofilm and cytotoxic activities of quinazolin-4(3H)-one derived schiff bases and their Cu(II) complexes. | Pindjakova D, Mascaretti S, Hricoviniova J, Hosek J, Gregorova J, Kos J, Cizek A, Hricoviniova Z, Jampilek J. | Heliyon | 10.1016/j.heliyon.2024.e29051 | 2024 | | |
| Antimicrobial and ADME properties of methoxylated, methylated and nitrated 2-hydroxynaphthalene-1 carboxanilides. | Vrablova L, Gonec T, Kauerova T, Oravec M, Jendrzejewska I, Kollar P, Cizek A, Jampilek J. | ADMET DMPK | 10.5599/admet.2642 | 2025 | | |
| Alkaloids of Dicranostigma franchetianum (Papaveraceae) and Berberine Derivatives as a New Class of Antimycobacterial Agents. | Wijaya V, Jandourek O, Kroustkova J, Hradiska-Breiterova K, Korabecny J, Sobolova K, Kohelova E, Hostalkova A, Konecna K, Safratova M, Vrabec R, Kunes J, Opletal L, Chlebek J, Cahlikova L. | Biomolecules | 10.3390/biom12060844 | 2022 | | |
| New Unnatural Gallotannins: A Way toward Green Antioxidants, Antimicrobials and Antibiofilm Agents. | Hricoviniova Z, Mascaretti S, Hricoviniova J, Cizek A, Jampilek J. | Antioxidants (Basel) | 10.3390/antiox10081288 | 2021 | | |
| Pathogenicity | Dibasic Derivatives of Phenylcarbamic Acid against Mycobacterial Strains: Old Drugs and New Tricks? | Malik I, Csollei J, Solovic I, Pospisilova S, Michnova H, Jampilek J, Cizek A, Kapustikova I, Curillova J, Pechacova M, Stolarikova J, Pecher D, Oravec M. | Molecules | 10.3390/molecules23102493 | 2018 | |
| Pathogenicity | Bioactivity of Methoxylated and Methylated 1-Hydroxynaphthalene-2-Carboxanilides: Comparative Molecular Surface Analysis. | Michnova H, Pospisilova S, Gonec T, Kapustikova I, Kollar P, Kozik V, Musiol R, Jendrzejewska I, Vanco J, Travnicek Z, Cizek A, Bak A, Jampilek J. | Molecules | 10.3390/molecules24162991 | 2019 | |
| Pathogenicity | N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity. | Gonec T, Pospisilova S, Kauerova T, Kos J, Dohanosova J, Oravec M, Kollar P, Coffey A, Liptaj T, Cizek A, Jampilek J. | Molecules | 10.3390/molecules21081068 | 2016 | |
| A novel real-time PCR assay for specific detection and quantification of Mycobacterium avium subsp. paratuberculosis in milk with the inherent possibility of differentiation between viable and dead cells. | Dzieciol M, Volgger P, Khol J, Baumgartner W, Wagner M, Hein I. | BMC Res Notes | 10.1186/1756-0500-3-251 | 2010 | | |
| Novel mass spectrometry-based tool for genotypic identification of mycobacteria. | Lefmann M, Honisch C, Bocker S, Storm N, von Wintzingerode F, Schlotelburg C, Moter A, van den Boom D, Gobel UB. | J Clin Microbiol | 10.1128/jcm.42.1.339-346.2004 | 2004 | | |
| Enzymology | Evaluation of the invader assay with the BACTEC MGIT 960 system for prompt isolation and identification of mycobacterial species from clinical specimens. | Ichimura S, Nagano M, Ito N, Shimojima M, Egashira T, Miyamoto C, Ohkusu K, Ezaki T. | J Clin Microbiol | 10.1128/jcm.02289-06 | 2007 | |
| In vitro assessment of Brazilian red propolis against mycobacteria: antibacterial potency, synergy, inhibition of biofilm formation, and intramacrophage effects. | Martins SB, Teixeira SC, de Souza G, Alhatlani BY, Abdallah EM, Ambrosio SR, Silva TS, Bastos JK, Tanimoto MH, Barbosa BF, Ferro EAV, Martins CHG. | Front Pharmacol | 10.3389/fphar.2025.1630134 | 2025 | | |
| Genetics | Genomic-based genotype and drug susceptibility profile of Mycobacterium kansasii in China. | Wang Y, Ou X, Zhao B, Xia H, Zheng Y, Zhou Y, Xing R, Song Y, Wang S, Zhao Y, Zheng H. | Front Microbiol | 10.3389/fmicb.2025.1573448 | 2025 | |
| Genetics | Phylogeographic Analysis of Mycobacterium kansasii Isolates from Patients with M. kansasii Lung Disease in Industrialized City, Taiwan. | Tobias Cudahy PG, Liu PC, Warren JL, Sobkowiak B, Yang C, Ioerger TR, Wu CY, Lu PL, Wang JY, Chang HH, Huang HL, Cohen T, Lin HH. | Emerg Infect Dis | 10.3201/eid3008.240021 | 2024 | |
| Repurposing beta-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study. | Munoz-Munoz L, Ainsa JA, Ramon-Garcia S. | Antibiotics (Basel) | 10.3390/antibiotics12020335 | 2023 | | |
| Genetics | Phylogenomic and genomic analysis reveals unique and shared genetic signatures of Mycobacterium kansasii complex species. | Machado E, Vasconcellos S, Gomes L, Catanho M, Ramos J, de Carvalho L, Goldenberg T, Redner P, Caldas P, Campos C, Dalcolmo M, Lourenco MC, Lasunskaia E, Mussi V, Spinasse L, Vinhas S, Rigouts L, Cogneau S, de Rijk P, Utpatel C, Kaustova J, van der Laan T, de Neeling H, Rastogi N, Levina K, Kutt M, Mokrousov I, Zhuravlev V, Makhado N, Zolnir-Dovc M, Jankovic V, de Waard J, Sisco MC, van Soolingen D, Niemann S, de Jong BC, Meehan CJ, Suffys P. | Microb Genom | 10.1099/mgen.0.001266 | 2024 | |
| High-Performance Detection of Mycobacterium bovis in Milk Using Recombinase-Aided Amplification-Clustered Regularly Interspaced Short Palindromic Repeat-Cas13a-Lateral Flow Detection. | Wang J, Wang N, Xu L, Zeng X, Cheng J, Zhang X, Zhang Y, Yin D, Gou J, Pan X, Zhu X. | Foods | 10.3390/foods13111601 | 2024 | | |
| Isoniazid pharmacokinetics/pharmacodynamics as monotherapy and in combination regimen in the hollow fiber system model of Mycobacterium kansasii. | Boorgula GD, Singh S, Shankar P, Gumbo T, Heysell SK, Srivastava S. | Tuberculosis (Edinb) | 10.1016/j.tube.2022.102289 | 2023 | | |
| Rifampin Pharmacokinetics/Pharmacodynamics in the Hollow-Fiber Model of Mycobacterium kansasii Infection. | Srivastava S, Boorgula GD, Wang JY, Huang HL, Howe D, Gumbo T, Heysell SK. | Antimicrob Agents Chemother | 10.1128/aac.02320-21 | 2022 | | |
| Detection of Mtb and NTM: preclinical validation of a new asymmetric PCR-binary deoxyribozyme sensor assay. | Neves YCd, Reis AJ, Rodrigues MA, Chimara E, da Silva Lourenco MC, Fountain J, Ramis IB, von Groll A, Gerasimova Y, Rohde KH, Almeida da Silva PE. | Microbiol Spectr | 10.1128/spectrum.03506-23 | 2024 | | |
| Genetics | Comprehensive essentiality analysis of the Mycobacterium kansasii genome by saturation transposon mutagenesis and deep sequencing. | Levendosky K, Janisch N, Quadri LEN. | mBio | 10.1128/mbio.00573-23 | 2023 | |
| Enzymology | Detection of Mycobacterium kansasii using a combination of loop-mediated isothermal amplification (LAMP) and lateral flow biosensors. | Chen C, Lu J, Long B, Rao Z, Gao Y, Wang W, Gao W, Yang J, Zhang S. | Int Microbiol | 10.1007/s10123-020-00143-z | 2021 | |
| Genetics | Pathogenic Determinants of the Mycobacterium kansasii Complex: An Unsuspected Role for Distributive Conjugal Transfer. | Tagini F, Pillonel T, Bertelli C, Jaton K, Greub G. | Microorganisms | 10.3390/microorganisms9020348 | 2021 | |
| Phylogeny | Molecular Characterisation of M. kansasii Isolates by Whole-Genome Sequencing. | Rajendran P, Padmapriyadarsini C, Nagarajan N, Samyuktha R, Govindaraju V, Golla R, Ashokkumar S, Shanmugam S. | Pathogens | 10.3390/pathogens12101249 | 2023 | |
| Genetics | Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity. | Machado E, Vasconcellos SEG, Cerdeira C, Gomes LL, Junqueira R, Carvalho LD, Ramos JP, Redner P, Campos CED, Caldas PCS, Gomes APCS, Goldenberg T, Montes FF, Mello FCQ, Mussi VO, Lasunskaia E, Soolingen DV, Miranda AB, Rigouts L, Jong BC, Meehan CJ, Catanho M, Suffys PN. | Mem Inst Oswaldo Cruz | 10.1590/0074-02760180085 | 2018 | |
| A Novel Inhibitor against the Biofilms of Non-Tuberculous Mycobacteria. | Kaur P, Krishnamurthy RV, Shandil RK, Mohan R, Narayanan S. | Pathogens | 10.3390/pathogens13010040 | 2023 | | |
| Genomic and phenotypic characterization of Mycobacterium tuberculosis' closest-related non-tuberculous mycobacteria. | Sous C, Frigui W, Pawlik A, Sayes F, Ma L, Cokelaer T, Brosch R. | Microbiol Spectr | 10.1128/spectrum.04126-23 | 2024 | | |
| Synthesis, Antibacterial Effects, and Toxicity of Licochalcone C. | Ozanique PR, Helena AL, Menezes RP, Goncalves DS, Santiago MB, Dilarri G, Sardi JCO, Ferreira H, Martins CHG, Regasini LO. | Pharmaceuticals (Basel) | 10.3390/ph17050634 | 2024 | | |
| A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro. | Guo Q, Xu L, Tan F, Zhang Y, Fan J, Wang X, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00889-21 | 2021 | | |
| A comprehensive evaluation of a novel targeted-sequencing workflow for Mycobacterium species identification and anti-tuberculosis drug-resistance detection. | Ou X, Pei S, Li H, Qin Z, Anthony R, Wang J, Song Z, Xing R, Zhang L, Teng C, Xia H, Zhou Y, Song Y, Zheng Y, Wang S, Zhao B, Zhao Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1584237 | 2025 | | |
| Genetics | Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China. | Guo Y, Cao Y, Liu H, Yang J, Wang W, Wang B, Li M, Yu F. | Microbiol Spectr | 10.1128/spectrum.01475-21 | 2022 | |
| In Vitro Activity of the Sudapyridine (WX-081) against Non-Tuberculous Mycobacteria Isolated in Beijing, China. | Zhu R, Shang Y, Chen S, Xiao H, Ren R, Wang F, Xue Y, Li L, Li Y, Chu N, Huang H. | Microbiol Spectr | 10.1128/spectrum.01372-22 | 2022 | | |
| Population genomics provides insights into the evolution and adaptation to humans of the waterborne pathogen Mycobacterium kansasii. | Luo T, Xu P, Zhang Y, Porter JL, Ghanem M, Liu Q, Jiang Y, Li J, Miao Q, Hu B, Howden BP, Fyfe JAM, Globan M, He W, He P, Wang Y, Liu H, Takiff HE, Zhao Y, Chen X, Pan Q, Behr MA, Stinear TP, Gao Q. | Nat Commun | 10.1038/s41467-021-22760-6 | 2021 | | |
| Blocking ADP-ribosylation expands the anti-mycobacterial spectrum of rifamycins. | Ganapathy US, Lan T, Dartois V, Aldrich CC, Dick T. | Microbiol Spectr | 10.1128/spectrum.01900-23 | 2023 | | |
| Investigation of Copaifera genus as a new source of antimycobaterial agents. | Alves JA, Abrao F, da Silva Moraes T, Damasceno JL, Dos Santos Moraes MF, Sola Veneziani RC, Ambrosio SR, Bastos JK, Dantas Miranda ML, Gomes Martins CH. | Future Sci OA | 10.2144/fsoa-2020-0018 | 2020 | | |
| Pathogenicity | Transposon mutagenesis in Mycobacterium kansasii links a small RNA gene to colony morphology and biofilm formation and identifies 9,885 intragenic insertions that do not compromise colony outgrowth. | Budell WC, Germain GA, Janisch N, McKie-Krisberg Z, Jayaprakash AD, Resnick AE, Quadri LEN. | Microbiologyopen | 10.1002/mbo3.988 | 2020 | |
| Berberine and its nanoformulations and extracts: potential strategies and future perspectives against multi-drug resistant bacterial infections. | Yang X, Wang Y, Li L, Tang D, Yan Z, Li M, Jiang J, Bi D. | Front Microbiol | 10.3389/fmicb.2025.1643409 | 2025 | | |
| Phylogeny | Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of Major Mycobacterium Species. | Xiao G, He X, Zhang S, Liu Y, Liang Z, Liu H, Zhang J, Ou M, Cai S, Lai W, Zhang T, Ren L, Zhang G. | J Clin Microbiol | 10.1128/jcm.01368-19 | 2020 | |
| Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii. | Chapagain M, Gumbo T, Heysell SK, Srivastava S. | Antimicrob Agents Chemother | 10.1128/aac.00810-20 | 2020 | | |
| Complete Genome Sequences of Mycobacterium kansasii Strains Isolated from Rhesus Macaques. | Panda A, Nagaraj S, Zhao X, Tettelin H, DeTolla LJ. | Genome Announc | 10.1128/genomea.00187-17 | 2017 | | |
| Antibacterial Activity of Isobavachalcone (IBC) Is Associated with Membrane Disruption. | Assis LR, Theodoro RDS, Costa MBS, Nascentes JAS, Rocha MDD, Bessa MAS, Menezes RP, Dilarri G, Hypolito GB, Santos VRD, Duque C, Ferreira H, Martins CHG, Regasini LO. | Membranes (Basel) | 10.3390/membranes12030269 | 2022 | | |
| In vitro Susceptibility of Nontuberculous Mycobacteria to Tedizolid. | Zhang H, Hua W, Lin S, Zhang Y, Chen X, Wang S, Chen J, Zhang W. | Infect Drug Resist | 10.2147/idr.s362583 | 2022 | | |
| Clinical Evaluation of Nontuberculous Mycobacteria (NTM) Elite Agar, a New Medium for the Isolation of NTM: a Multicenter Study. | Broncano-Lavado A, Barrado L, Lopez-Roa P, Cacho J, Domingo D, Hernandez S, Garcia-Martinez J, Millan MR, Perez-Cecilia E, Ruiz-Serrano MJ, Salso S, Simon M, Tato M, Toro C, Valverde-Canovas JF, Esteban J. | J Clin Microbiol | 10.1128/jcm.00036-23 | 2023 | | |
| Draft Genome Sequences of Mycobacterium kansasii Strains 1010001454, 1010001458, 1010001468, 1010001493, 1010001495, and 1010001469, Isolated from Environmental Sources. | Strapagiel D, Borowka P, Marciniak B, Bakula Z, van Ingen J, Safianowska A, Brzostek A, Dziadek J, Jagielski T. | Genome Announc | 10.1128/genomea.00456-16 | 2016 | | |
| Pathogenicity | In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates. | Kim DH, Jhun BW, Moon SM, Kim SY, Jeon K, Kwon OJ, Huh HJ, Lee NY, Shin SJ, Daley CL, Koh WJ. | Antimicrob Agents Chemother | 10.1128/aac.00665-19 | 2019 | |
| Molecular Identification, and Characterization of Mycobacterium kansasii Strains Isolated from Four Tuberculosis Regional Reference Laboratories in Iran During 2016-2018. | Khosravi AD, Asban B, Hashemzadeh M, Nashibi R. | Infect Drug Resist | 10.2147/idr.s245295 | 2020 | | |
| Nouveau short-course therapy and morphism mapping for clinical pulmonary Mycobacterium kansasii. | Srivastava S, Wang JY, Magombedze G, Chapagain M, Huang HL, Deshpande D, Heysell SK, Pasipanodya JG, Gumbo T. | Antimicrob Agents Chemother | 10.1128/aac.01553-20 | 2023 | | |
| Pathogenicity | Clofazimine for the Treatment of Mycobacterium kansasii. | Srivastava S, Gumbo T. | Antimicrob Agents Chemother | 10.1128/aac.00248-18 | 2018 | |
| Transcriptome | Genetic Underpinnings of Carotenogenesis and Light-Induced Transcriptome Remodeling in the Opportunistic Pathogen Mycobacterium kansasii. | Janisch N, Levendosky K, Budell WC, Quadri LEN. | Pathogens | 10.3390/pathogens12010086 | 2023 | |
| Insights on the Emergence of Mycobacterium tuberculosis from the Analysis of Mycobacterium kansasii | Wang F, McIntosh F, Radomski N, Dewar K, Simeone R, Enninga J, Brosch R, Rocha EP, Veyrier FJ, Behr MA. | Genome biology and evolution. | 2015 | | ||
| Pathogenicity | Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii. | Bakula Z, Modrzejewska M, Pennings L, Proboszcz M, Safianowska A, Bielecki J, van Ingen J, Jagielski T. | Antimicrob Agents Chemother | 10.1128/aac.01788-17 | 2018 | |
| Draft Genome Sequence of Mycobacterium interjectum Strain ATCC 51457T. | Levasseur A, Asmar S, Robert C, Drancourt M. | Genome Announc | 10.1128/genomea.00452-16 | 2016 | | |
| Draft Genome Sequence of Mycobacterium arupense Strain GUC1. | Greninger AL, Cunningham G, Yu JM, Hsu ED, Chiu CY, Miller S. | Genome Announc | 10.1128/genomea.00630-15 | 2015 | | |
| Draft Genome Sequence of Mycobacterium bohemicum Strain DSM 44277T. | Asmar S, Phelippeau M, Robert C, Croce O, Drancourt M. | Genome Announc | 10.1128/genomea.00878-15 | 2015 | | |
| Dynamics of Immune Responses during Experimental Mycobacterium kansasii Infection of Cynomolgus Monkeys (Macaca fascicularis). | Min F, He L, Luo Y, Huang S, Pan J, Wang J, Wu R, Zhang L, Chen M. | Mediators Inflamm | 10.1155/2018/8354902 | 2018 | | |
| Pathogenicity | Impact of Methylthioxylose Substituents on the Biological Activities of Lipomannan and Lipoarabinomannan in Mycobacterium tuberculosis. | Palcekova Z, De K, Angala SK, Gilleron M, Zuberogoitia S, Gouxette L, Soto-Ojeda M, Gonzalez-Juarrero M, Obregon-Henao A, Nigou J, Wheat WH, Jackson M. | ACS Infect Dis | 10.1021/acsinfecdis.4c00079 | 2024 | |
| Heterologous Production of 1-Tuberculosinyladenosine in Mycobacterium kansasii Models Pathoevolution towards the Transcellular Lifestyle of Mycobacterium tuberculosis. | Ghanem M, Dube JY, Wang J, McIntosh F, Houle D, Domenech P, Reed MB, Raman S, Buter J, Minnaard AJ, Moody DB, Behr MA. | mBio | 10.1128/mbio.02645-20 | 2020 | | |
| Clinical Validation of the Xpert MTB/RIF Test for Identification of the Mycobacterium tuberculosis Complex in Acid-Fast Bacillus Smear-Positive MGIT Broth Cultures. | Armstrong DT, Fisher S, Totten M, Schwartz M, Gnanashanmugam D, Parrish N. | J Clin Microbiol | 10.1128/jcm.02164-21 | 2022 | | |
| Phylogeny | Does Choice Matter? Reference-Based Alignment for Molecular Epidemiology of Tuberculosis. | Lee RS, Behr MA. | J Clin Microbiol | 10.1128/jcm.00364-16 | 2016 | |
| Nosiheptide Harbors Potent In Vitro and Intracellular Inhbitory Activities against Mycobacterium tuberculosis. | Yu X, Zhu R, Geng Z, Kong Y, Wang F, Dong L, Zhao L, Xue Y, Ma X, Huang H. | Microbiol Spectr | 10.1128/spectrum.01444-22 | 2022 | | |
| Antimycobacterial activity of ellagitannin and ellagic acid derivate rich crude extracts and fractions of five selected species of Terminalia used for treatment of infectious diseases in African traditional medicine | Fyhrquist P, Laakso I, Garcia Marco S, Julkunen-Tiitto R, Hiltunen R. | S Afr J Bot | 10.1016/j.sajb.2013.08.018 | 2014 | | |
| Identification of nontuberculous mycobacteria species by multiplex real-time PCR with high-resolution melting. | Peixoto ADS, Montenegro LML, Lima AS, Melo FL, Barbosa Junior WL, Neves MMC, Ramos JP, Schindler HC, Medeiros ZM. | Rev Soc Bras Med Trop | 10.1590/0037-8682-0211-2020 | 2020 | | |
| Pathogenicity | In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China. | Luo J, Yu X, Jiang G, Fu Y, Huo F, Ma Y, Wang F, Shang Y, Liang Q, Xue Y, Huang H. | Antimicrob Agents Chemother | 10.1128/aac.00072-18 | 2018 | |
| Genetics | A genome-wide association study identified PRKCB as a causal gene and therapeutic target for Mycobacterium avium complex disease. | Zheng R, Li Z, Fang W, Lou H, Liu F, Sun Q, Shi X, Liu H, Chen Q, Shen X, Yao L, Guan L, Chen J, Xie Y, Yang Y, Yang H, Wang L, Qin L, Huang X, Wang J, Liu Z, Liu H, Ge B, Xu J, Sha W. | Cell Rep Med | 10.1016/j.xcrm.2024.101923 | 2025 | |
| Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase. | Slechta P, Needle AA, Jand'ourek O, Paterova P, Konecna K, Barta P, Kunes J, Kubicek V, Dolezal M, Kucerova-Chlupacova M. | Int J Mol Sci | 10.3390/ijms24032951 | 2023 | | |
| Pathogenicity | Rapid drug tolerance and dramatic sterilizing effect of moxifloxacin monotherapy in a novel hollow-fiber model of intracellular Mycobacterium kansasii disease. | Srivastava S, Pasipanodya J, Sherman CM, Meek C, Leff R, Gumbo T. | Antimicrob Agents Chemother | 10.1128/aac.04441-14 | 2015 | |
| Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria. | Munoz-Munoz L, Shoen C, Sweet G, Vitoria A, Bull TJ, Cynamon M, Thompson CJ, Ramon-Garcia S. | Antibiotics (Basel) | 10.3390/antibiotics10040381 | 2021 | | |
| The PE/PPE family proteins of Mycobacterium tuberculosis: evolution, function, and prospects for tuberculosis control. | Zhang Z, Dong L, Li X, Deng T, Wang Q. | Front Immunol | 10.3389/fimmu.2025.1606311 | 2025 | | |
| Bioactive Compounds from an Endophytic Pezicula sp. Showing Antagonistic Effects against the Ash Dieback Pathogen | Demir O, Zeng H, Schulz B, Schrey H, Steinert M, Stadler M, Surup F. | Biomolecules | 2023 | | ||
| Discovery of benzo[c]phenanthridine derivatives with potent activity against multidrug-resistant Mycobacterium tuberculosis. | Liang YC, Sun Z, Lu C, Lupien A, Xu Z, Berton S, Xu P, Behr MA, Yang W, Sun J. | Microbiol Spectr | 10.1128/spectrum.01246-24 | 2024 | | |
| Pathogenicity | Evolution and emergence of Mycobacterium tuberculosis. | Orgeur M, Sous C, Madacki J, Brosch R. | FEMS Microbiol Rev | 10.1093/femsre/fuae006 | 2024 | |
| Pathogenicity | In Vitro Activities of Bedaquiline and Delamanid against Nontuberculous Mycobacteria Isolated in Beijing, China. | Yu X, Gao X, Li C, Luo J, Wen S, Zhang T, Ma Y, Dong L, Wang F, Huang H. | Antimicrob Agents Chemother | 10.1128/aac.00031-19 | 2019 | |
| Pathogenicity | Antimycobacterial activity of natural and semi-synthetic lignans. | Silva ML, Martins CH, Lucarini R, Sato DN, Pavanb FR, Freitas NH, Andrade LN, Pereira AC, Bianco TN, Vinholis AH, Cunha WR, Bastos JK, Silva R, Da Silva Filho AA. | Z Naturforsch C J Biosci | 10.1515/znc-2009-11-1204 | 2009 | |
| Enzymology | Dual color fluorescence in situ hybridization (FISH) assays for detecting Mycobacterium tuberculosis and Mycobacterium avium complexes and related pathogens in cultures. | Shah J, Weltman H, Narciso P, Murphy C, Poruri A, Baliga S, Sharon L, York M, Cunningham G, Miller S, Caviedes L, Gilman R, Desmond E, Ramasamy R. | PLoS One | 10.1371/journal.pone.0174989 | 2017 | |
| Isoniazid and rifampin drug susceptibility testing: application of 2,3,5-triphenyl tetrazolium chloride assay and microscopic-observation drug-susceptibility assay directly on Ziehl-Neelsen smear positive sputum specimens. | Shinu P, Singh V, Nair A. | Braz J Infect Dis | 10.1016/j.bjid.2015.09.006 | 2016 | | |
| Simplicilones A and B Isolated from the Endophytic Fungus Simplicillium subtropicum SPC3. | Anoumedem EGM, Mountessou BYG, Kouam SF, Narmani A, Surup F. | Antibiotics (Basel) | 10.3390/antibiotics9110753 | 2020 | | |
| Pathogenicity | Evaluation of mycobactericidal activity of selected chemical disinfectants and antiseptics according to European standards. | Bocian E, Grzybowska W, Tyski S. | Med Sci Monit | 10.12659/msm.890175 | 2014 | |
| Exploring the Antibiotic Production Potential of Heterotrophic Bacterial Communities Isolated from the Marine Sponges Crateromorpha meyeri, Pseudaxinella reticulata, Farrea similaris, and Caulophacus arcticus through Synergistic Metabolomic and Genomic Analyses. | Tareen S, Schupp PJ, Iqbal N, Wink J. | Mar Drugs | 10.3390/md20070463 | 2022 | | |
| Molecular analysis of Mycobacterium kansasii isolates from the United States. | Zhang Y, Mann LB, Wilson RW, Brown-Elliott BA, Vincent V, Iinuma Y, Wallace RJ. | J Clin Microbiol | 10.1128/jcm.42.1.119-125.2004 | 2004 | | |
| Phylogeny | Shared Pathogenomic Patterns Characterize a New Phylotype, Revealing Transition toward Host-Adaptation Long before Speciation of Mycobacterium tuberculosis. | Sapriel G, Brosch R. | Genome Biol Evol | 10.1093/gbe/evz162 | 2019 | |
| Enzymology | Development of a One-Step Multiplex PCR Assay for Differential Detection of Major Mycobacterium Species. | Chae H, Han SJ, Kim SY, Ki CS, Huh HJ, Yong D, Koh WJ, Shin SJ. | J Clin Microbiol | 10.1128/jcm.00549-17 | 2017 | |
| Interaction of Mycobacteria With Host Cell Inflammasomes. | Rastogi S, Briken V. | Front Immunol | 10.3389/fimmu.2022.791136 | 2022 | | |
| Identification of covalent inhibitors that disrupt M. tuberculosis growth by targeting multiple serine hydrolases involved in lipid metabolism. | Babin BM, Keller LJ, Pinto Y, Li VL, Eneim AS, Vance SE, Terrell SM, Bhatt AS, Long JZ, Bogyo M. | Cell Chem Biol | 10.1016/j.chembiol.2021.08.013 | 2022 | | |
| Enzymology | 16S-23S Internal Transcribed Spacer Region PCR and Sequencer-Based Capillary Gel Electrophoresis has Potential as an Alternative to High Performance Liquid Chromatography for Identification of Slowly Growing Nontuberculous Mycobacteria. | Subedi S, Kong F, Jelfs P, Gray TJ, Xiao M, Sintchenko V, Chen SC. | PLoS One | 10.1371/journal.pone.0164138 | 2016 | |
| Metabolism | Comprehensive Comparative Analysis of Cholesterol Catabolic Genes/Proteins in Mycobacterial Species. | van Wyk R, van Wyk M, Mashele SS, Nelson DR, Syed K. | Int J Mol Sci | 10.3390/ijms20051032 | 2019 | |
| Pathogenicity | Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible? | Ho II, Chan CY, Cheng AF. | Antimicrob Agents Chemother | 10.1128/aac.44.1.39-42.2000 | 2000 | |
| 5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation. | Ambrozkiewicz W, Kucerova-Chlupacova M, Jandourek O, Konecna K, Paterova P, Barta P, Vinsova J, Dolezal M, Zitko J. | Molecules | 10.3390/molecules25071561 | 2020 | | |
| Development of 2nd generation aminomethyl spectinomycins that overcome native efflux in Mycobacterium abscessus. | Phelps GA, Cheramie MN, Fernando DM, Selchow P, Meyer CJ, Waidyarachchi SL, Dharuman S, Liu J, Meuli M, Molin MD, Killam BY, Murphy PA, Reeve SM, Wilt LA, Anderson SM, Yang L, Lee RB, Temrikar ZH, Lukka PB, Meibohm B, Polikanov YS, Hobbie SN, Bottger EC, Sander P, Lee RE. | Proc Natl Acad Sci U S A | 10.1073/pnas.2314101120 | 2024 | | |
| The mycobacterial LysR-type regulator OxyS responds to oxidative stress and negatively regulates expression of the catalase-peroxidase gene. | Li Y, He ZG. | PLoS One | 10.1371/journal.pone.0030186 | 2012 | | |
| Disparate host immunity to Mycobacterium avium subsp. paratuberculosis antigens in calves inoculated with M. avium subsp. paratuberculosis, M. avium subsp. avium, M. kansasii, and M. bovis. | Stabel JR, Waters WR, Bannantine JP, Palmer MV. | Clin Vaccine Immunol | 10.1128/cvi.00051-13 | 2013 | | |
| Phylogeny | Identification of Mycobacterium species by comparative analysis of the dnaA gene. | Mukai T, Miyamoto Y, Yamazaki T, Makino M. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2005.00031.x | 2006 | |
| Phylogeny | In vitro antimicrobial activities of capuramycin analogues against non-tuberculous mycobacteria. | Dubuisson T, Bogatcheva E, Krishnan MY, Collins MT, Einck L, Nacy CA, Reddy VM. | J Antimicrob Chemother | 10.1093/jac/dkq372 | 2010 | |
| Gran1: A Granulysin-Derived Peptide with Potent Activity against Intracellular Mycobacterium tuberculosis. | Noschka R, Wondany F, Kizilsavas G, Weil T, Weidinger G, Walther P, Michaelis J, Stenger S. | Int J Mol Sci | 10.3390/ijms22168392 | 2021 | | |
| Pathogenicity | Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors. | Bouz G, Juhas M, Niklova P, Jandourek O, Paterova P, Janousek J, Tumova L, Kovalikova Z, Kastner P, Dolezal M, Zitko J. | Molecules | 10.3390/molecules22101797 | 2017 | |
| Enzymology | Long-Term Storage at -80°C: Effect on Rate of Recovery of Mycobacterium tuberculosis From Direct Acid-Fast Bacilli Smear-Positive Sputum Samples. | Shinu P, AshokKumar Singh V, Nair A, Farooq R, Ishaq S. | J Clin Lab Anal | 10.1002/jcla.21904 | 2016 | |
| Enzymology | Direct detection of Mycobacterium tuberculosis complex in bovine and bubaline tissues through nested-PCR. | Araujo CP, Osorio AL, Jorge KS, Ramos CA, Souza Filho AF, Vidal CE, Vargas AP, Roxo E, Rocha AS, Suffys PN, Fonseca AA, Silva MR, Barbosa Neto JD, Cerqueira VD, Araujo FR. | Braz J Microbiol | 10.1590/s1517-83822014000200035 | 2014 | |
| Phylogeny | Comparison of DNA pyrosequencing with alternative methods for identification of mycobacteria. | Heller LC, Jones M, Widen RH. | J Clin Microbiol | 10.1128/jcm.02001-07 | 2008 | |
| Pathogenicity | Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii. | Alcaide F, Calatayud L, Santin M, Martin R. | Antimicrob Agents Chemother | 10.1128/aac.48.12.4562-4565.2004 | 2004 | |
| Metabolism | Functional characterisation of three o-methyltransferases involved in the biosynthesis of phenolglycolipids in Mycobacterium tuberculosis. | Simeone R, Huet G, Constant P, Malaga W, Lemassu A, Laval F, Daffe M, Guilhot C, Chalut C. | PLoS One | 10.1371/journal.pone.0058954 | 2013 | |
| Phylogeny | Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. | Alcaide F, Richter I, Bernasconi C, Springer B, Hagenau C, Schulze-Robbecke R, Tortoli E, Martin R, Bottger EC, Telenti A. | J Clin Microbiol | 10.1128/jcm.35.8.1959-1964.1997 | 1997 | |
| Detection of Mixed Populations of Clarithromycin-Susceptible and -Resistant Mycobacterium abscessus Strains. | Shallom SJ, Zelazny AM. | J Clin Microbiol | 10.1128/jcm.01694-21 | 2022 | | |
| Metabolism | Genome-guided and mass spectrometry investigation of natural products produced by a potential new actinobacterial strain isolated from a mangrove ecosystem in Futian, Shenzhen, China. | Hu D, Gao C, Sun C, Jin T, Fan G, Mok KM, Lee SM. | Sci Rep | 10.1038/s41598-018-37475-w | 2019 | |
| Synthesis and In Vitro Antimycobacterial Activity of Novel N-Arylpiperazines Containing an Ethane-1,2-diyl Connecting Chain. | Gonec T, Malik I, Csollei J, Jampilek J, Stolarikova J, Solovic I, Mikus P, Keltosova S, Kollar P, O'Mahony J, Coffey A. | Molecules | 10.3390/molecules22122100 | 2017 | | |
| Identification of Mycobacterium kansasii by using a DNA probe (AccuProbe) and molecular techniques. | Richter E, Niemann S, Rusch-Gerdes S, Hoffner S. | J Clin Microbiol | 10.1128/jcm.37.4.964-970.1999 | 1999 | | |
| Preclinical Models of Nontuberculous Mycobacteria Infection for Early Drug Discovery and Vaccine Research. | Rampacci E, Stefanetti V, Passamonti F, Henao-Tamayo M. | Pathogens | 10.3390/pathogens9080641 | 2020 | | |
| Metabolism | Horizontal acquisition of a hypoxia-responsive molybdenum cofactor biosynthesis pathway contributed to Mycobacterium tuberculosis pathoadaptation. | Levillain F, Poquet Y, Mallet L, Mazeres S, Marceau M, Brosch R, Bange FC, Supply P, Magalon A, Neyrolles O. | PLoS Pathog | 10.1371/journal.ppat.1006752 | 2017 | |
| Comparative Study of Eis-like Enzymes from Pathogenic and Nonpathogenic Bacteria. | Green KD, Pricer RE, Stewart MN, Garneau-Tsodikova S. | ACS Infect Dis | 10.1021/acsinfecdis.5b00036 | 2015 | | |
| Metabolism | Mycobacterium tuberculosis Rv0899 defines a family of membrane proteins widespread in nitrogen-fixing bacteria. | Marassi FM. | Proteins | 10.1002/prot.23151 | 2011 | |
| Antimycobacterial activity of a Brevibacillus laterosporusstrain isolated from a moroccan soil. | Hassi M, Guendouzi SE, Haggoud A, David S, Ibnsouda S, Houari A, Iraqui M. | Braz J Microbiol | 10.1590/s1517-838220120004000036 | 2012 | | |
| Detection of Mycobacterium bovis in bovine and bubaline tissues using nested-PCR for TbD1. | Araujo CP, Osorio AL, Jorge KS, Ramos CA, Filho AF, Vidal CE, Roxo E, Nishibe C, Almeida NF, Junior AA, Silva MR, Neto JD, Cerqueira VD, Zumarraga MJ, Araujo FR. | PLoS One | 10.1371/journal.pone.0091023 | 2014 | | |
| Pathogenicity | In Vitro Evaluation of Povidone-Iodine and Chlorhexidine against Outbreak and Nonoutbreak Strains of Mycobacterium abscessus Using Standard Quantitative Suspension and Carrier Testing. | Cheng A, Sun HY, Tsai YT, Wu UI, Chuang YC, Wang JT, Sheng WH, Hsueh PR, Chen YC, Chang SC. | Antimicrob Agents Chemother | 10.1128/aac.01364-17 | 2018 | |
| Enzymology | Evaluation of a modified single-enzyme amplified-fragment length polymorphism technique for fingerprinting and differentiating of Mycobacterium kansasii type I isolates. | Gaafar A, Unzaga MJ, Cisterna R, Clavo FE, Urra E, Ayarza R, Martin G. | J Clin Microbiol | 10.1128/jcm.41.8.3846-3850.2003 | 2003 | |
| Cultivation | Effect of PANTA on growth of Mycobacterium kansasii in BACTEC 12B medium. | Conville PS, Andrews JW, Witebsky FG. | J Clin Microbiol | 10.1128/jcm.33.8.2012-2015.1995 | 1995 | |
| Metabolism | Advances in Research on Bioactivity, Toxicity, Metabolism, and Pharmacokinetics of Usnic Acid In Vitro and In Vivo. | Wang H, Xuan M, Huang C, Wang C. | Molecules | 10.3390/molecules27217469 | 2022 | |
| Rapid PCR Detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum. | Cunningham SA, Mandrekar JN, Rosenblatt JE, Patel R. | Int J Bacteriol | 10.1155/2013/168742 | 2013 | | |
| Enzymology | Usefulness of a new mycobacteriophage-based technique for rapid diagnosis of pulmonary tuberculosis. | Alcaide F, Gali N, Dominguez J, Berlanga P, Blanco S, Orus P, Martin R. | J Clin Microbiol | 10.1128/jcm.41.7.2867-2871.2003 | 2003 | |
| Specificity of a Mycobacterium kansasii phenolic glycolipid (mycoside A) immunoserum. | Papa F, Riviere M, Fournie JJ, Puzo G, David H. | J Clin Microbiol | 10.1128/jcm.25.12.2270-2273.1987 | 1987 | | |
| Metabolism | Multiplicity of 3-Ketosteroid-9alpha-Hydroxylase enzymes in Rhodococcus rhodochrous DSM43269 for specific degradation of different classes of steroids. | Petrusma M, Hessels G, Dijkhuizen L, van der Geize R. | J Bacteriol | 10.1128/jb.00274-11 | 2011 | |
| Metabolism | Mycobacterium tuberculosis releases an antacid that remodels phagosomes. | Buter J, Cheng TY, Ghanem M, Grootemaat AE, Raman S, Feng X, Plantijn AR, Ennis T, Wang J, Cotton RN, Layre E, Ramnarine AK, Mayfield JA, Young DC, Jezek Martinot A, Siddiqi N, Wakabayashi S, Botella H, Calderon R, Murray M, Ehrt S, Snider BB, Reed MB, Oldfield E, Tan S, Rubin EJ, Behr MA, van der Wel NN, Minnaard AJ, Moody DB. | Nat Chem Biol | 10.1038/s41589-019-0336-0 | 2019 | |
| Pathogenicity | A quantitative test method for the examination of antimycobacterial disinfection procedures. | Hingst V, Wurster C, Sonntag HG. | Zentralbl Hyg Umweltmed | 1990 | | |
| The Use of High Performance Liquid Chromatography to Speciate and Characterize the Epidemiology of Mycobacteria. | Jeong J, Kim SR, Lee SH, Lim JH, Choi JI, Park JS, Chang CL, Choi JY, Richman DD, Smith DM. | Lab Med | 10.1309/lmddehpsye6zdm3c | 2011 | | |
| Metabolism | Identification of phthiodiolone ketoreductase, an enzyme required for production of mycobacterial diacyl phthiocerol virulence factors. | Onwueme KC, Vos CJ, Zurita J, Soll CE, Quadri LE. | J Bacteriol | 10.1128/jb.187.14.4760-4766.2005 | 2005 | |
| Metabolism | Structural Variability of EspG Chaperones from Mycobacterial ESX-1, ESX-3, and ESX-5 Type VII Secretion Systems. | Tuukkanen AT, Freire D, Chan S, Arbing MA, Reed RW, Evans TJ, Zenkeviciute G, Kim J, Kahng S, Sawaya MR, Chaton CT, Wilmanns M, Eisenberg D, Parret AHA, Korotkov KV. | J Mol Biol | 10.1016/j.jmb.2018.11.003 | 2019 | |
| Derivatives of 3-Aminopyrazine-2-carboxamides: Synthesis, Antimicrobial Evaluation, and in Vitro Cytotoxicity. | Bouz G, Semelkova L, Jandourek O, Konecna K, Paterova P, Navratilova L, Kubicek V, Kunes J, Dolezal M, Zitko J. | Molecules | 10.3390/molecules24071212 | 2019 | | |
| Purification and characterization of C28-55 fatty acids from Mycobacterium smegmatis. | Sathyamoorthy N, Qureshi N, Takayama K. | Can J Microbiol | 10.1139/m85-041 | 1985 | | |
| Pathogenicity | Synthesis and antimycobacterial and photosynthesis-inhibiting evaluation of 2-[(E)-2-substituted-ethenyl]-1,3-benzoxazoles. | Imramovsky A, Kozic J, Pesko M, Stolarikova J, Vinsova J, Kralova K, Jampilek J. | ScientificWorldJournal | 10.1155/2014/705973 | 2014 | |
| Phylogeny | Rapid identification of mycobacteria to species level by PCR-restriction fragment length polymorphism analysis of the hsp65 gene and proposition of an algorithm to differentiate 34 mycobacterial species. | Devallois A, Goh KS, Rastogi N. | J Clin Microbiol | 10.1128/jcm.35.11.2969-2973.1997 | 1997 | |
| Microbial community functional structures in wastewater treatment plants as characterized by GeoChip. | Wang X, Xia Y, Wen X, Yang Y, Zhou J. | PLoS One | 10.1371/journal.pone.0093422 | 2014 | | |
| Identification of a novel conjugative plasmid in mycobacteria that requires both type IV and type VII secretion. | Ummels R, Abdallah AM, Kuiper V, Aajoud A, Sparrius M, Naeem R, Spaink HP, van Soolingen D, Pain A, Bitter W. | mBio | 10.1128/mbio.01744-14 | 2014 | | |
| Pathogenicity | Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase. | Palencia A, Li X, Bu W, Choi W, Ding CZ, Easom EE, Feng L, Hernandez V, Houston P, Liu L, Meewan M, Mohan M, Rock FL, Sexton H, Zhang S, Zhou Y, Wan B, Wang Y, Franzblau SG, Woolhiser L, Gruppo V, Lenaerts AJ, O'Malley T, Parish T, Cooper CB, Waters MG, Ma Z, Ioerger TR, Sacchettini JC, Rullas J, Angulo-Barturen I, Perez-Herran E, Mendoza A, Barros D, Cusack S, Plattner JJ, Alley MR. | Antimicrob Agents Chemother | 10.1128/aac.01339-16 | 2016 | |
| False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections. | Jorgensen JH, Salinas JR, Paxson R, Magnon K, Patterson JE, Patterson TF. | J Clin Microbiol | 10.1128/jcm.37.1.175-178.1999 | 1999 | | |
| Pathogenicity | Interaction between 30 S ribosomal components in a viomycin resistant mutant of Mycobacterium smegmatis. | Mizuguchi Y, Suga K, Yamada T. | Microbiol Immunol | 10.1111/j.1348-0421.1979.tb00500.x | 1979 | |
| Enzymology | Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens. | Lin SY, Rodwell TC, Victor TC, Rider EC, Pham L, Catanzaro A, Desmond EP. | J Clin Microbiol | 10.1128/jcm.01821-13 | 2014 | |
| Redox homeostasis in Mycobacterium tuberculosis is modulated by a novel actinomycete-specific transcription factor. | Khan MZ, Singha B, Ali MF, Taunk K, Rapole S, Gourinath S, Nandicoori VK. | EMBO J | 10.15252/embj.2020106111 | 2021 | | |
| Pathogenicity | The non-pathogenic mycobacteria M. smegmatis and M. fortuitum induce rapid host cell apoptosis via a caspase-3 and TNF dependent pathway. | Bohsali A, Abdalla H, Velmurugan K, Briken V. | BMC Microbiol | 10.1186/1471-2180-10-237 | 2010 | |
| Phylogeny | Characterization of a trinucleotide repeat sequence (CGG)5 and potential use in restriction fragment length polymorphism typing of Mycobacterium tuberculosis. | Otsuka Y, Parniewski P, Zwolska Z, Kai M, Fujino T, Kirikae F, Toyota E, Kudo K, Kuratsuji T, Kirikae T. | J Clin Microbiol | 10.1128/jcm.42.8.3538-3548.2004 | 2004 | |
| Phylogeny | Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). | Kim BJ, Lee SH, Lyu MA, Kim SJ, Bai GH, Chae GT, Kim EC, Cha CY, Kook YH. | J Clin Microbiol | 10.1128/jcm.37.6.1714-1720.1999 | 1999 | |
| Phylogeny | Mycobacterial Pan-Genome Analysis Suggests Important Role of Plasmids in the Radiation of Type VII Secretion Systems. | Dumas E, Christina Boritsch E, Vandenbogaert M, Rodriguez de la Vega RC, Thiberge JM, Caro V, Gaillard JL, Heym B, Girard-Misguich F, Brosch R, Sapriel G. | Genome Biol Evol | 10.1093/gbe/evw001 | 2016 | |
| Metabolism | Biochemical and structural analysis of aminoglycoside acetyltransferase Eis from Anabaena variabilis. | Pricer RE, Houghton JL, Green KD, Mayhoub AS, Garneau-Tsodikova S. | Mol Biosyst | 10.1039/c2mb25341k | 2012 | |
| Pathogenicity | Effect of a bacteriocin produced by Mycobacterium smegmatis on growth of cultured tumor and normal cells. | Saito H, Watanabe T. | Cancer Res | 1979 | | |
| Phylogeny | Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum. | Zhu L, Jiang G, Wang S, Wang C, Li Q, Yu H, Zhou Y, Zhao B, Huang H, Xing W, Mitchelson K, Cheng J, Zhao Y, Guo Y. | J Clin Microbiol | 10.1128/jcm.00158-10 | 2010 | |
| Enzymology | Mycobacterium smegmatis has two pyrazinamidase enzymes, PncA and pzaA. | Guo M, Sun Z, Zhang Y. | J Bacteriol | 10.1128/jb.182.13.3881-3884.2000 | 2000 | |
| Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. | Ortalo-Magne A, Lemassu A, Laneelle MA, Bardou F, Silve G, Gounon P, Marchal G, Daffe M. | J Bacteriol | 10.1128/jb.178.2.456-461.1996 | 1996 | | |
| Pathogenicity | The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo. | Gao W, Kim JY, Anderson JR, Akopian T, Hong S, Jin YY, Kandror O, Kim JW, Lee IA, Lee SY, McAlpine JB, Mulugeta S, Sunoqrot S, Wang Y, Yang SH, Yoon TM, Goldberg AL, Pauli GF, Suh JW, Franzblau SG, Cho S. | Antimicrob Agents Chemother | 10.1128/aac.04054-14 | 2015 | |
| Enzymology | Cloning and expression of the gene for the cross-reactive alpha antigen of Mycobacterium kansasii. | Matsuo K, Yamaguchi R, Yamazaki A, Tasaka H, Terasaka K, Yamada T. | Infect Immun | 10.1128/iai.58.2.550-556.1990 | 1990 | |
| Characterization of a specific Mycobacterium paratuberculosis recombinant clone expressing 35,000-molecular-weight antigen and reactivity with sera from animals with clinical and subclinical Johne's disease. | El-Zaatari FA, Naser SA, Graham DY. | J Clin Microbiol | 10.1128/jcm.35.7.1794-1799.1997 | 1997 | | |
| Evolution of the mycobacterial SigK regulon. | Veyrier F, Said-Salim B, Behr MA. | J Bacteriol | 10.1128/jb.01452-07 | 2008 | | |
| Phylogeny | Differentiation of mycobacterial species by PCR-restriction analysis of DNA (342 base pairs) of the RNA polymerase gene (rpoB). | Kim BJ, Lee KH, Park BN, Kim SJ, Bai GH, Kim SJ, Kook YH. | J Clin Microbiol | 10.1128/jcm.39.6.2102-2109.2001 | 2001 | |
| Phylogeny | Differentiation of phylogenetically related slowly growing mycobacteria by their gyrB sequences. | Kasai H, Ezaki T, Harayama S. | J Clin Microbiol | 10.1128/jcm.38.1.301-308.2000 | 2000 | |
| Enzymology | Identification of Mycobacterium spp. of veterinary importance using rpoB gene sequencing. | Higgins J, Camp P, Farrell D, Bravo D, Pate M, Robbe-Austerman S. | BMC Vet Res | 10.1186/1746-6148-7-77 | 2011 | |
| Pathogenicity | In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis. | Parrish NM, Houston T, Jones PB, Townsend C, Dick JD. | Antimicrob Agents Chemother | 10.1128/aac.45.4.1143-1150.2001 | 2001 | |
| MAP1272c encodes an NlpC/P60 protein, an antigen detected in cattle with Johne's disease. | Bannantine JP, Lingle CK, Stabel JR, Ramyar KX, Garcia BL, Raeber AJ, Schacher P, Kapur V, Geisbrecht BV. | Clin Vaccine Immunol | 10.1128/cvi.00195-12 | 2012 | | |
| Enzymology | In vitro comparison of NALC-NaOH, tween 80, and C18-carboxypropylbetaine for processing of specimens for recovery of mycobacteria. | Thornton CG, MacLellan KM, Brink TL, Passen S. | J Clin Microbiol | 10.1128/jcm.36.12.3558-3566.1998 | 1998 | |
| Mycobacterial biomaterials and resources for researchers. | Hazbon MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, Ohkuma M, Kiss K, Wu L, Ma J, Hamada M, Strong M, Salfinger M, Daley CL, Nick JA, Lee JS, Rastogi N, Couvin D, Hurtado-Ortiz R, Bizet C, Suresh A, Rodwell T, Albertini A, Lacourciere KA, Deheer-Graham A, Alexander S, Russell JE, Bradford R, Riojas MA. | Pathog Dis | 10.1093/femspd/fty042 | 2018 | | |
| Pathogenicity | Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. | Ardito F, Posteraro B, Sanguinetti M, Zanetti S, Fadda G. | J Clin Microbiol | 10.1128/jcm.39.12.4440-4444.2001 | 2001 | |
| Metabolism | Independent evolutionary origins of functional polyamine biosynthetic enzyme fusions catalysing de novo diamine to triamine formation. | Green R, Hanfrey CC, Elliott KA, McCloskey DE, Wang X, Kanugula S, Pegg AE, Michael AJ. | Mol Microbiol | 10.1111/j.1365-2958.2011.07757.x | 2011 | |
| Enzymology | Performance characteristics of the BDProbeTec system for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. | Pfyffer GE, Funke-Kissling P, Rundler E, Weber R. | J Clin Microbiol | 10.1128/jcm.37.1.137-140.1999 | 1999 | |
| Metabolism | Toxin-antitoxin systems of Mycobacterium smegmatis are essential for cell survival. | Frampton R, Aggio RB, Villas-Boas SG, Arcus VL, Cook GM. | J Biol Chem | 10.1074/jbc.m111.286856 | 2012 | |
| Pathogenicity | Multitarget drug discovery for tuberculosis and other infectious diseases. | Li K, Schurig-Briccio LA, Feng X, Upadhyay A, Pujari V, Lechartier B, Fontes FL, Yang H, Rao G, Zhu W, Gulati A, No JH, Cintra G, Bogue S, Liu YL, Molohon K, Orlean P, Mitchell DA, Freitas-Junior L, Ren F, Sun H, Jiang T, Li Y, Guo RT, Cole ST, Gennis RB, Crick DC, Oldfield E. | J Med Chem | 10.1021/jm500131s | 2014 | |
| In vitro cellular immune response to homologous and heterologous antigens in rabbits sensitized by five species of Mycobacterium and Nocardia asteroides. | Kubin M, Pekarek J, Svejcar J, Prochazka B. | Infect Immun | 10.1128/iai.33.3.725-727.1981 | 1981 | | |
| Enzymology | Comparison of the mycobacteria growth indicator tube with MB redox, Löwenstein-Jensen, and Middlebrook 7H11 media for recovery of mycobacteria in clinical specimens. | Somoskovi A, Magyar P. | J Clin Microbiol | 10.1128/jcm.37.5.1366-1369.1999 | 1999 | |
| Identification of mycobacteria by high-performance liquid chromatography. | Butler WR, Jost KC, Kilburn JO. | J Clin Microbiol | 10.1128/jcm.29.11.2468-2472.1991 | 1991 | | |
| Pathogenicity | Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). | Nash KA. | Antimicrob Agents Chemother | 10.1128/aac.47.10.3053-3060.2003 | 2003 | |
| Enzymology | Comparison of the Mycobacteria Growth Indicator Tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. | Pfyffer GE, Welscher HM, Kissling P, Cieslak C, Casal MJ, Gutierrez J, Rusch-Gerdes S. | J Clin Microbiol | 10.1128/jcm.35.2.364-368.1997 | 1997 | |
| Pathogenicity | Dual-probe assay for rapid detection of drug-resistant Mycobacterium tuberculosis by real-time PCR. | Wada T, Maeda S, Tamaru A, Imai S, Hase A, Kobayashi K. | J Clin Microbiol | 10.1128/jcm.42.11.5277-5285.2004 | 2004 | |
| Metabolism | Distribution analysis of hydrogenases in surface waters of marine and freshwater environments. | Barz M, Beimgraben C, Staller T, Germer F, Opitz F, Marquardt C, Schwarz C, Gutekunst K, Vanselow KH, Schmitz R, LaRoche J, Schulz R, Appel J. | PLoS One | 10.1371/journal.pone.0013846 | 2010 | |
| Metabolism | Characterization of binding sites for a bacteriocin produced by Mycobacterium smegmatis. | Watanabe T, Saito H. | J Bacteriol | 10.1128/jb.144.1.428-431.1980 | 1980 | |
| Enzymology | Identification of Mycobacterium avium complex in sarcoidosis. | el-Zaatari FA, Naser SA, Markesich DC, Kalter DC, Engstand L, Graham DY. | J Clin Microbiol | 10.1128/jcm.34.9.2240-2245.1996 | 1996 | |
| Pathogenicity | Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. | Caviedes L, Lee TS, Gilman RH, Sheen P, Spellman E, Lee EH, Berg DE, Montenegro-James S. | J Clin Microbiol | 10.1128/jcm.38.3.1203-1208.2000 | 2000 | |
| Serological response of patients with leprosy to a 28- to 30-kilodalton protein doublet from early cultures of Mycobacterium bovis BCG. | Pessolani MC, Rumjanek FD, Marques MA, de Melo FS, Sarno EN. | J Clin Microbiol | 10.1128/jcm.27.10.2184-2189.1989 | 1989 | | |
| Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. | Andersen AB, Andersen P, Ljungqvist L. | Infect Immun | 10.1128/iai.60.6.2317-2323.1992 | 1992 | | |
| Phylogeny | Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria. | Luquin M, Ausina V, Lopez Calahorra F, Belda F, Garcia Barcelo M, Celma C, Prats G. | J Clin Microbiol | 10.1128/jcm.29.1.120-130.1991 | 1991 | |
| Phylogeny | The division between fast- and slow-growing species corresponds to natural relationships among the mycobacteria. | Stahl DA, Urbance JW. | J Bacteriol | 10.1128/jb.172.1.116-124.1990 | 1990 | |
| Compilation of small ribosomal subunit RNA structures. | Neefs JM, Van de Peer Y, De Rijk P, Chapelle S, De Wachter R. | Nucleic Acids Res | 10.1093/nar/21.13.3025 | 1993 | | |
| Chemical basis of rough and smooth variation in mycobacteria. | Belisle JT, Brennan PJ. | J Bacteriol | 10.1128/jb.171.6.3465-3470.1989 | 1989 | | |
| Phylogeny | Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis. | Tonjum T, Welty DB, Jantzen E, Small PL. | J Clin Microbiol | 10.1128/jcm.36.4.918-925.1998 | 1998 | |
| Phylogeny | Multiprimer PCR system for differential identification of mycobacteria in clinical samples. | Del Portillo P, Thomas MC, Martinez E, Maranon C, Valladares B, Patarroyo ME, Carlos Lopez M. | J Clin Microbiol | 10.1128/jcm.34.2.324-328.1996 | 1996 | |
| Systemic Mycobacterium kansasii infection and regulation of the alloantigenic response. | Collins FM, Cunningham DS. | Infect Immun | 10.1128/iai.32.2.614-624.1981 | 1981 | | |
| Enzymology | Rapid and sensitive detection of Mycobacterium leprae using a nested-primer gene amplification assay. | Plikaytis BB, Gelber RH, Shinnick TM. | J Clin Microbiol | 10.1128/jcm.28.9.1913-1917.1990 | 1990 | |
| Natural occurrence of horizontal transfer of Mycobacterium avium- specific insertion sequence IS1245 to Mycobacterium kansasii. | da Silva Rabello MC, de Oliveira RS, Silva RM, Leao SC. | J Clin Microbiol | 10.1128/jcm.02256-09 | 2010 | | |
| Disseminated mycobacterium kansasii infection revealing GATA2 haploinsufficiency after presumed tuberculosis and early lung cancer. | Wang CH, Hwang LE, Liu WD, Yen YT, Chen JS, Chang YL, Lin CK, Chang HM, Cheng A, Wu UI. | Int J Infect Dis | 10.1016/j.ijid.2025.108074 | 2025 | | |
| The Resistance Trends in Mycobacterium kansasii Pulmonary Isolates and identification of risk factors for drug resistance in Taiwan. | Fan SB, Huang HL, Tu HP, Sobkowiak B, Cheng MH, Huang WC, Huang YW, Lin SY, Chong IW, Lu PL. | J Glob Antimicrob Resist | 10.1016/j.jgar.2025.11.001 | 2025 | | |
| Efficient recombinant protein secretion in Mycobacterium smegmatis: A valuable platform for protein production involved in biomedical development targeting mycobacterial diseases. | Takeuchi H, Mizuno S, Matsuo K. | J Biotechnol | 10.1016/j.jbiotec.2025.10.013 | 2026 | | |
| Genetics | A retrospective cohort study of Mycobacterium kansasii complex pulmonary infections at a tertiary teaching hospital. | Lin YC, Lee HH, Lao CK, Yang JH, Chen NY, Yeh CF, Huang PY, Shie SS, Huang WC, Lin CW, Li SH, Wang CL, Lin SW, Huang CC, Lu JJ, Chiu CH, Lai HC, Wu TS. | J Microbiol Immunol Infect | 10.1016/j.jmii.2025.08.006 | 2025 | |
| Lenvatinib-Associated Non-Tuberculous Mycobacterial Pulmonary Disease: A Case Report. | Wang Q, Du L, Wang Y, Zhang L. | Respirol Case Rep | 10.1002/rcr2.70316 | 2025 | | |
| Prognostic factors in cavitary non-tuberculous mycobacterial pulmonary disease and proposal of Double-7 imaging pattern: A multicenter cohort study. | Lin CR, Chen YH, Chen YH, Lee MR, Liu CJ, Wang JY, Ho CC, Shih JY. | J Microbiol Immunol Infect | 10.1016/j.jmii.2025.05.001 | 2025 | | |
| Genetics | Expedited diagnosis of disseminated Mycobacterium kansasii infection using targeted (amplicon-based) next-generation sequencing in an immunocompromised patient. | Fuller R, Petersen BE, Hussein S, Salib C, Duffield A, Gaglia R, Gabrilove JL, Hernandez C, Ramirez JD, Jacobs SE, Paniz-Mondolfi A. | ASM Case Rep | 10.1128/asmcr.00110-24 | 2025 | |
| Detection of tuberculous and non-tuberculous mycobacterial species in trans-tracheal washes of cattle and buffaloes with respiratory distress. | Prajapati SK, Narang D, Chandra M, Sharma A, Singh ST. | Trop Anim Health Prod | 10.1007/s11250-025-04408-5 | 2025 | | |
| Effect of cavity absorption on treatment outcomes of Mycobacterium kansasii pulmonary disease. | Zou X, Yi S, Luo M, Zeng Q, Yao S, Chen L, Yao X, Hu Y, Liu Z. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2025.116712 | 2025 | | |
| Mycobacterium kansasii chronic olecranon bursitis: A rare case report and literature review. | Guru S, Saroya J, Guru N, Bai P. | IDCases | 10.1016/j.idcr.2025.e02326 | 2025 | | |
| Disseminated Mycobacterium kansasii disease complicating Talaromyces marneffei infection in patient with anti-IFN-gamma autoantibodies: a case report. | Wei S, Meng D, Qin J, Mo S, Jiang Z, Zhang P. | BMC Infect Dis | 10.1186/s12879-025-11535-9 | 2025 | | |
| Distribution and epidemiological characteristics of nontuberculous mycobacterium species in jianghan plain. | Li J, Chen H, Liu J, Yang S, Wang X, Zhang Y, Yuan X, Wang Q, Zhang Y. | Sci Rep | 10.1038/s41598-025-24583-7 | 2025 | | |
| Pathogenicity | Disseminated Mycobacterium kansasii infection due to surgical site infection following allogeneic hematopoietic stem cell transplantation: A case report and literature review. | Sekiguchi E, Kurosawa S, Iketani Y, Yoshimura Y, Nakazato T. | Int J Infect Dis | 10.1016/j.ijid.2024.107123 | 2024 | |
| Nontuberculous Mycobacterial Infection and Pulmonary Disease in Northern Israel: A Focus on Mycobacterium simiae. | Even-Dar R, Raz I, Brodsky M, Stein N, Adir Y, Saliba W, Ken-Dror S, Najjar-Debbiny R, Cohen R, Shteinberg M. | Chest | 10.1016/j.chest.2024.11.026 | 2025 | | |
| Dust to Disease: Cavitary Lung Lesion With Mycobacterium kansasii in a Black Lung Patient. | Machineni NVK, Gullapalli D, Tangutoori S, Tipparthi A, Lahori S, Khater F, Ganti SS. | J Investig Med High Impact Case Rep | 10.1177/23247096251348906 | 2025 | | |
| Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii: a systematic review and meta-analysis. | Narimisa N, Goodarzi F, Bostanghadiri N, Masjedian Jazi F. | Expert Rev Anti Infect Ther | 10.1080/14787210.2024.2313051 | 2024 | | |
| Diagnosing Mycobacterium Kansasii in Shoulder Periprosthetic Joint Infection: A Rare Case Report. | Peresada D, Mungalpara N, Deshpande A, Patetta M, Goldberg B. | J Orthop Case Rep | 10.13107/jocr.2025.v15.i01.5134 | 2025 | | |
| Disseminated Mycobacterium kansasii and Mycobacterium avium complex co-infection in GATA2 mutated myelodysplastic syndrome: a case report. | Newstead S, Montelongo D, Shakir S, Swaminathan N. | Ther Adv Infect Dis | 10.1177/20499361251359825 | 2025 | | |
| Pathogenicity | Mycobacterial Infections Mimicking Malignancy in Solitary Pulmonary Lesions: A Cone Beam CT-Guided Biopsy Case Series. | Onyancha S, Lonnes R, Hollaus P, Schreiner W, Rohde G. | Respirol Case Rep | 10.1002/rcr2.70300 | 2025 | |
| AI-assisted differentiation of nontuberculous mycobacterial pulmonary disease from colonization: a multi-center study. | Liu CJ, Liu YC, Chen YH, Huang YS, Kuo PC, Lee MR, Kuo LC, Wang JY, Ho CC, Shih JY, Yu CJ. | Insights Imaging | 10.1186/s13244-025-02131-1 | 2025 | | |
| Nontuberculous scrofuloderma with sweet syndrome leading to anti-interferon-gamma autoantibody-associated adult-onset immunodeficiency: A case report. | Nutthapan N. | JAAD Case Rep | 10.1016/j.jdcr.2025.05.029 | 2025 | | |
| Chemical composition and antimycobacterial, anti-Malassezia furfur and cytotoxic activities of essential oils from Callistemon viminalis (Sol. ex Gaertn.) G. Don leaves and flowers. | Silva IJMM, Fernandes CC, Silva NBS, Calefi GG, Martins CHG, Silva JBA, Crotti AEM, Miranda MLD. | Nat Prod Res | 10.1080/14786419.2024.2386120 | 2025 | | |
| Disseminated coinfection with Mycobacterium Avium complex and Mycobacterium Kansasii in a patient with idiopathic CD4+ lymphocytopenia: A case report. | Somboonviboon D, Thongtaeparak W, Suntavaruk P, Nasomsong W. | J Infect Chemother | 10.1016/j.jiac.2023.08.006 | 2023 | | |
| First recorded isolation of Mycobacterium kansasii in a nonendemic setting. | Dajani J, Shakhshir A, Sawalmeh A, Awashra A, Dweekat M, Al-Ali K, Adnan Fatayer AM. | Radiol Case Rep | 10.1016/j.radcr.2024.10.151 | 2025 | | |
| Clinical evaluation of multiplex PCR for the differential diagnosis of major pathogenic mycobacteria in East China. | Fang T, Peng L, Li Z, Li H, Li H, Cai L. | Medicine (Baltimore) | 10.1097/md.0000000000045906 | 2025 | | |
| Cumulative antimicrobial susceptibilities for respiratory clinical isolates of Mycobacterium avium Complex, Mycobacterium kansasii, and Mycobacterium abscessus from Pakistan 2018 to 2022. | Shakoor S, Shafiq S, Shahid A, Mir F, Ali R, Hasan R. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_136_23 | 2023 | | |
| [Solitary pulmonary nodule as an unusual presentation of infection by Mycobacterium abscessus. Report of a clinical case]. | Gutierrez J, Yumay P, Schiappacasse G, Raimundo S, Valenzuela H, Cabello H. | Rev Med Chil | 10.4067/s0034-98872023001201636 | 2023 | | |
| Mixed nontuberculous mycobacteria in an immunocompromised patient with probable progressive multifocal leukoencephalopathy. | Opperman C, Scott J, Steyn J, Singh S, Ghebrekristos Y, Croxford R, Warren R, Esmail A, Ghielmetti G, Goosen W. | IJID Reg | 10.1016/j.ijregi.2024.100502 | 2025 | | |
| Screening, epidemic trends and drug sensitivity analysis of nontuberculous mycobacteria in a local area of China. | Lin WH, Yao C, Mei L, Wang DP, Bao XD, Liu SS. | Am J Transl Res | 10.62347/majy5046 | 2024 | | |
| Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation. | Boorgula GD, Gumbo T, Singh S, McShane PJ, Philley JV, Srivastava S. | Tuberculosis (Edinb) | 10.1016/j.tube.2024.102519 | 2024 | | |
| Mycobacterium kansasii Infection in a Farmed White-Tailed Deer (Odocoileus virginianus) in Florida, USA. | Cottingham SL, Cheng AC, de Oliveira Viadanna PH, Subramaniam K, Craft WF, Iredale ME, Wisely SM, Campos Krauer JM. | Animals (Basel) | 10.3390/ani14101511 | 2024 | | |
| Clinical Presentations and Species Spectrum of Nontuberculous Mycobacteria in Suspected Pulmonary Tuberculosis Cases. | Das S, Mohapatra PR, Rath S, Bhuniya S, Mishra B. | J Glob Infect Dis | 10.4103/jgid.jgid_152_24 | 2025 | | |
| Ten years of experience with elbow native joint arthritis: a multicenter retrospective cohort study. | Damronglerd P, Khodadadi RB, El Zein S, McHugh JW, Abu Saleh OM, Morrey ME, Tande AJ, Suh GA. | J Bone Jt Infect | 10.5194/jbji-10-25-2025 | 2025 | | |
| Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease. | Lin WH, Tang F, Liu SS. | Am J Transl Res | 10.62347/hhrh8076 | 2024 | | |
| In vitro susceptibility testing of tetracycline-class antibiotics against slowly growing non-tuberculous mycobacteria. | Li A, Tan Z, He S, Chu H. | Clin Exp Pharmacol Physiol | 10.1111/1440-1681.13777 | 2023 | | |
| Beyond the Needle: Unmasking Atypical Mycobacteria in Postvaccination Abscesses in Children. | Shah A, Joshi DN, Shah A. | J Indian Assoc Pediatr Surg | 10.4103/jiaps.jiaps_262_23 | 2024 | | |
| A Rare Case of Symptomatic Pulmonary Infection Caused by Mycobacterium paraffinicum. | Vinh H, Sutaria N, Adlakha A. | Cureus | 10.7759/cureus.86982 | 2025 | | |
| Reactive oxygen species trigger inflammasome activation after intracellular microbial interaction. | Rosa CP, Belo TCA, Santos NCM, Silva EN, Gasparotto J, Corsetti PP, de Almeida LA. | Life Sci | 10.1016/j.lfs.2023.122076 | 2023 | | |
| Efficacy and treatment outcome of infected patients with pulmonary Mycobacterium kansasii: A systematic review. | Andalibi F, Bostanghadiri N, Amirmozafari N, Irajian G, Mirkalantari S. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2024.100463 | 2024 | | |
| Diagnosing and treating Mycobacterium kansasii. | Moore RR, Holder D, Earnest S. | JAAPA | 10.1097/01.jaa.0000824932.43060.3f | 2022 | | |
| From Triumph to Trial: A Case Study of Non-Tuberculous Mycobacterium After Tetralogy of Fallot (TOF) Correction in an Immunocompetent Child. | Khan S, Ali Y, Baig KS, Hussain U, Ali Z. | Cureus | 10.7759/cureus.62207 | 2024 | | |
| Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel. | Hershko Y, Adler A. | Microb Drug Resist | 10.1089/mdr.2023.0024 | 2023 | | |
| Incidence of mycobacteria in pulmonary granulomatous lesions. | Meireles SI, Cruz MV, Irffi GP, Testagrossa LA. | Clinics (Sao Paulo) | 10.1016/j.clinsp.2024.100564 | 2025 | | |
| Clinical Characteristics of Nontuberculous Mycobacterial Positivity Occurring During Multidrug-Resistant Tuberculosis Treatment: A Retrospective Study. | Wang M, Khan MT, Yang Z, Feng Z, Zhang H, Yuan Y, Wu D, Chen Z, Kuang H, Tan S. | Trop Med Infect Dis | 10.3390/tropicalmed10030083 | 2025 | | |
| Haemophagocytic lymphohistiocytosis caused by GATA2 deficiency: a report on three patients. | Wu L, Wang J, Song D, You Y, Wang Z. | BMC Infect Dis | 10.1186/s12879-024-09356-3 | 2024 | | |
| Genetics | Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment. | Zhang Y, Yu C, Jiang Y, Zheng X, Wang L, Li J, Shen X, Xu B. | Clin Microbiol Infect | 10.1016/j.cmi.2022.10.002 | 2023 | |
| Clinical value of quantitative PCR in diagnosis of suspected mycobacterial pulmonary infections. | Chen J, Chen C, Xie Y, Xu G, Lin M, Gong X, Zhang X, Chen X, Chen J, Zhang L, He G. | BMC Infect Dis | 10.1186/s12879-025-11935-x | 2025 | | |
| Prevalence of Mycobacterium kansasii in clinical and environmental isolates, a systematic review and meta-analysis. | Narimisa N, Bostanghadiri N, Goodarzi F, Razavi S, Jazi FM. | Front Microbiol | 10.3389/fmicb.2024.1321273 | 2024 | | |
| Concomitantly Diagnosed Disseminated M kansasii Infection and Hairy Cell Leukemia With Review of Pathophysiology. | Stanton DJ, Quadri NZ, Tanabe MB. | J Investig Med High Impact Case Rep | 10.1177/23247096241253343 | 2024 | | |
| Clinical features of patients presenting with fever of unknown origin caused by non-tuberculous mycobacterium infection. | Liu H, Zhang T, Wang Y, Fan H, Huang X, Jiao Y. | J Infect Dev Ctries | 10.3855/jidc.17610 | 2023 | | |
| Clinical characteristics and outcomes of tuberculosis and non-tuberculous mycobacteria infections: a population-based study of concurrent and sequential infections. | Fei ZT, Zhou DP, Huang W, Liu P, Lu QP, Li H, Yang Y, Ye D, Liu XH, Xia L. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-025-05151-3 | 2025 | | |
| Novel pyrimidine-1,3,4-oxadiazole hybrids and their precursors as potential antimycobacterial agents. | Pflegr V, Stolarikova J, Pal A, Kordulakova J, Kratky M. | Future Med Chem | 10.4155/fmc-2023-0096 | 2023 | | |
| Surveillance of public health pathogens in Lagos wastewater canals: a cross-sectional study. | Chukwu EE, Okwuraiwe A, Kunle-Ope CN, Igbasi UT, Onyejepu N, Osuolale K, Shaibu JO, Ojogbede A, Abuh D, Afocha E, Awoderu O, Obiozor K, Mustapha A, Audu R. | BMC Public Health | 10.1186/s12889-024-21157-6 | 2024 | | |
| Immunogenicity and vaccine potential of clinical isolate Mycobacterium kansasii strain against Mycobacterium tuberculosis infection. | Kim H, Shin SJ. | Microbiol Spectr | 10.1128/spectrum.00819-24 | 2024 | | |
| Lymphocyte subsets and the increased risk for opportunistic infections in severe restrictive anorexia nervosa. | Vidmar P, Altenburg J, van Leeuwen EM, van Bellegem ACM, Verhoef C, de Bree GJ, Soeters MR. | J Eat Disord | 10.1186/s40337-025-01235-9 | 2025 | | |
| Ethambutol optic neuropathy. | Sudhakar P, Acharya K, Kini TA. | Front Neurol | 10.3389/fneur.2025.1626909 | 2025 | | |
| Pleural infection caused by Mycobacterium kansasii in a patient after lung transplantation. | Plank PM, Hinze CA, Sedlacek L, Welte T, Suhling H, Gottlieb J. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2023.100380 | 2023 | | |
| Multiple Bone Destruction Secondary to Mycobacterium kansasii Pulmonary Disease: A Case Report. | Dai L, Wu Y, Zhou X, Liu S, Fan J, Xie H, Wang L, Tian X, Xu W. | Diagnostics (Basel) | 10.3390/diagnostics13111970 | 2023 | | |
| Case Report: Mycobacterium kansasii causing infective endocarditis explored by metagenomic next-generation sequencing. | Yang L, Peng L, Yuan K, Cai K, Feng C, Yang G, Wang S, Zhu X, Zhang J, Wang F, Lu H. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1227537 | 2023 | | |
| Mycobacterial avium intracellulare (MAI) extensor tenosynovitis of wrist: An uncommon entity. | Kalia V, Garvin G, Yan Y, Kalia V. | Radiol Case Rep | 10.1016/j.radcr.2024.11.004 | 2025 | | |
| Dual M. kansasii infection in one household: a reconsideration of our understanding of transmission routes. | Moody SJ, Johnson L, Moody T. | BMJ Case Rep | 10.1136/bcr-2022-254448 | 2023 | | |
| Evaluation of a Commercial Multiplex Real-Time PCR with Melting Curve Analysis for the Detection of Mycobacterium tuberculosis Complex and Five Nontuberculous Mycobacterial Species. | Kim KJ, Chang Y, Yun SG, Nam MH, Cho Y. | Microorganisms | 10.3390/microorganisms13010026 | 2024 | | |
| Ethambutol-induced bullous skin lesions in mycobacterium kansasii lung infection. | Kollipara VK, Horowitz M, Lantz J, Nagy-Agren S. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_204_21 | 2022 | | |
| Clinical correlation study of non-tuberculous mycobacterial isolates from bronchoalveolar lavage fluid. | Ning H, He G, Mei Y, Yu J, Shi J, Cui X, Qiu C, Jiang X. | AMB Express | 10.1186/s13568-025-01842-4 | 2025 | | |
| An Integrated Mycobacterial CT Imaging Dataset with Multispecies Information. | Han Z, Zhang Y, Ding W, Zhao X, Jia B, Liu T, Wan L, Xing Z. | Sci Data | 10.1038/s41597-025-04838-8 | 2025 | | |
| Nontuberculous mycobacteria isolation from sputum specimens: A retrospective analysis of 1061 cases. | Babalik A, Koc EN, Sekerbey HG, Donmez GE, Balikci A, Kilicaslan Z. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_10_23 | 2023 | | |
| Spectroscopic Characterization of a Diferric Mycobacterial Hemerythrin-Like Protein with Unprecedented Reactivity toward Nitric Oxide. | Albert T, Moenne-Loccoz P. | J Am Chem Soc | 10.1021/jacs.2c07113 | 2022 | | |
| The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species. | Yan M, Brode SK, Marras TK. | Chest | 10.1016/j.chest.2022.09.025 | 2023 | | |
| Synthesis of a Tridecasaccharide Lipooligosaccharide Antigen from the Opportunistic Pathogen Mycobacterium kansasii. | Shen K, Bai B, Liu YH, Lowary TL. | Angew Chem Int Ed Engl | 10.1002/anie.202111549 | 2021 | | |
| Mixed Mycobacterium kansasii and Mycobacterium smegmatis infection in an adult-onset immunodeficiency patient with anti-interferon-gamma autoantibodies. | Chou YT, Liao WA, Kuo CW. | Respirol Case Rep | 10.1002/rcr2.1178 | 2023 | | |
| Nontuberculous mycobacteria in patients of a specialty hospital. | Barboza GCS, Almeida IN, Santos LBD, Augusto CJ, Leal EA, Padua CAM, Cesar ALA, Kritski AL, Carvalho WDS, Miranda SS, Figueredo LJA. | Rev Inst Med Trop Sao Paulo | 10.1590/s1678-9946202365042 | 2023 | | |
| Distinct lung microbiota community states are associated with pulmonary nontuberculous mycobacterial disease prognosis. | Chen Y, Miao Q, Bao R, Qu H, Shen J, Li N, Luan S, Yin X, Pan J, Hu B. | BMC Microbiol | 10.1186/s12866-025-04420-7 | 2025 | | |
| Nanopore targeted sequencing in lower respiratory infections: a retrospective study on diagnostic applications, clinical characterization, and antimicrobial guidance. | Chen Q, Qiu Y, Zhang J, Chen S, Han X, Zeng Q, Wang G, Ji X, Dong L. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1660347 | 2025 | | |
| Nontuberculous Mycobacterial Flexor Tenosynovitis of the Wrist and Hand. | Malisetyan T, Harmon SR, Reyes M, Shoja MM, Schwartz G. | Cureus | 10.7759/cureus.58716 | 2024 | | |
| Cutaneous Mycobacteriosis Caused by Mycobacterium kansasii in a Yellow-naped Amazon Parrot (Amazona auropalliata). | Duvall A, Greenacre C, Grunkemeyer V, Craig L. | J Avian Med Surg | 10.1647/20-00036 | 2021 | | |
| Successful cord blood transplantation for myelodysplastic syndrome complicated by Mycobacterium kansasii pneumonia. | Yamada A, Akahane D, Katagiri S, Yoshizawa S, Furuya N, Fujimoto H, Gotoh M, Gotoh A. | Transpl Infect Dis | 10.1111/tid.13463 | 2021 | | |
| [Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai]. | Zheng XB, He YF, Wang L, Sun Q, Shen XN, Wu XC, Yang JH, Yao L, Cui HY, Xu B, Yu FY, Sha W. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.cn112147-20230111-00018 | 2023 | | |
| Genetics | Ultra-high field strength electroporation enables efficient DNA transformation and genome editing in nontuberculous mycobacteria. | Tang D, Wang M, Wang D, Yang D, Cai Y, Luo T, He J, Wang Q. | Microbiol Spectr | 10.1128/spectrum.01944-25 | 2025 | |
| Comparative analysis of non-tuberculous mycobacterial lung disease and lung colonization: a case-control study. | Chen S, Zhong J, Yang Q, Song X, Zhang L, Ruan G, Zhou B, Shi X, Liu X. | BMC Infect Dis | 10.1186/s12879-024-10067-y | 2024 | | |
| A single outer-sphere amino-acid substitution turns on the NO reactivity of a hemerythrin-like protein. | Albert T, Pence N, Zhong F, Pletneva EV, Moenne-Loccoz P. | Chem Sci | 10.1039/d4sc07529c | 2025 | | |
| Chronic Mycobacterium kansasii tenosynovitis in an immunocompromised host : case report. | Lemmens L, Van Beek N, Corluy L, Verfaillie S. | Acta Orthop Belg | 2020 | | ||
| Cell-free DNA next-generation sequencing for Mycobacterium tuberculosis obtained from plasma of children with active tuberculosis. | Quan S, Tian X, Sun Y, Qi H, Jiao W, Sun B, Xu F, Fang M, Yang X, Zeng X, Duan K, Wang J, Fu X, Duan L, Sun L, Shen A. | BMC Pediatr | 10.1186/s12887-025-05526-7 | 2025 | | |
| Non-Mycobacteria Tuberculosis in Africa: A Literature Review. | Ojo OT, Odeyemi AO. | Ethiop J Health Sci | 10.4314/ejhs.v33i5.21 | 2023 | | |
| Spontaneous resolution of Mycobacterium kansasii presenting as a spiculated lung mass. | Oudah M, Sabath BF. | Respir Med Case Rep | 10.1016/j.rmcr.2021.101512 | 2021 | | |
| Performance of Interferon-gamma Release Assays in Patients with Mycobacterium kansasii Infection. | Gao CH, Zhang YA, Wang MS. | Infect Drug Resist | 10.2147/idr.s385570 | 2022 | | |
| The important role of Perforin in protecting against Mycobacterium avium infection in mice. | Ikeda T, Shundo Y, On R, Matsumoto T, Ouchi H, Fujita M. | Sci Rep | 10.1038/s41598-025-16943-0 | 2025 | | |
| Severe inflammatory disorder in trisomy 8 without myelodysplastic syndrome and response to methylprednisolone: A case report. | Pan FY, Fan HZ, Zhuang SH, Pan LF, Ye XH, Tong HJ. | World J Clin Cases | 10.12998/wjcc.v11.i26.6206 | 2023 | | |
| Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India. | Das S, Mishra B, Mohapatra PR, Preetam C, Rath S. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_68_22 | 2022 | | |
| Giant Bilateral Iliopsoas Abscesses, Secondary to Pott's Disease: Challenging Diagnostic-Therapeutic Protocol Management (Modern and Innovative Open Approach Technique Through J.L. Petit Triangle)-A Case Report and Literature Review. | Pirvu MD, Popa CC, Lupu I, Grasa CN, Gheorghe AT, Sarbu V. | Diagnostics (Basel) | 10.3390/diagnostics15192506 | 2025 | | |
| Septic Arthritis Caused by Mycobacterium Kansasii in a Bone Marrow Transplant Recipient. | Sugiyama M, Terashita Y, Hara K, Cho Y, Asano T, Iguchi A. | J Pediatr Hematol Oncol | 10.1097/mph.0000000000001746 | 2020 | | |
| Rapid identification of major Mycobacterium species by loop-mediated isothermal amplification assay using novel species-specific genomic targets. | Zou Y, Wang Z, Wei Z, Bai G, Wang X, Qu S, Zhong G, Gao Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1653602 | 2025 | | |
| Genetics | Performance of metagenomic next-generation sequencing in bronchoalveolar lavage fluid for pathogen detection in patients with acute exacerbations of bronchiectasis. | Zhuang Q, Xu R, Sun X, Pan X, Wan L, Li S, Chen H, Yu X, Zheng L, Yu Y, Deng Z, Zheng X, Chen Z. | Medicine (Baltimore) | 10.1097/md.0000000000045606 | 2025 | |
| Genetics | Population structure of Mycobacterium avium subsp. hominissuis provides new insights into genomic evolution. | Olawoye IB, Alexander D, Guthrie JL. | Microb Genom | 10.1099/mgen.0.001543 | 2025 | |
| Non-tuberculous mycobacterial thoracic osteomyelitis in an immunocompetent host: a rare presentation of Mycobacterium kansasii. | Becker T, Smith M, Parsons M, Goto M. | BMJ Case Rep | 10.1136/bcr-2022-249629 | 2022 | | |
| Large Extracellular Cord Formation in a Zebrafish Model of Mycobacterium kansasii Infection. | Johansen MD, Kremer L. | J Infect Dis | 10.1093/infdis/jiaa187 | 2020 | | |
| Spontaneous pneumothorax and COVID-19: Precipitants to a complex HIV-AIDS diagnosis. | Philip T, Sittirat PD, Eickenhorst D, Bhatti N. | Radiol Case Rep | 10.1016/j.radcr.2022.12.010 | 2023 | | |
| Laboratory tests and analysis of drug resistance in non-tuberculous mycobacteria. | Tan J, Wang Y, Li Z, Xia S, Guo Z, Li W, Yuan Y, Gao J, Wang W. | Heliyon | 10.1016/j.heliyon.2024.e28665 | 2024 | | |
| Comparative cellular immune responses in calves after infection with Mycobacterium avium subsp. paratuberculosis, M. avium subsp. avium, M. kansasii and M. bovis. | Stabel JR, Waters WR, Bannantine JP, Palmer MV. | Vet Immunol Immunopathol | 10.1016/j.vetimm.2021.110268 | 2021 | | |
| Pediatric Non-Cystic Fibrosis Pulmonary Nontuberculous Mycobacterium Infections: A Global Population Based Study. | Gad El Sayed MBMZ, Tai D, Yu L, Novak D, Dosanjh A. | Pediatric Health Med Ther | 10.2147/phmt.s515071 | 2025 | | |
| Nanopore Sequencing Technology: A Reliable Method for Pathogen Diagnosis in Elderly Patients with Community-Acquired Pneumonia. | Zhang X, Ye J, Wang L, Zhang L, Wang L, Jin H. | Infect Drug Resist | 10.2147/idr.s475861 | 2024 | | |
| Evaluating a Dual-Gene qPCR Melting Curve Assay for Rapid Detection of Tuberculosis in Suspected Pulmonary Cases. | Ma J, Wang L, Zheng X, Cui H, Sha W. | Infect Drug Resist | 10.2147/idr.s498180 | 2025 | | |
| A Patient With Mycobacteremia Due to Two Different Nontuberculous Mycobacteria. | Hill E, Wooten D. | Open Forum Infect Dis | 10.1093/ofid/ofac519 | 2022 | | |
| Pleural Effusion/Empyema With Mycobacterium kansasii. | Luttmann KF, Starnes VR, Rostad K, Girdhar KK, Duggan J. | Cureus | 10.7759/cureus.21300 | 2022 | | |
| Multiple refractory intracellular pathogen infections in a human immunodeficiency virus-negative patient with anti-interferon-gamma autoantibodies: a case report. | Wang H, Lei R, Ji Y, Xu W, Zhang K, Guo X. | BMC Infect Dis | 10.1186/s12879-023-08404-8 | 2023 | | |
| Prevalence of nontuberculous mycobacteria and the emergence of rare species in Henan Province, China. | Hongmei S, Ruixia L, Jiankang L, Han W, Chang Z, Yan MY, Kang WZ, Li LF, Zhi DC, Xin L. | Epidemiol Infect | 10.1017/s095026882400061x | 2024 | | |
| Tracheobronchial infectious diseases in adult-onset immunodeficiency with anti-interferon-gamma autoantibodies. | Liang X, Ma N, Liang S, Huang X, Liang H, Wu S, Ning Y, Pang H, Zhang Z, Chen N, Hong L, He Z. | BMC Infect Dis | 10.1186/s12879-025-11523-z | 2025 | | |
| GATA2 deficiency and hemophagocytic lymphohistiocytosis (HLH): a systematic review of reported cases. | Rukerd MRZ, Mirkamali H, Nakhaie M, Alizadeh SD. | BMC Infect Dis | 10.1186/s12879-024-10145-1 | 2024 | | |
| Non-Tuberculous Mycobacteria: Single Center Analyses of Risk Factors, Management and Mortality Outcomes of Adults with HIV. | Nqwata L, Pasipanodya JG, Black M, Feldman C. | Diagnostics (Basel) | 10.3390/diagnostics14232682 | 2024 | | |
| Successful Treatment of a Patient With Chronic Bronchiectasis Using an Induced Native Phage Cocktail: A Case Report. | Jernigan DA, Hentish RD. | Cureus | 10.7759/cureus.77681 | 2025 | | |
| Diagnostic Significance of Hematological Parameters and Ratios in the Context of Mycobacterium Avium Complex Pulmonary Disease Across Various Age Groups. | Long X, Li Q, Wang H, Wang S, Ren Z, Wang X, Gao Y. | Infect Drug Resist | 10.2147/idr.s543622 | 2025 | | |
| Treatment of pulmonary disease caused by Mycobacterium kansasii. | Huang HL, Lu PL, Lee CH, Chong IW. | J Formos Med Assoc | 10.1016/j.jfma.2020.05.018 | 2020 | | |
| Use of saline to evaluate a cavity due to Mycobacterium kansasii infection during ultrathin bronchoscopy and endobronchial ultrasonography. | Hamaguchi M, Kurimoto N, Tsubata Y, Okuno T, Tanino A, Hotta T, Isobe T. | Respirol Case Rep | 10.1002/rcr2.766 | 2021 | | |
| Prosthetic Knee Joint Infection Caused by Mycobacterium kansasii. | Dasari SP, Hadro AE, Singh R, Neilson JC. | J Am Acad Orthop Surg Glob Res Rev | 10.5435/jaaosglobal-d-21-00183 | 2022 | | |
| Intracranial infection caused by Mycobacterium rhodesiae with specific imaging findings and good response to medication: a case report and literature review. | Chen S, Sun W, Liu R, Yao L, Peng Q. | Front Med (Lausanne) | 10.3389/fmed.2024.1414369 | 2024 | | |
| Analysis of Antibiotic Resistance Genes in Water Reservoirs and Related Wastewater from Animal Farms in Central China. | Rui Y, Qiu G. | Microorganisms | 10.3390/microorganisms12020396 | 2024 | | |
| Diagnostic accuracy of interferon-gamma release assay and mucosal-associated invariant T cells in spinal tuberculosis. | Mekariya K, Ayutthaya PSN, Naowanirut A, Wongsa A, Tassaneetrithep B, Tantibhedhyangkul W, Ngamskulrungroj P, Muangsomboon S, Cheiwvit P, Wilartratsami S, Luksanapruksa P, Danchaivijitr N, Boonchai K, Rattanatanasarn A, Ruangchainikom M. | Sci Rep | 10.1038/s41598-025-23408-x | 2025 | | |
| Pathogenicity | Pulmonary Nontuberculous Mycobacteria Infection in Bronchiectasis: A Narrative Review of Current Status and Future. | Fujita M. | Health Sci Rep | 10.1002/hsr2.70749 | 2025 | |
| Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review. | Brunasso AMG, Javor S, Pontali E, Sola S, Massone C. | Dermatol Reports | 10.4081/dr.2021.8797 | 2021 | | |
| Epidemiology and Drug Susceptibility of Nontuberculous Mycobacteria in the Province of Pavia (Northern Italy): An Overview. | Siciliano M, Amisano F, Bagnarino J, Grassia G, Cambieri P, Baldanti F, Monzillo V, Barbarini D. | Microorganisms | 10.3390/microorganisms13112547 | 2025 | | |
| Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. | Lange C, Bottger EC, Cambau E, Griffith DE, Guglielmetti L, van Ingen J, Knight SL, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, Wagner D, Winthrop K, Daley CL, expert panel group for management recommendations in non-tuberculous mycobacterial pulmonary diseases. | Lancet Infect Dis | 10.1016/s1473-3099(21)00586-7 | 2022 | | |
| Toto, we're not in Kansas anymore: First reported case of M. persicum septic arthritis. | Dumais MG, Wengenack NL, Norgan AP, Amin S, Sia IG, Rhee PC, Connelly BJ, Arment CA. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2023.100352 | 2023 | | |
| [Analysis of the clinical characteristics and species distribution of non-tuberculous mycobacteria in a general hospital]. | Chai JJ, Liu T, Sun HL, Xu J, Zhu HD, Cai BQ. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.cn112147-20201229-01201 | 2021 | | |
| Unusual Presentation of Disseminated Mycobacterium kansasii Infection in Renal Transplant Recipients and Rapid Diagnosis Using Plasma Microbial Cell-free DNA Next-generation Sequencing. | Ogunsiakan T, Fajgenbaum KD, Montgomery TB, Phadke GM, Gajurel K. | Transplant Direct | 10.1097/txd.0000000000001291 | 2022 | | |
| Diagnostic performance of metagenomics sequencing for pulmonary fungal infections: a clinical evaluation using the Nanopore platform | Liu Z, Yao Y, Wang L, Yu Y, Zhou H. | J Thorac Dis | 2025 | | ||
| Nontuberculous Mycobacterial Lung Disease Management in Belgium: A Longitudinal Pharmacy Database Study. | Peeters E, Obradovic M, van der Laan R, Cai R, Lorent N. | Drugs Real World Outcomes | 10.1007/s40801-025-00507-9 | 2025 | | |
| Evaluation of Mycobacterium kansasii extracellular vesicles role in BALB/c mice immune modulatory. | Tavassol ZH, Aziziraftar SK, Behrouzi A, Ghazanfari M, Masoumi M, Fateh A, Vaziri F, Siadat SD. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_212_19 | 2020 | | |
| MYCOBACTERIA IN SKIN LESIONS AND THE HABITAT OF THE ENDANGERED HOUSTON TOAD (ANAXYRUS HOUSTONENSIS). | Vemulapally S, Villamizar A, Guerra T, Tocidlowski ME, Spradley M, Mays S, Forstner MRJ, Hahn D. | J Wildl Dis | 10.7589/jwd-d-20-00145 | 2021 | | |
| Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series. | Licata MA, Monteleone G, Schiavi E, Musso M, Mencarini P, Mastrobattista A, Carli SM, Cerva C, Sgalla G, Richeldi L, Palmieri F, Gualano G. | Infect Dis Rep | 10.3390/idr17020028 | 2025 | | |
| Case of uncontrolled asthma with Ceriporia lacerata-related broncholithiasis. | Nakano C, Kodaka N, Oharaseki T, Matsuse H. | Ann Thorac Med | 10.4103/atm.atm_386_22 | 2023 | | |
| Repurposing drugs to advance the treatment of Buruli ulcer. | Singh S, Yotsu R, Nuremberger E, Srivastava S. | Antimicrob Agents Chemother | 10.1128/aac.00029-25 | 2025 | | |
| Infection of a Free-Living Wild Boar (Sus scrofa) with a Bacterium from the Mycobacterium kansasii Complex. | Radulski L, Krajewska-Wedzina M, Lipiec M, Szulowski K. | Animals (Basel) | 10.3390/ani12080964 | 2022 | | |
| Programmatic Assessment of Ethambutol-Related Optic Neuropathy in Patients with Mycobacterial Infections: A Prospective Observational Cohort Study. | Liu SS, Feng SC, Wu MF, Chin CS, Chen HC, Huang WC. | Infect Dis Ther | 10.1007/s40121-025-01219-x | 2025 | | |
| A case report of a male patient receiving treatment for anorexia nervosa and comorbid obsessive compulsive disorder who was later diagnosed with nontuberculosis Mycobacterium. | MacNeil BA, MacNeil BA, Hudson CC, Nadkarni P, Dempsey K. | Eat Weight Disord | 10.1007/s40519-020-00967-8 | 2021 | | |
| Pneumonia due to Mycobacterium cosmeticum in a patient with systemic sclerosis: A case report. | Hu Y, Zhang C, Jia L. | Clin Case Rep | 10.1002/ccr3.7464 | 2023 | | |
| Paediatric pulmonary disease-are we diagnosing it right? | Rajendran P, Thomas SV, Balaji S, Selladurai E, Jayachandran G, Malayappan A, Bhaskar A, Palanisamy S, Ramamoorthy T, Hasini S, Hissar S. | Front Pediatr | 10.3389/fped.2024.1370687 | 2024 | | |
| Duplex recombinase aided amplification-lateral flow dipstick assay for rapid distinction of Mycobacterium tuberculosis and Mycobacterium avium complex. | Chen K, Zhang J, Wang S, Yi Z, Fu Y. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1454096 | 2024 | | |
| NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria. | Szczerba M, Ganesh A, Gil-Marques ML, Briken V, Goldberg MB. | mBio | 10.1128/mbio.00818-25 | 2025 | | |
| Enzymology | Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteers. | Rodvold KA, Gotfried MH, Ussery XT, Wong SL, Hamed KA. | Antimicrob Agents Chemother | 10.1128/aac.01103-24 | 2024 | |
| Screening and preclinical assessment of novel Mycobacterium tuberculosis recombinant antigens based tuberculin skin testing. | Ou X, Liu E, Rashid F, Pei S, Zhang G, Anthony R, Xing R, Huang F, Xia H, Zheng Y, Song Y, Zhou Y, Zhao B, Wang S, Lin M, Zhou L, Zhao Y. | Front Immunol | 10.3389/fimmu.2025.1498448 | 2025 | | |
| Clinicopathological Profile in Patients with Tubercular Cervical Lymphadenitis and Its Treatment Outcome. | Kaur J, Jain A, Rai AK. | Indian J Otolaryngol Head Neck Surg | 10.1007/s12070-024-04786-6 | 2024 | | |
| The Presence of esat-6 and cfp10 and Other Gene Orthologs of the RD 1 Region in Non-Tuberculous Mycobacteria, Mycolicibacteria, Mycobacteroides and Mycolicibacter as Possible Impediments for the Diagnosis of (Animal) Tuberculosis | Gcebe N, Hlokwe T, Bouw A, Michel A, Rutten V. | Microorganisms | 2024 | | ||
| Assessment of Healthcare Professionals' Knowledge Regarding Nontuberculosis Mycobacterial Infections at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia, 2024: A Cross-Sectional Study. | Kiros T, Erkihun M, Sharew B, Almaw A, Assefa A, Tiruneh T, Getie B, Solomon Y, Damtie S. | J Clin Lab Anal | 10.1002/jcla.70035 | 2025 | | |
| Determination of Clinical Characteristics of Mycobacterium kansasii-Derived Species by Reanalysis of Isolates Formerly Reported as M. kansasii. | Kim YG, Lee HY, Kwak N, Park JH, Kim TS, Kim MJ, Lee JS, Park SS, Yim JJ, Seong MW. | Ann Lab Med | 10.3343/alm.2021.41.5.463 | 2021 | | |
| Unveiling the Clinical Diversity in Nontuberculous Mycobacteria (NTM) Infections: A Comprehensive Review. | Bhanushali J, Jadhav U, Ghewade B, Wagh P. | Cureus | 10.7759/cureus.48270 | 2023 | | |
| The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease. | Wang PH, Pan SW, Wang SM, Shu CC, Chang CH. | Front Microbiol | 10.3389/fmicb.2022.909274 | 2022 | | |
| Enzymology | Mycobacterium kansasii arthritis of the elbow in an immunocompetent patient with a suspected soft-tissue tumor. | Okuno H, Tanaka H, Hagiya H, Yoshida H, Hamaguchi S, Hori Y, Morii E, Hamada K, Yoshikawa H, Tomono K. | J Infect Chemother | 10.1016/j.jiac.2019.07.015 | 2020 | |
| Identification and Antimicrobial Susceptibilities for Patients with Non-tuberculous Mycobacteria Infection in Jeju Island: Single-Center Retrospective Study. | Kim M, Heo ST, Lee J, Lee JH, Kim M, Kim C, Seong GM, Kang MJ, Yoo JR. | Infect Chemother | 10.3947/ic.2023.0052 | 2024 | | |
| Evaluation of nucleotide MALDI-TOF-MS for the identification of Mycobacterium species. | Zhu Y, Liu Z, Peng L, Liu B, Wu K, Zhang M, Wang X, Pan J. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1335104 | 2024 | | |
| mlstverse-web: advancing real-time identification of mycobacteria from sputum using targeted sequencing NALC-Seq. | Matsumoto Y, Fukushima K, Zhang S, Fauzyah Y, Motooka D, Saito H, Yamauchi J, Nitta T, Nii T, Matsuki T, Tsujino K, Miki K, Kida H, Nakamura S. | Funct Integr Genomics | 10.1007/s10142-025-01609-x | 2025 | | |
| Swollen Necrotic Lymphadenitis Infected with Mycobacterium Paracondontium in an AIDS Patient: a Case Report and Literature Review. | Yan J, Zheng R, Zhang Z, Shi J, Yan T, Liu H, Li F. | Infect Drug Resist | 10.2147/idr.s473762 | 2024 | | |
| Phylogeny | Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India. | Thangavelu K, Krishnakumariamma K, Pallam G, Dharm Prakash D, Chandrashekar L, Kalaiarasan E, Das S, Muthuraj M, Joseph NM. | J Infect Public Health | 10.1016/j.jiph.2020.12.027 | 2021 | |
| MmpL12 transports lipooligosaccharides and impacts virulence in Mycobacterium marinum. | Bailo R, Kumar CMS, Singh A, Lund PA, Bavro VN, Bhatt A. | Microbiology (Reading) | 10.1099/mic.0.001618 | 2025 | | |
| Joint application of multiplex drop-off digital PCR, droplet digital PCR, and metagenomic next-generation sequencing for the diagnosis of suspected infectious diseases: A retrospective cohort study. | Jin S, Meng S, Huang Q, Xie H, Zheng J, Wang R. | J Intensive Med | 10.1016/j.jointm.2025.03.006 | 2025 | | |
| Aetiologic diagnosis of thoracic granulomatous diseases: a retrospective multicentre study in South-Central China. | Jiang M, Li W, He Y, Meng J. | BMJ Open | 10.1136/bmjopen-2025-102521 | 2025 | | |
| Simultaneous Onset of Mycobacterium kansasii Pulmonary Infection and Systemic Lupus Erythematosus: A Case Report. | Bruno D, Tanti G, Cingolani A, Ria F, Gremese E, Mirone L. | Am J Case Rep | 10.12659/ajcr.929866 | 2021 | | |
| Evaluation of the Mycobacterium RealTime Kit Vircell (MRTVircell) Assay for Detecting Mycobacterium Species in Clinical Specimens. | Aguilera Franco M, Sampedro Padilla A, Gutierrez-Bautista JF, Gonzalez Martinez A, Cobo F, Gutierrez-Fernandez J, Reguera JA, Navarro Mari JM, Rodriguez-Granger J. | Pathogens | 10.3390/pathogens14050429 | 2025 | | |
| Pathogenicity | Drug susceptibility profile of Mycobacterium kansasii clinical isolates from Brazil. | de Carvalho LD, de Queiroz Mello FC, Redner P, Campos CED, de Souza Caldas PC, da Silva Lourenco MC, Ramos JP. | J Glob Antimicrob Resist | 10.1016/j.jgar.2019.05.003 | 2019 | |
| Side-by-Side Profiling of Oxazolidinones to Estimate the Therapeutic Window against Mycobacterial Infections. | Negatu DA, Aragaw WW, Cangialosi J, Dartois V, Dick T. | Antimicrob Agents Chemother | 10.1128/aac.01655-22 | 2023 | | |
| Hypercalcaemia in Mycobacterium kansasii pulmonary infection. | Flowers RC, Ocampo J, Krautbauer J, Kupin WL. | BMJ Case Rep | 10.1136/bcr-2021-245800 | 2021 | | |
| Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020. | Kim KJ, Oh SH, Jeon D, Chang CL. | Tuberc Respir Dis (Seoul) | 10.4046/trd.2022.0115 | 2023 | | |
| A Rare Case of Brodie's Abscess in HIV Patient Caused by Mycobacterium kansasii. | Bansal K, Nambi P. | Cureus | 10.7759/cureus.10153 | 2020 | | |
| Rapid discrimination of Mycobacterium tuberculosis and non-tuberculous mycobacteria disease via interpretive machine learning analysis of routine laboratory tests. | Tang JW, Xiong XS, Huang TT, Zhang YL, Yao LF, Zhang WW, Xie YY, Liang QF, Tan ZX, Jiang K, Liu X, Wang L. | BMJ Health Care Inform | 10.1136/bmjhci-2025-101575 | 2025 | | |
| A Case Series of Non-Tuberculous Mycobacterial Pulmonary Disease Masquerading as Malignancy From a Community-Based Hospital. | Saad E, Abunseir M, Abdalla MS, Mustafa A, Faris ME, Friedman H. | J Med Cases | 10.14740/jmc4098 | 2023 | | |
| In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates. | Kim DH, Kim SY, Koh WJ, Jhun BW. | Antimicrob Agents Chemother | 10.1128/aac.02306-20 | 2021 | | |
| Huge cutaneous abscess and severe symptomatic hypercalcaemia secondary to Mycobacterium kansasii infection in an immunocompetent patient. | Vivatvakin S, Amnuay K, Suankratay C. | BMJ Case Rep | 10.1136/bcr-2021-241662 | 2021 | | |
| MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance. | DeCurtis EK, Machado I, Kuss-Duerkop SK, Wang Y, Khare R. | Microbiol Spectr | 10.1128/spectrum.01638-24 | 2024 | | |
| A case of chronic wounds caused by Sporothrix schenckii infection was rapidly detected by metagenomic next generation sequencing. | Jin W, Liu Y, Ning Q, Wu S, Su S, Zheng D, Ma S, Zou J, Yang M, Hu D, Ding H. | Heliyon | 10.1016/j.heliyon.2024.e24420 | 2024 | | |
| Extrapulmonary Tuberculosis Presenting As Stage V Bilateral Cervical Lymphadenitis With Cortical Cerebral Watershed Infarct Along With Maxillary and Sphenoid Sinusitis. | Yadav S. | Cureus | 10.7759/cureus.56055 | 2024 | | |
| Pathogenicity | Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches. | Kwon YS, Daley CL, Koh WJ. | Expert Rev Respir Med | 10.1080/17476348.2019.1638765 | 2019 | |
| Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis. | Wang PH, Shu CC, Sheu CC, Chang CL, Hsieh MH, Hsu WH, Chen MT, Ou WF, Wei YF, Yang TM, Lan CC, Wang CY, Lin CB, Lin MS, Wang YT, Lin CH, Liu SF, Cheng MH, Chen YF, Cheng WC, Peng CK, Chan MC, Chen CY, Jao LY, Wang YH, Chen CJ, Chen SP, Tsai YH, Cheng SL, Lin HC, Chien JY, Wang HC. | Open Forum Infect Dis | 10.1093/ofid/ofae427 | 2024 | | |
| Drug susceptibility profiling of pulmonary Mycobacterium kansasii and its correlation with treatment outcome. | Rajendran P, Padmapriyadarsini C, Vijayaraghavan V, Manoharan T, Lokanathan LM, Kadhar PB, Jayabal L, Sivaramakrishnan G. | Ann Thorac Med | 10.4103/atm.atm_45_21 | 2021 | | |
| Identification of Significant Pathogenic Nontuberculous Mycobacteria Species from Presumptive TB Patients Using Partial hsp65 Gene Sequencing. | Pascapurnama DN, Zavitri NG, Koesoemadinata RC, Cahyadi AI, Chaidir L. | Infect Drug Resist | 10.2147/idr.s419956 | 2023 | | |
| Enzymology | An enoyl-ACP reductase inhibitor, NITD-916, expresses anti-Mycobacterium abscessus activity. | Jia Y, Fan J, Tan Z, Li A, He S, Lin Y, Li J, Zhang Z, Li B, Chu H. | Antimicrob Agents Chemother | 10.1128/aac.00249-25 | 2025 | |
| Genetics | Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review. | Kaji M, Namkoong H, Nagao G, Azekawa S, Nakagawara K, Tanaka H, Morita A, Asakura T, Kamata H, Uwamino Y, Yoshida M, Fukunaga K, Hasegawa N. | Infect Drug Resist | 10.2147/idr.s415197 | 2023 | |
| Enzymology | Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease. | Moon SM, Choe J, Jhun BW, Jeon K, Kwon OJ, Huh HJ, Lee NY, Daley CL, Koh WJ. | Respir Med | 10.1016/j.rmed.2019.01.012 | 2019 | |
| Pathogenicity | Lower pre-conditioning absolute lymphocyte counts are associated with worse outcomes in haploidentical stem cell transplantation with myeloablative regimen in children. | Cui K, Zhang S, Du Y, Chai Y, Liang M, Hu S, Li J. | Front Immunol | 10.3389/fimmu.2025.1552263 | 2025 | |
| Risk factors and drug resistance of non-tuberculous mycobacteria in HIV/AIDS patients: a retrospective study in southern China. | Ye J, Yang Q, Huang Y, Lin M, Xian X, Huang L, Qin H, Zhou C, Zhang Y, Liang X, Ou J, Cui Z. | Front Public Health | 10.3389/fpubh.2025.1660472 | 2025 | | |
| Mycobacterium marseillense bloodstream infection combined with skin fungal infection: a case report and literature review. | Wang D, Xue D, Chen X, Wu X, Gao W, Liang X, Yuan W, Wang H, Wang Q. | BMC Infect Dis | 10.1186/s12879-024-09741-y | 2024 | | |
| Outcome of patients with and poor prognostic factors for Mycobacterium kansasii-pulmonary disease. | Liu CJ, Huang HL, Cheng MH, Lu PL, Shu CC, Wang JY, Chong IW. | Respir Med | 10.1016/j.rmed.2019.03.015 | 2019 | | |
| A Rare Case of Pulmonary Cavitary Disease Caused by Mycobacterium xenopi. | Dogra M, Thakur M, Thakur G, Kumar A. | Cureus | 10.7759/cureus.34561 | 2023 | | |
| Enzymology | Double lung transplantation in an HIV-positive patient with Mycobacterium kansasii infection. | Ambaraghassi G, Ferraro P, Poirier C, Rouleau D, Fortin C. | Transpl Infect Dis | 10.1111/tid.12999 | 2019 | |
| The hemerythrin-like diiron protein from Mycobacterium kansasii is a nitric oxide peroxidase. | Ma Z, Holland AA, Szlamkowicz I, Anagnostopoulos V, Caldas Nogueira ML, Caranto JD, Davidson VL. | J Biol Chem | 10.1016/j.jbc.2022.101696 | 2022 | | |
| Detection of clinically important non tuberculous mycobacteria (NTM) from pulmonary samples through one-step multiplex PCR assay. | Singh K, Kumari R, Tripathi R, Gupta S, Anupurba S. | BMC Microbiol | 10.1186/s12866-020-01952-y | 2020 | | |
| Induced Native Phage Cocktails for Multi-microbial Activation Syndrome in Treatment-Resistant Illnesses. | Jernigan DA. | Cureus | 10.7759/cureus.72587 | 2024 | | |
| Identification of apoptosis-related genes as potential biomarkers and therapeutic targets in cystic fibrosis patients progressing to pulmonary nontuberculous mycobacterial disease. | Pan J, Liu A, Xiao S, Ma X. | Sci Rep | 10.1038/s41598-025-24346-4 | 2025 | | |
| Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract. | He G, Wu L, Zheng Q, Jiang X. | Ann Med | 10.1080/07853890.2022.2121984 | 2022 | | |
| Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii. | Komine-Aizawa S, Mizuno S, Matsuo K, Namiki T, Hayakawa S, Honda M. | Vaccines (Basel) | 10.3390/vaccines9111260 | 2021 | | |
| Exploring the Association of Bacterial Coinfections with Clinical Characteristics of Patients with Nontuberculous Mycobacterial Pulmonary Disease. | Moon SM, Cho H, Shin B. | Tuberc Respir Dis (Seoul) | 10.4046/trd.2024.0003 | 2024 | | |
| Pathogenicity | "Lichenoid Granulomatous Pattern" in a Case of Lupus Vulgaris. | Desai C, Shaikh I. | Dermatopathology (Basel) | 10.3390/dermatopathology9020016 | 2022 | |
| Case Report: Nontuberculous mycobacterial infections in children with complete DiGeorge anomaly. | Hicks ED, Agada NO, Yates TR, Kelly MS, Tam JS, Ferdman RM, Dibernardo LR, Madden JF, Moody MA, Markert ML. | Front Immunol | 10.3389/fimmu.2023.1078976 | 2023 | | |
| Pathogenicity | In-vitro evaluation of the antibacterial activity of the essential oils of Micromeria barbata, Eucalyptus globulus and Juniperus excelsa against strains of Mycobacterium tuberculosis (including MDR), Mycobacterium kansasii and Mycobacterium gordonae. | El Omari K, Hamze M, Alwan S, Osman M, Jama C, Chihib NE. | J Infect Public Health | 10.1016/j.jiph.2019.01.058 | 2019 | |
| Enzymology | Profile of patients with pulmonary non-tuberculous mycobacterial disease mimicking pulmonary tuberculosis. | Gomathy NS, Padmapriyadarsini C, Silambuchelvi K, Nabila A, Tamizhselvan M, Banurekha VV, Lavanya J, Chandrasekar C. | Indian J Tuberc | 10.1016/j.ijtb.2019.04.013 | 2019 | |
| Mycobacterium heraklionense: An emerging cause of hand tenosynovitis. | El Moussaoui M, Lambert N, Massage P, Meex C, Hayette MP, Delvenne P, Rinkin C, Moutschen M, Darcis G, Malaise O, Giot JB. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2024.100479 | 2024 | | |
| Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report. | Naito M, Fukushima K, Kusakabe S, Endo T, Shiroyama T, Ohira K, Azuma K, Tanizaki S, Yamamoto Y, Hosono Y, Naito Y, Futami S, Miyake K, Hirata H, Takeda Y, Kumanogoh A. | BMC Infect Dis | 10.1186/s12879-023-08510-7 | 2023 | | |
| Overlapping infections of Mycobacterium canariasense and Nocardia farcinica in an immunocompetent patient: A case report. | Huang HY, Bu KP, Liu JW, Wei J. | World J Clin Cases | 10.12998/wjcc.v12.i12.2079 | 2024 | | |
| Treatment outcomes in NTM-PD in a high TB burden context. | Kang S, Schmidt JE, Chen I, Tiberi S. | IJTLD Open | 10.5588/ijtldopen.24.0413 | 2024 | | |
| Plasma cytokine levels as markers of pathogenesis and treatment response in patients with non-tuberculous mycobacterial pulmonary disease. | Zhao S, Zhang Z, Xu J, Zhou Z, Wu Y, Wu Y, Jiang G. | Braz J Med Biol Res | 10.1590/1414-431x2024e13755 | 2024 | | |
| What do the clinical features of positive nontuberculous mycobacteria isolates from patients with HIV/AIDS in China reveal? A systematic review and meta-analysis. | Yuan J, Wang Y, Wang L, Wang H, Ren Y, Yang W. | J Glob Health | 10.7189/jogh.13.04093 | 2023 | | |
| Enzymology | Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients. | Karami-Zarandi M, Bahador A, Gizaw Feysia S, Kardan-Yamchi J, Hasan-Nejad M, Mosavari N, Feizabadi MM. | Arch Razi Inst | 10.22092/ari.2019.127144.1372 | 2019 | |
| Usefulness of the BACES score in nontuberculous mycobacterial pulmonary disease for various clinical outcomes. | Kim HJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ, Park JS, Cho YJ, Lee CT, Lee JH. | Sci Rep | 10.1038/s41598-023-33782-z | 2023 | | |
| Pathogenicity | In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria. | Martin A, Godino IT, Aguilar-Ayala DA, Mathys V, Lounis N, Villalobos HR. | J Med Microbiol | 10.1099/jmm.0.001025 | 2019 | |
| Effects of non-tuberculous mycobacteria on BCG vaccine efficacy: A narrative review. | Ghasemi F, Kardan-Yamchi J, Heidary M, Karami-Zarandi M, Akrami S, Maleki A, Khoshnood S, Kazemian H. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2024.100451 | 2024 | | |
| SK-03-92 Drug Kills Intracellular Mycobacterium tuberculosis. | Schwan WR. | Antibiotics (Basel) | 10.3390/antibiotics12091385 | 2023 | | |
| Export of eDNA is a mechanism used by Mycobacterium avium subsp. hominissuis for survival within host macrophages. | Joseph JJ, Leestemaker-Palmer A, Bermudez LE. | Arch Microbiol | 10.1007/s00203-025-04396-y | 2025 | | |
| Microbiological profile of slow-growing non-tuberculous mycobacteria species other than Mycobacterium avium complex. | Fernandez-Pittol M, Batista S, Narvaez S, Roman A, San Nicolas L, Martinez D, Oliver L, Gonzalez-Moreno O, Martinez JA, Garcia F, Amaro-Rodriguez R, Soler N, Gene A, Gonzalez-Cuevas A, Tudo G, Gonzalez-Martin J. | Front Microbiol | 10.3389/fmicb.2025.1572162 | 2025 | | |
| Mycobacterium abscessus Pneumonia in Severe Alcoholism. | Acharya S, Anwar S, Medina Y, Thapa S, Glaser A. | Cureus | 10.7759/cureus.26251 | 2022 | | |
| CT informs detection and treatment options in rheumatoid arthritis complicated by pulmonary non-tuberculous mycobacterial disease from the FIRST registry. | Funada M, Miyazaki Y, Nakayamada S, Sonomoto K, Kubo S, Miyagawa I, Tanaka H, Tanaka Y. | RMD Open | 10.1136/rmdopen-2023-004049 | 2024 | | |
| Pulmonary Mycobacterium abscessus Infection: A Pathogen in Disguise. | Waugh KM, Wajahat R. | Cureus | 10.7759/cureus.46897 | 2023 | | |
| Enzymology | Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease. | Bakula Z, Kosciuch J, Safianowska A, Proboszcz M, Bielecki J, van Ingen J, Krenke R, Jagielski T. | Respir Med | 10.1016/j.rmed.2018.05.007 | 2018 | |
| Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan. | Lin H-M, Shu C-C, Chen C-H, Chen N-Y, Yang J-H, Chen C-H, Li S-H, Wang C-L, Yu C-T, Lin S-M, Kao K-C, Huang C-C, Yang C-T, Lu J-J, Chiu C-H, Lai H-C, Wu T-S. | Microbiol Spectr | 10.1128/spectrum.00309-25 | 2025 | | |
| Pathogenicity | Study of characteristics of mycobacteriophage - A novel tool to treat Mycobacterium spp. | Satish R, Desouza A. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_42_19 | 2019 | |
| Alere Determine-tuberculosis lipoarabinomannan positivity in disseminated non-tuberculous mycobacteria: An illustrative case series. | Greyling R, Meintjes G, Sossen B. | South Afr J HIV Med | 10.4102/sajhivmed.v23i1.1369 | 2022 | | |
| Crystal structures of Mycobacterium tuberculosis and Mycobacterium thermoresistibile glycyl-tRNA synthetases in various liganded states. | Fenwick MK, DeRocher AE, Craig JK, Harmon EK, Seibold S, Liu L, Battaile KP, Barrett LK, Van Voorhis WC, Phan IQ, Staker BL, Subramanian S, Lovell S, Myler PJ. | PLoS One | 10.1371/journal.pone.0326500 | 2025 | | |
| Rapid Diagnosis of Pneumocystis jirovecii Pneumonia and Respiratory Tract Colonization by Next-Generation Sequencing. | Xing F, Deng C, Luo Z, Zou S, Liu M, Ye H, Sun L, Tsang CC, Lo SKF, Lau SKP, Woo PCY. | Mycopathologia | 10.1007/s11046-024-00849-y | 2024 | | |
| Systemic Mycobacterium kansasii Infection in a Domestic Shorthair Cat. | Lee SH, Go DM, Woo SH, Park HT, Kim E, Yoo HS, Kim DY. | J Comp Pathol | 10.1016/j.jcpa.2017.07.009 | 2017 | | |
| Multicenter evaluation of the biochip assay for rapid detection of mycobacterial isolates in smear-positive specimens. | Fang H, Shangguan Y, Wang H, Ji Z, Shao J, Zhao R, Wang S, Zheng L, Jin X, Huang S, Xu K, Sheng J. | Int J Infect Dis | 10.1016/j.ijid.2019.01.036 | 2019 | | |
| Analysis of Clinical Isolation Characteristics of Nontuberculous Mycobacteria and Drug Sensitivity of Rapidly Growing Mycobacteria in the General Hospital of Guangzhou, China. | Liu X, Lin Z, Li Y, Zhong Z, Wu A, Jiang Y. | Infect Drug Resist | 10.2147/idr.s465468 | 2024 | | |
| Enzymology | Case Report: Disseminated Mycobacterium kansasii Disease in a Patient with Anti-Interferon-Gamma Antibody. | Kashihara E, Fujita K, Uchida N, Yamamoto Y, Mio T, Koyama H. | Am J Trop Med Hyg | 10.4269/ajtmh.19-0047 | 2019 | |
| Metagenomic Next-Generation Sequencing for the Diagnosis of Suspected Opportunistic Infections in People Living with HIV. | Xu J, Huang Q, Yu J, Liu S, Yang Z, Wang F, Shi Y, Li E, Li Z, Xiao Y. | Infect Drug Resist | 10.2147/idr.s350047 | 2022 | | |
| Genetics | Clinicopathological characteristics and diagnostic performance of metagenomic pathogen detection technology in mycobacterial infections among HIV patients. | Li M, Chen J, Zhang L, Chen X, Zhou J, Liu F, Zhou X, Xiao J, Yang K, Qi L, Han X, Liu T, Zhao H, Zhou Z, Chen X, Sun L. | Front Cell Infect Microbiol | 10.3389/fcimb.2025.1584189 | 2025 | |
| Chronic laryngitis caused by Mycobacterium Kansasii in a traveler. | Lehman B, Procop GW, Silva Merea V, Harrington SM, Mawhorter SD, Benninger MS. | Laryngoscope | 10.1002/lary.27952 | 2019 | | |
| Mycobacterium marinum Infection and Interferon-Gamma Release Assays Cross-Reactivity: A Case Report. | Patel PM, Camps N, Rivera CI, Tuda C, VanOstran G. | Cureus | 10.7759/cureus.21420 | 2022 | | |
| Novel Quinazolinones Active against Multidrug-Resistant Mycobacterium Tuberculosis: Synthesis, Antimicrobial Evaluation, and in Silico Exploration of Penicillin-Binding Protein 1A as a Potential Target. | Kerda M, Nawrot D, Slechta P, Domansky M, Askari A, Kamangar H, Jandourek O, Konecna K, Paterova P, Hlbocanova I, Machacek M, Mori M, Meneghetti F, Dolezal M, Zitko J, Bouz G. | ChemMedChem | 10.1002/cmdc.202500147 | 2025 | | |
| Pathogenicity | Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds. | Kratky M, Jandourek O, Baranyai Z, Novotna E, Stolarikova J, Bosze S, Vinsova J. | Eur J Med Chem | 10.1016/j.ejmech.2019.111578 | 2019 | |
| Genetics | Clinical utility of metagenomic next-generation sequencing on bronchoalveolar lavage fluid in diagnosis of lower respiratory tract infections. | Zheng Y, Liu W, Xiao T, Chen H, Liu Y. | BMC Pulm Med | 10.1186/s12890-024-03237-w | 2024 | |
| Phylogeny | Evaluation of Q Gene Mycobacteria: A novel and easy nucleic acid chromatography method for mycobacterial species identification. | Chikamatsu K, Aono A, Kawai A, Hata H, Iwamoto T, Igarashi Y, Takaki A, Yamada H, Mitarai S. | J Microbiol Methods | 10.1016/j.mimet.2019.105657 | 2019 | |
| Plasmid-mediated drug resistance in mycobacteria: the tip of the iceberg? | Derbyshire KM, Salfinger M. | J Clin Microbiol | 10.1128/jcm.00628-23 | 2023 | | |
| Detection of Mycobacterium avium-intracellulare Complex (MAC) by Bronchial Lavage and the Relationship with Titers of Anti-Glycopeptidolipid-Core IgA Antibodies to MAC in Patients with Pulmonary MAC Disease. | Shimada D, Sagawa M, Seki M. | Infect Drug Resist | 10.2147/idr.s400200 | 2023 | | |
| Ethambutol-resistant Mycobacterium kansasii cervical lymphadenitis in an immunocompetent adult patient: A case report and literature review. | Asensi V, Palacios JJ, Rivas-Carmenado M, Suarez-Zarracina T, Garcia-Carus E, Fernandez LM, Torres HE, Fierer J, Carton JA. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2019.100137 | 2020 | | |
| Metastatic pulmonary calcification mimicking pulmonary tuberculosis: A case report. | Loh TC, Pang YK, Liam CK, Chew MF, Tan JL. | Respirol Case Rep | 10.1002/rcr2.1030 | 2022 | | |
| Anti-interferon-gamma Antibody-seropositive Disseminated Nontuberculous Mycobacterial Infection Mimicking POEMS and TAFRO Syndromes. | Hidekawa C, Yoshimi R, Kishimoto D, Kato H, Mitsuhashi M, Sakurai N, Sato Y, Uehara T, Iizuka Y, Komiya T, Hamada N, Nagai H, Soejima Y, Kamiyama R, Takase-Minegishi K, Kirino Y, Sakagami T, Nakajima H. | Intern Med | 10.2169/internalmedicine.8366-21 | 2022 | | |
| Phylogeny | Clinical Characteristics and Outcomes of Extrapulmonary Nontuberculous Mycobacterial Infections in a Tertiary-Care Hospital: A Retrospective Study. | Kim S, Kim AR, Bae M, Lim S, Lee SJ. | J Clin Med | 10.3390/jcm13154373 | 2024 | |
| [Frequently Isolated Slow Growing Nontuberculous Mycobacteria from Pulmonary Samples and Evaluation of Drug Susceptibility Testing Results in a Referral Hospital in Turkey]. | Ceyhan I, Ozkara S, Guler MZ, Dulkar G, Altinsoy R, Vezir S. | Mikrobiyol Bul | 10.5578/mb.68091 | 2019 | | |
| Metagenomic next-generation sequencing for rapid detection of pulmonary infection in patients with acquired immunodeficiency syndrome. | Zhong J, Liu Y, Luo N, Wei Q, Su Q, Zou J, Wu X, Huang X, Jiang Y, Liang L, Li H, Lin J. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-023-00608-9 | 2023 | | |
| Pathogenicity | Extended spectrum of antibiotic susceptibility for tuberculosis, Djibouti. | Bouzid F, Astier H, Osman DA, Javelle E, Hassan MO, Simon F, Garnotel E, Drancourt M. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2017.07.007 | 2018 | |
| Diagnostic Utility of a Mycobacterium Multiplex PCR Detection Panel for Tuberculosis and Nontuberculous Mycobacterial Infections. | Uwamino Y, Aono A, Tomita Y, Morimoto K, Kawashima M, Kamata H, Sasaki Y, Nagai H, Hasegawa N, Mitarai S. | Microbiol Spectr | 10.1128/spectrum.05162-22 | 2023 | | |
| B3LYP Study of 3-hydroxynaphthalene-2-carboxanilide para-derivatives. | Michalik M, Poliak P, Lukes V. | Acta Chim Slov | 10.17344/acsi.2017.3371 | 2018 | | |
| Disseminated nontuberculous mycobacteria infection in an immunocompetent host: A case report. | Shin HS, Yang B, Kim SR, Kim HS, Shin KS, Shin YM. | Medicine (Baltimore) | 10.1097/md.0000000000032416 | 2023 | | |
| BACES score: a predictor of health-related quality of life and associated factors in patients with nontuberculous mycobacterial pulmonary disease. | Park Y, Kwak N, Hwang H, Jeon D, Jhun BW, Jo KW, Kang YA, Kim HJ, Kim JY, Kim YR, Kwon YS, Lee JH, Shim TS, Sohn H, Whang J, Kim J, Park N, Lee GI, Yim JJ, Mok J. | Sci Rep | 10.1038/s41598-025-09971-3 | 2025 | | |
| Trends in Non-Tuberculous Mycobacterial Lung Disease and Treatment Outcomes in a Low-Tuberculosis Prevalence Setting: A Retrospective Analysis. | Mohanty BK, Eagan TML, Aarli BB, Skutlaberg DH, Mustafa T. | Pathogens | 10.3390/pathogens13040344 | 2024 | | |
| Failure among Patients with Non-Tuberculous Mycobacterial Infections in Skin, Soft Tissue, and Musculoskeletal System in Southern Taiwan, 2012-2015. | Hsueh JH, Fang SY, Hsieh YH, Chen LW, Lee SS. | Surg Infect (Larchmt) | 10.1089/sur.2018.314 | 2019 | | |
| A valuable endobronchial ultrasound scoring system predicting malignant lymph nodes. | Guler N, Tertemiz KC, Gurel D. | Turk Gogus Kalp Damar Cerrahisi Derg | 10.5606/tgkdc.dergisi.2023.23568 | 2023 | | |
| Pleuritis due to Mycobacterium xenopi without pulmonary infection. | Bachar K, Shulimzon T, Ofek E, Segel MJ. | Access Microbiol | 10.1099/acmi.0.000328 | 2022 | | |
| Pathogenicity | Vic9 mycobacteriophage: the first subcluster B2 phage isolated in Russia. | Zaychikova M, Malakhova M, Bespiatykh D, Kornienko M, Klimina K, Strokach A, Gorodnichev R, German A, Fursov M, Bagrov D, Vnukova A, Gracheva A, Kazyulina A, Shleeva M, Shitikov E. | Front Microbiol | 10.3389/fmicb.2024.1513081 | 2024 | |
| Unraveling Mycobacterium tuberculosis acid resistance and pH homeostasis mechanisms. | Laudouze J, Canaan S, Gouzy A, Santucci P. | FEBS Lett | 10.1002/1873-3468.70023 | 2025 | | |
| Haemophagocytic syndrome caused by disseminated nontuberculous mycobacterial infection. | Baldovino Chiquillo L, Rico DL, Leal DD, Romero M. | BMJ Case Rep | 10.1136/bcr-2023-255226 | 2023 | | |
| Epidemiological profile and follow-up of patients with pulmonary disease by non-tuberculous mycobacteria in Baixada Santista area, São Paulo. | Coelho AGV, Chiou AC, Pedro HDSP, Nardi SMT, Chimara E. | Einstein (Sao Paulo) | 10.31744/einstein_journal/2022ao5510 | 2022 | | |
| Refractory Osteomyelitis Caused by Mycobacterium aubagnense and Its L-Form: Case Report and Review of the Literature. | Cheng J, Zhang L, Huang Q, Li C, Yu J, Zhu M. | Infect Drug Resist | 10.2147/idr.s388629 | 2022 | | |
| Influence of Temperature on Growth of Four Different Opportunistic Pathogens in Drinking Water Biofilms. | van der Wielen PWJJ, Dignum M, Donocik A, Prest EI. | Microorganisms | 10.3390/microorganisms11061574 | 2023 | | |
| Enzymology | Pulmonary Mycobacterium kansasii disease in immunocompetent host: Treatment outcomes with short-course chemotherapy. | Padmapriyadarsini C, Nair D, Gomathi NS, Velayudham B. | Indian J Med Microbiol | 10.4103/0255-0857.195370 | 2016 | |
| Health providers induced iatrogenic delusions of infestation. | Shah PR, Cusick E, Nousari Y, Sandoz A, Tausk F. | Clin Cosmet Investig Dermatol | 10.2147/ccid.s218894 | 2019 | | |
| Genetics | The etiological diagnostic value of metagenomic next-generation sequencing in suspected community-acquired pneumonia. | Liu M, Zhang H, Li L, Mao J, Li R, Yin J, Wu X. | BMC Infect Dis | 10.1186/s12879-024-09507-6 | 2024 | |
| Illumina and Nanopore sequencing in culture-negative samples from suspected lower respiratory tract infection patients. | Ma L, Zhu C, Yan T, Hu Y, Zhou J, Li Y, Du F, Zhou J. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1230650 | 2024 | | |
| Rapid and accurate identification and differentiation of Mycobacterium tuberculosis and non-tuberculous mycobacteria using PCR kits available in a high-burden setting. | Castro-Rodriguez B, Franco-Sotomayor G, Rodriguez-Pazmino AS, Cardenas-Franco GE, Orlando SA, Hermoso de Mendoza J, Parra-Vera H, Garcia-Bereguiain MA. | Front Public Health | 10.3389/fpubh.2024.1358261 | 2024 | | |
| Prognosis of chronic pulmonary aspergillosis in patients with pulmonary non-tuberculous mycobacterial disease. | Naito M, Kurahara Y, Yoshida S, Ikegami N, Kobayashi T, Minomo S, Tachibana K, Tsuyuguchi K, Hayashi S, Suzuki K. | Respir Investig | 10.1016/j.resinv.2018.04.002 | 2018 | | |
| Profile of non-tuberculous mycobacteria amongst tuberculosis presumptive people in Cameroon. | Donkeng Donfack VF, Fokou TAZ, Wadje LEN, Le Grand Napa Tchuedji Y, Djieugoue YJ, Nguimfack Teagho S, Shile Takong B, Assolo YP, Ongboulal SM, Simo YWK, Awungafac SN, Eyangoh S. | BMC Microbiol | 10.1186/s12866-024-03256-x | 2024 | | |
| Metagenomic next-generation sequencing assistance in identifying non-tuberculous mycobacterial infections. | Wang S, Xing L. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1253020 | 2023 | | |
| Orbital and conjunctival nontuberculous mycobacteria infection. | Kuo CT, Chen YT, Tsai IL, Tsai CY, Chen ZT. | Taiwan J Ophthalmol | 10.4103/2211-5056.354534 | 2023 | | |
| Mycobacterium abscessus peritonitis and ventriculitis associated with ventriculoperitoneal shunt. | Clabots D, Serrat A. | IDCases | 10.1016/j.idcr.2022.e01445 | 2022 | | |
| Necrotizing pneumonia in a patient with untreated Mycobacterium kansasii infection. | Toor A, De Freitas G, Torras J. | Respir Med Case Rep | 10.1016/j.rmcr.2019.100849 | 2019 | | |
| Nontuberculous Mycobacterial Lung Disease in the Patients with Cystic Fibrosis-A Challenging Diagnostic Problem. | Wyrostkiewicz D, Opoka L, Filipczak D, Jankowska E, Skorupa W, Augustynowicz-Kopec E, Szturmowicz M. | Diagnostics (Basel) | 10.3390/diagnostics12071514 | 2022 | | |
| Detection of non-tuberculous mycobacterial species using PCR-RFLP analysis in trans-tracheal washes in cattle and buffaloes with respiratory distress. | Slathia P, Narang D, Chandra M, Sharma A, Narang A. | Iran J Vet Res | 2020 | | ||
| Comparison of the molecular FluoroType Mycobacteria VER 1.0 and the Maldi BioTyper Mycobacteria assays for the identification of non-tuberculous mycobacteria. | Guiraud J, Piau C, Enault C, Nkpa Charron E, Ducos D, Lafuente C, Menard A, Peuchant O. | J Clin Microbiol | 10.1128/jcm.01206-24 | 2025 | | |
| Nontuberculous Mycobacterial Infection Mimicking Inflammatory Tenosynovitis: A Real Head Scratcher. | Bhandari S, Perdomo W, Rudinskaya A, Chawdhary K, Odujoko O. | Cureus | 10.7759/cureus.20845 | 2021 | | |
| Clinical characteristics of nontuberculous mycobacterial disease in people living with HIV/AIDS in South Korea: A multi-center, retrospective study. | Lee EH, Chin B, Kim YK, Yoo JS, Choi YH, Kim S, Lee KH, Lee SJ, Kim J, Baek YJ, Kim JH, Ahn JY, Jeong SJ, Ku NS, Yeom JS, Choi JY. | PLoS One | 10.1371/journal.pone.0276484 | 2022 | | |
| Enzymology | Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis. | Saleem N, Saba R, Maddika S, Weinstein M. | Am J Med Sci | 10.1016/j.amjms.2016.03.001 | 2017 | |
| Laryngeal Inflammatory Pseudotumour Secondary to Mycobacterium kansasii. | Al-Zahid S, Wright T, Reece P. | Case Rep Pathol | 10.1155/2018/9356243 | 2018 | | |
| Involvement of Mycobacterium smegmatis small noncoding RNA B11 in triacylglycerol accumulation and altered cell wall permeability. | Wu Z, Liu W, Tan Q, Chen Y, Lai X, Hong J, Liang H, Wu H, Liang J, Chen X. | BMC Microbiol | 10.1186/s12866-025-03826-7 | 2025 | | |
| Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous mycobacteria. | Schulthess B, Schafle D, Kalin N, Widmer T, Sander P. | Antimicrob Agents Chemother | 10.1128/aac.02131-20 | 2023 | | |
| Triazole-Resistant Aspergillus fumigatus in an Israeli Patient with Chronic Cavitary Pulmonary Aspergillosis Due to a Novel E306K Substitution in Hmg1. | Handelman M, Morogovsky A, Liu W, Ben-Ami R, Osherov N. | Antimicrob Agents Chemother | 10.1128/aac.01089-21 | 2021 | | |
| Nontuberculous mycobacteria: A report of eighteen cases from a tertiary care center in India. | Gupta N, Mittal A, Niyas VKM, Banerjee S, Ray Y, Kodan P, Malla S, Khot W, Fazal F, Singh BK, Jorwal P, Nischal N, Soneja M, Wig N. | Lung India | 10.4103/lungindia.lungindia_365_19 | 2020 | | |
| Conservative Approach and Management of Complicated Lung Abscess. | Boucher B, Virlan D, Buddharaju V, Chaudhari S. | Cureus | 10.7759/cureus.31910 | 2022 | | |
| Lipase-catalyzed kinetic resolution of novel antitubercular benzoxazole derivatives. | Lukowska-Chojnacka E, Kowalkowska A, Napiorkowska A. | Chirality | 10.1002/chir.22806 | 2018 | | |
| Atypical mycobacterium infection following anterior cruciate ligament reconstruction. | Aier S, Kalra S, Varma M, Pandey V. | BMJ Case Rep | 10.1136/bcr-2022-253440 | 2023 | | |
| Atypical Mycobacterial Tenosynovitis in the Setting of Adalimumab Use. | Patel J, Guzman N, Wukitsch K. | Cureus | 10.7759/cureus.18952 | 2021 | | |
| Identification of mycobacteria species by molecular methods. | Kunduracilar H. | Int Wound J | 10.1111/iwj.13238 | 2020 | | |
| Preventive treatment for latent tuberculosis from Indian perspective. | Hashim Z, Tyagi R, Singh GV, Nath A, Kant S. | Lung India | 10.4103/lungindia.lungindia_336_23 | 2024 | | |
| Mycobacterium intracellulare Tenosynovitis with Rice Body Formation with Literature Review. | Jeon CH, Kim TW, Park JY, Hwang CS, Lim S. | Infect Chemother | 10.3947/ic.2022.0025 | 2023 | | |
| Disseminated Mycobacterium kansasii infection in a white-tailed deer and implications for public and livestock health. | Ford AK, Niedringhaus KD, Anderson AN, LaCour JM, Nemeth NM. | J Vet Diagn Invest | 10.1177/1040638719895475 | 2020 | | |
| Enzymology | Respiratory infections due to nontuberculous mycobacterias. | Maiz Carro L, Barbero Herranz E, Nieto Royo R. | Med Clin (Barc) | 10.1016/j.medcli.2017.07.010 | 2018 | |
| The role of ABC transporter DrrABC in the export of PDIM in Mycobacterium tuberculosis. | Moolla N, Weaver H, Bailo R, Singh A, Bavro VN, Bhatt A. | Cell Surf | 10.1016/j.tcsw.2024.100132 | 2024 | | |
| Pulmonary tuberculosis associated acute fibrinous and organizing pneumonia: A case report and literature review. | Zhao X, Cheng Y, Xiong Y, Wang G. | Clin Respir J | 10.1111/crj.13626 | 2023 | | |
| Immune Reconstitution Inflammatory Syndrome Secondary to Mycobacterium kansasii Infection in a Kidney Transplant Recipient. | Lemoine M, Laurent C, Hanoy M, Leporrier J, Francois A, Guerrot D, Godin M, Bertrand D. | Am J Transplant | 10.1111/ajt.13433 | 2015 | | |
| Mycobacterium kansasii osteomyelitis - a masquerading disease. | Bhatt K, Banavathi K. | JMM Case Rep | 10.1099/jmmcr.0.005114 | 2018 | | |
| Evaluation of mycobacteria infection prevalence and optimization of the identification process in North Sardinia, Italy. | Chen X, Sechi LA, Molicotti P. | Microbiol Spectr | 10.1128/spectrum.03179-23 | 2024 | | |
| Phylogeny | Proposal of a new method for subtyping of Mycobacterium kansasii based upon PCR restriction enzyme analysis of the tuf gene. | Bakula Z, Modrzejewska M, Safianowska A, van Ingen J, Proboszcz M, Bielecki J, Jagielski T. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2015.12.009 | 2016 | |
| Ocular and Adnexal Diseases in Human Immunodeficiency Virus-Infected Pregnant Women Attending HIV Clinics in Ibadan, Nigeria. | Olayiwola OT, Oluleye TS, Awolude OA, Adeyanju AO. | J West Afr Coll Surg | 10.4103/jwas.jwas_284_22 | 2025 | | |
| Enzymology | Non-Tuberculosis mycobacterium speciation using HPLC under Revised National TB Control Programme (RNTCP) in India. | Sebastian G, Nagaraja SB, Vishwanatha T, Voderhobli M, Vijayalakshmi N, Kumar P. | J Appl Microbiol | 10.1111/jam.13604 | 2018 | |
| Chronic Tenosynovitis due to Mycobacteria kansasii in an Immunocompetent Host. | Wang MS, Berry M, Lehto-Hoffman A, Vi L, Ramessar N. | Case Rep Infect Dis | 10.1155/2018/3297531 | 2018 | | |
| Pathogenicity | [Distribution and drug resistance of nontuberculous Mycobacteria in Beijing]. | Zhang J, Su JR, Ding BC, Liu JW, Yi JL, Yang XY, Wang NH, Wang SM. | Zhonghua Jie He He Hu Xi Za Zhi | 10.3760/cma.j.issn.1001-0939.2017.03.013 | 2017 | |
| Mycobacterium Kansasii Infection and Microscopic Polyangiitis: An Unexpected Association. | Alnaser A, Parperis K. | Cureus | 10.7759/cureus.2831 | 2018 | | |
| Mycobacterium xenopi infection of the kidney and lymph nodes: A case report. | Zeng G, Lu J. | Open Med (Wars) | 10.1515/med-2023-0646 | 2023 | | |
| Enzymology | Isoniazid-resistant Mycobacterium kansasii in an HIV-positive patient, and possible development of immune reconstitution inflammatory syndrome after initiation of highly active antiretroviral therapy: case report. | Despotovic A, Savic B, Salemovic D, Ranin J, Jevtovic D. | Int J Infect Dis | 10.1016/j.ijid.2015.11.012 | 2016 | |
| Apical fibrobullous lung disease in ankylosing spondylitis: case report and literature review. | Catarina da Silva Alfaiate A, Maria Rego Durao V, Seabra Patricio J, Pedrosa Silva Duarte MP. | Eur Clin Respir J | 10.1080/20018525.2022.2086359 | 2022 | | |
| Secondary anaerobic infection in a case of multidrug resistant tubercular paraspinal abscess: A rare presentation. | Sreenivasan P, Sharma B, Singh A, Kataria MS, Ray P, Angrup A. | Access Microbiol | 10.1099/acmi.0.000253 | 2021 | | |
| Antibiotic treatment for nontuberculous mycobacterial lung disease. | Kang YA, Koh WJ. | Expert Rev Respir Med | 10.1586/17476348.2016.1165611 | 2016 | | |
| [A SURGICAL CASE OF MYCOBACTERIUM KANSASII LUNG DISEASE MIMICKING PRIMARY LUNG CANCER]. | Yamanaka S, Tomoyasu H. | Kekkaku | 2015 | | ||
| Cutaneous Manifestations of Mycobacterium kansasii Infection. | Hojat L, Tobolowsky F, Franco-Paredes C. | Curr Trop Med Rep | 10.1007/s40475-018-0160-8 | 2018 | | |
| Revolutionizing chronic endometritis diagnosis: real-time polymerase chain reaction unveils microbial pathogens in Indian women with abnormal bleeding and reproductive challenges. | Nandagopal M, Rajan N R, Padhiar C, Abhaya M, Bansal U, Ghambir P. | AJOG Glob Rep | 10.1016/j.xagr.2024.100377 | 2024 | | |
| A Cold-Blooded Tiptoer: Nonresolving Cellulitis in an Immunocompromised Patient. | Kitaura S, Okamoto K, Wakabayashi Y, Okada Y, Okazaki A, Ikeda M, Okugawa S, Fujimoto F, Bujo C, Minatsuki S, Tsushima K, Chikamatsu K, Mitarai S, Moriya K. | Open Forum Infect Dis | 10.1093/ofid/ofac074 | 2022 | | |
| Clinical Efficacy of Serum Antiglycopeptidolipid Core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study. | Choi H, Hughes C, Eke Z, Shuttleworth M, Shteinberg M, Polverino E, Goeminne PC, Welte T, Blasi F, Shoemark A, Long MB, Aliberti S, Haworth CS, Ringshausen FC, Loebinger MR, Lorent N, Chalmers JD. | Chest | 10.1016/j.chest.2024.10.029 | 2025 | | |
| Accuracy of QuantiFERON in active tuberculosis suspects with comorbidities and nontuberculous mycobacterial infection in Northern California. | Lu J, Murugesan K, Senchyna F, Budvytiene I, Banaei N. | J Clin Microbiol | 10.1128/jcm.00775-23 | 2023 | | |
| Draft Genome Sequences of Mycobacterium kansasii Clinical Strains. | Borowka P, Lach J, Bakula Z, van Ingen J, Safianowska A, Brzostek A, Dziadek J, Strapagiel D, Jagielski T. | Genome Announc | 10.1128/genomea.00406-17 | 2017 | | |
| A Preliminary Study on Microbiota Characteristics of Bronchoalveolar Lavage Fluid in Patients with Pulmonary Nodules Based on Metagenomic Next-Generation Sequencing. | Yuan Q, Wang X, Li Z, Guo W, Cheng H, Cao Q. | Biomedicines | 10.3390/biomedicines11020631 | 2023 | | |
| Enzymology | Interferon-gamma release assays in patients with Mycobacterium kansasii pulmonary infection: A retrospective survey. | Sato R, Nagai H, Matsui H, Kawabe Y, Takeda K, Kawashima M, Suzuki J, Ohshima N, Masuda K, Yamane A, Tamura A, Akagawa S, Ohta K. | J Infect | 10.1016/j.jinf.2016.03.011 | 2016 | |
| Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis. | Zhou Y, Mu W, Zhang J, Wen SW, Pakhale S. | BMJ Open | 10.1136/bmjopen-2021-055672 | 2022 | | |
| Chemical Composition, Antioxidant and Antimicrobial Activity of Piper carpunya and Simira ecuadorensis: A Comparative Study of Four Extraction Methods | Guaman-Balcazar M, Hualpa D, Infante G, Luzuriaga L, Riofrio J, Jarro A, Lopez E, Salas-Gomez V, Salazar R, Reyes J, Meneses M. | Plants (Basel) | 2025 | | ||
| An alveolus lung-on-a-chip model of Mycobacterium fortuitum lung infection. | Ektnitphong V, Dias BRS, Campos PC, Shiloh MU. | Dis Model Mech | 10.1242/dmm.052085 | 2025 | | |
| Mycobacterial Interspersed Repeat Unit-Variable Number Tandem Repeat Typing of Mycobacterium avium Strains Isolated from the Lymph Nodes of Free-Living Carnivorous Animals in Poland. | Orlowska B, Majchrzak M, Didkowska A, Anusz K, Krajewska-Wedzina M, Zabost A, Brzezinska S, Kozinska M, Augustynowicz-Kopec E, Urbanska K, Welz M, Parniewski P. | Pathogens | 10.3390/pathogens12091184 | 2023 | | |
| A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013. | Morimoto K, Hasegawa N, Izumi K, Namkoong H, Uchimura K, Yoshiyama T, Hoshino Y, Kurashima A, Sokunaga J, Shibuya S, Shimojima M, Ato M, Mitarai S. | Ann Am Thorac Soc | 10.1513/annalsats.201607-573oc | 2017 | | |
| Scedosporium apiospermum lung disease in a patient with nontuberculous mycobacteria. | Ogata H, Harada E, Okamoto I. | Respirol Case Rep | 10.1002/rcr2.691 | 2021 | | |
| Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature. | Siddiqa A, Khan S, Rodriguez GD, Urban C, Segal-Maurer S, Turett G. | IDCases | 10.1016/j.idcr.2023.e01703 | 2023 | | |
| [A case of pulmonary Mycobacterium kansasii infection with pleural effusion, distinguished from pulmonary tuberculosis]. | Kimura Y, Kurosawa T, Hosaka K. | Kekkaku | 2014 | | ||
| Vertebral Osteomyelitis Caused by Mycobacterium arupense Mimicking Tuberculous Spondylitis: First Reported Case and Literature Review. | Kasamatsu A, Fukushima K, Igarashi Y, Mitarai S, Nagata Y, Horiuchi M, Sekiya N. | Open Forum Infect Dis | 10.1093/ofid/ofad019 | 2023 | | |
| Enzymology | GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report. | Mendes-de-Almeida DP, Andrade FG, Borges G, Dos Santos-Bueno FV, Vieira IF, da Rocha LKMDS, Mendes-da-Cruz DA, Zancope-Oliveira RM, Calado RT, Pombo-de-Oliveira MS. | BMC Med Genet | 10.1186/s12881-019-0799-6 | 2019 | |
| Development and preliminary evaluation toward a new tuberculosis treatment monitoring tool: the PATHFAST TB LAM Ag assay. | Akinaga A, Takahashi M, Yamazaki T, Chikamatsu K, Matsushita S, Hashimoto Y, Iyoda T, Saika T, Mitarai S. | J Clin Microbiol | 10.1128/jcm.00629-24 | 2024 | | |
| [CLINICO-MICROBIOLOGICAL CHARACTERISTICS OF MYCOBACTERIUM KANSASII PULMONARY DISEASE AT A SPECIALIZED MYCOBACTERIOSIS HOSPITAL IN TOKYO, JAPAN]. | Morimoto K, Maeda S, Yoshiyama T, Matsuda S, Uchimura K, Sasaki Y, Kurashima A, Ogata H, Kudoh S, Gotoh H. | Kekkaku | 2015 | | ||
| Clinical relevance of lung microbiota composition in critically ill children with acute lower respiratory tract infections: insights from a retrospective analysis of metagenomic sequencing. | Men Z, Chen Z, Gu X, Wang Y, Zhang X, Fang F, Shen M, Huang S, Wu S, Zhou L, Bai Z. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-024-04980-y | 2025 | | |
| Osteomyelitis due to Mycobacterium kansasii in a patient with sarcoidosis. | van Herwaarden N, Bavelaar H, Janssen R, Werre A, Dofferhoff A. | IDCases | 10.1016/j.idcr.2017.04.001 | 2017 | | |
| Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome. | Yin SM, Ferdman RM, Wang L, Markert ML, Tam JS. | J Clin Immunol | 10.1007/s10875-015-0171-3 | 2015 | | |
| Enzymology | Fatal aortic pseudoaneurysm from disseminated Mycobacterium kansasii infection: case report. | Ehsani L, Reddy SC, Mosunjac M, Kraft CS, Guarner J. | Hum Pathol | 10.1016/j.humpath.2014.11.005 | 2015 | |
| Isolated Mycobacterium kansasii wound infection and Osteomyelitis in an immunocompetent patient. | Turk T, Almahmoud MF, Raslan K. | Oxf Med Case Reports | 10.1093/omcr/omw087 | 2016 | | |
| Pathogenicity | Roles of autophagy in killing of mycobacterial pathogens by host macrophages - Effects of some medicinal plants. | Tatano Y, Shimizu T, Sano C, Tomioka H. | Eur J Microbiol Immunol (Bp) | 10.1556/1886.2023.00062 | 2024 | |
| Mendelian Susceptibility to Mycobacterial Disease: The First Case of a Diagnosed Adult Patient in the Czech Republic. | Prucha M, Grombirikova H, Zdrahal P, Bloomfield M, Parackova Z, Freiberger T. | Case Reports Immunol | 10.1155/2020/8836685 | 2020 | | |
| Non-tuberculous mycobacteria: clinical and laboratory characterisation (2009 and 2019). | Lopes M, Batista M, Garcia T, Alves H, Boaventura L, Pontes C, Rodrigues F. | Epidemiol Infect | 10.1017/s0950268822000899 | 2022 | | |
| Enzymology | Molecular characterisation of clinical and environmental isolates of Mycobacterium kansasii isolates from South African gold mines. | Kwenda G, Churchyard GJ, Thorrold C, Heron I, Stevenson K, Duse AG, Marais E. | J Water Health | 10.2166/wh.2014.161 | 2015 | |
| Systemic Mycobacterium kansasii Infection in Two Related Cats. | Cerna P, Mitchell JL, Lodzinska J, Cazzini P, Varjonen K, Gunn-Moore DA. | Pathogens | 10.3390/pathogens9110959 | 2020 | | |
| Mycobacterium kansasii cutaneous infection in a patient with sarcoidosis treated with anti-TNF agents. | Spiliopoulou I, Foka A, Bounas A, Marangos MN. | Acta Clin Belg | 10.1179/0001551214z.00000000052 | 2014 | | |
| First case of acute granulomatous interstitial nephritis with immune reconstitution inflammatory syndrome in a patient with HIV coinfected with disseminated Mycobacterium kansasii. | Kapoor V, Latif A, Warraich FH, Majeed A. | BMJ Case Rep | 10.1136/bcr-2017-222149 | 2018 | | |
| Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view. | Guglielmetti L, Mougari F, Lopes A, Raskine L, Cambau E. | Future Microbiol | 10.2217/fmb.15.64 | 2015 | | |
| Antimicrobial Susceptibility Testing Using the MYCO Test System and MIC Distribution of 8 Drugs against Clinical Isolates of Nontuberculous Mycobacteria from Shanghai. | Ying R, Yang J, Wu X, Yu F, Sha W. | Microbiol Spectr | 10.1128/spectrum.02549-22 | 2023 | | |
| Enhancing the antimycobacterial efficacy of pyridine-4-carbohydrazide: linkage to additional antimicrobial agents via oxocarboxylic acids. | Pflegr V, Konecna K, Stolarikova J, Osterreicher J, Jandourek O, Kratky M. | RSC Med Chem | 10.1039/d4md00663a | 2025 | | |
| Nontuberculosis Mycobacteria: Isolation from clinical samples in Iraq. | Ahmed ST, Alsudani AA, Ali RM, Shihab BA, Hussein SA. | Int J Mycobacteriol | 10.1016/j.ijmyco.2016.09.028 | 2016 | | |
| Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China. | Kong Y, Geng Z, Jiang G, Jia J, Wang F, Jiang X, Gu Y, Qi Z, Chu N, Huang H, Yu X. | Heliyon | 10.1016/j.heliyon.2023.e21216 | 2023 | | |
| Genetics | Comparative Genomic and Transcriptomic Analyses of Mycobacterium kansasii Subtypes Provide New Insights Into Their Pathogenicity and Taxonomy. | Guan Q, Ummels R, Ben-Rached F, Alzahid Y, Amini MS, Adroub SA, van Ingen J, Bitter W, Abdallah AM, Pain A. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.00122 | 2020 | |
| Enzymology | An unusual lung mass post stem cell transplantation. | Lyons J, Vandenberghe E, Fahy R, McDonnell C, Keane J, McLaughlin AM. | Transpl Infect Dis | 10.1111/tid.12257 | 2014 | |
| Atypical presentation of nontuberculous mycobacterial pulmonary infection in a patient with interstitial lung abnormality: A case report. | Park J, Park B. | Eur J Radiol Open | 10.1016/j.ejro.2021.100353 | 2021 | | |
| Rare case of Mycobacterium nebraskense presenting as asymptomatic cavitary lung lesion. | Abdulfattah O, Lixon A, Kandel S, Rahman EU, Roy S, Dahal S, Alnafoosi Z, Schmidt F. | J Community Hosp Intern Med Perspect | 10.1080/20009666.2017.1418120 | 2018 | | |
| Hematological profiles of patients with tuberculosis and nontuberculous mycobacteria infections in Bamako, Mali. | Sanogo F, Kodio O, Sarro YS, Diarra B, Coulibaly G, Tolofoudie M, Fofana DB, Maiga A, Somboro AM, Diallo F, G Togo AC, Somboro A, Baya B, Kone B, Sanogo M, Dabitao D, Kone A, Diakite M, Doumbia S, Mamoudou M. | Int J Mycobacteriol | 10.4103/ijmy.ijmy_208_22 | 2023 | | |
| Changing epidemiology of nontuberculous mycobacterial lung disease over the last two decades in a region of the Basque country. | Pedrero S, Tabernero E, Arana-Arri E, Urra E, Larrea M, Zalacain R. | ERJ Open Res | 10.1183/23120541.00110-2018 | 2019 | | |
| Enzymology | Mycobacteria in aquarium fish: results of a 3-year survey indicate caution required in handling pet-shop fish. | Kusar D, Zajc U, Jencic V, Ocepek M, Higgins J, Zolnir-Dovc M, Pate M. | J Fish Dis | 10.1111/jfd.12558 | 2017 | |
| Enzymology | Predictors of developing Mycobacterium kansasii pulmonary disease within 1 year among patients with single isolation in multiple sputum samples: A retrospective, longitudinal, multicentre study. | Huang HL, Cheng MH, Lu PL, Liu CJ, Chong IW, Wang JY. | Sci Rep | 10.1038/s41598-018-36255-w | 2018 | |
| The Enterococcus secretome inhibits the growth of Mycobacterium tuberculosis complex mycobacteria. | Achache W, Mege JL, Fellag M, Drancourt M. | Access Microbiol | 10.1099/acmi.0.000471.v3 | 2023 | | |
| [Establishment of multiplex PCR method for rapid detection of nontuberculous mycobacteriums infection in the hand]. | Liu LL, Chen SJ, Long H, Wang C, Cao TY, Hu ZX, Wu D. | Zhonghua Yi Xue Za Zhi | 10.3760/cma.j.issn.0376-2491.2016.14.011 | 2016 | | |
| Opportunistic Infections, Mortality Risk, and Prevention Strategies in Patients With Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome. | Czech M, Cuellar-Rodriguez J, Patel BA, Groarke EM, Cowen EW, Turturice B, Beck DB, Wilson L, Goodspeed W, Darden I, Young NS, Hickstein D, Ombrello A, Hoffman P, Arikan EA, Sinaii N, Hathaway L, Castelo-Soccio L, Fike A, Kastner DB, Grayson PC, Ferrada MA. | Open Forum Infect Dis | 10.1093/ofid/ofae405 | 2024 | | |
| Enzymology | Clinical Case of the Month. A 44-Year-Old HIV-Infected Man With Righ-Shoulder Swelling. | Mickman C, Caruthers C, Spiegel J, Schiro R, Maffei J, Sanders CV, Lopez FA. | J La State Med Soc | 2014 | | |
| Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. | Liu CF, Song YM, He WC, Liu DX, He P, Bao JJ, Wang XY, Li YM, Zhao YL. | Infect Dis Poverty | 10.1186/s40249-021-00844-1 | 2021 | | |
| Pathogenicity | The Chemical Composition and Anti-mycobacterial Activities of Trachyspermum copticum and Pelargonium graveolens Essential Oils. | Kardan-Yamchi J, Mahboubi M, Kazemian H, Hamzelou G, Feizabadi MM. | Recent Pat Antiinfect Drug Discov | 10.2174/1574891x14666191028113321 | 2020 | |
| [Pathogenicity of Mycobacterium kansasii]. | Vesenbeckh S, Wagner S, Mauch H, Roth A, Streubel A, Russmann H, Bauer TT, Matthiessen W, Schonfeld N. | Pneumologie | 10.1055/s-0034-1377288 | 2014 | | |
| Mycobacterium kansasii infection of the spine in a patient with sarcoidosis: a case report and literature review. | Bakhsh WR, Mesfin A. | J Surg Orthop Adv | 10.3113/jsoa.2014.0162 | 2014 | | |
| Mycobacterium szulgai Infection after Carpal Tunnel Release Requiring Extensive Debridement and ALT Flap Reconstruction. | Saeed A, Narayan N, Karmiris N, Troisi L. | J Hand Microsurg | 10.1055/s-0040-1709215 | 2021 | | |
| Marine sponge microbe provides insights into evolution and virulence of the tubercle bacillus. | Pidot SJ, Klatt S, Ates LS, Frigui W, Sayes F, Majlessi L, Izumi H, Monk IR, Porter JL, Bennett-Wood V, Seemann T, Otter A, Taiaroa G, Cook GM, West N, Tobias NJ, Fuerst JA, Stutz MD, Pellegrini M, McConville M, Brosch R, Stinear TP. | PLoS Pathog | 10.1371/journal.ppat.1012440 | 2024 | | |
| Evaluation of molecular diagnostic test for detection of adult pulmonary tuberculosis: A generic protocol. | Jayaprakasam M, Pandey RM, Choudhary H, Shanmugam S, Sivaramakrishnan GN, Gupta N. | Indian J Med Res | 10.4103/ijmr.ijmr_2316_23 | 2024 | | |
| DNA microarrays to identify etiological agents, as sensors of environmental wellbeing. | Arena-Ortiz ML, Sanchez-Rodriguez EC, Apodaca-Hernandez JE, Ortiz-Alcantara JM, Rios-Contreras K, Chiappa-Carrara X. | Front Bioeng Biotechnol | 10.3389/fbioe.2023.1085976 | 2023 | | |
| Shift of human pathogen community composition and their potential human health risk after supply suspension in tap water. | Liu S, Li Q, Jiang R, Liu P, Zhang XX. | Sci Rep | 10.1038/s41598-023-39225-z | 2023 | | |
| Phylogeny | Combining comparative genomic analysis with machine learning reveals some promising diagnostic markers to identify five common pathogenic non-tuberculous mycobacteria. | Jia X, Yang L, Li C, Xu Y, Yang Q, Chen F. | Microb Biotechnol | 10.1111/1751-7915.13815 | 2021 | |
| Metabolism | Lithium inhibits growth of intracellular Mycobacterium kansasii through enhancement of macrophage apoptosis. | Sohn H, Kim K, Lee KS, Choi HG, Lee KI, Shin AR, Kim JS, Shin SJ, Song CH, Park JK, Kim HJ. | J Microbiol | 10.1007/s12275-014-3469-6 | 2014 | |
| Successful treatment of non-tuberculous mycobacterial pleurisy with acute fever by antimycobacterial therapy. | Yamoto M, Kawagishi Y, Murata A, Tsuji H. | BMJ Case Rep | 10.1136/bcr-2017-222439 | 2018 | | |
| Pathogenicity | Drug susceptibility testing of nontuberculous mycobacteria. | van Ingen J, Kuijper EJ. | Future Microbiol | 10.2217/fmb.14.60 | 2014 | |
| Chronic Tenosynovitis of the Upper Extremities Caused by Mycobacterium kansasii : A Clinical Case and Systematic Review of Literature. | Huayllani MT, Sisti A, Boczar D, Restrepo DJ, Parker AS, Sarabia-Estrada R, Rinker BD, Forte AJ. | Indian J Plast Surg | 10.1055/s-0040-1709377 | 2020 | | |
| High-throughput nanopore targeted sequencing for efficient drug resistance assay of Mycobacterium tuberculosis | Tang C, Wu L, Li M, Dai J, Shi Y, Wang Q, Xu F, Zheng L, Xiao X, Cai J, Zhang Y, Yang Y, Zheng X, Xiang G. | Front Microbiol | 2024 | | ||
| Enzymology | Mycobacterium kansasii septicaemia in an AIDS patient complicated by acute respiratory distress syndrome and acute liver failure. | Shaaban H, Layne T, Sensakovic JW, Boghossian J. | Int J STD AIDS | 10.1177/0956462413496080 | 2014 | |
| Management of infected recurrent mediastinal bronchogenic cyst with tuberculous mediastinal lymphadenitis. | Hiremath CS, Kumar D, Doddamane AN, Kamath A. | Indian J Thorac Cardiovasc Surg | 10.1007/s12055-019-00850-x | 2020 | | |
| Changes in the rate of bacillus tuberculosis infection in health workers in the first year of the COVID-19 epidemic in Kashan- Iran. | Sehat M, Razzaghi R, Ghamsary M, Faghir Ganji M, Sehat M. | Heliyon | 10.1016/j.heliyon.2023.e20560 | 2023 | | |
| Nontuberculous mycobacteria by metagenomic next-generation sequencing: Three cases reports and literature review. | Liu Y, Ma X, Chen J, Wang H, Yu Z. | Front Public Health | 10.3389/fpubh.2022.972280 | 2022 | | |
| Prognosis of nontuberculous mycobacterial pulmonary disease according to the method of microbiologic diagnosis. | Sin S, Han S, Lee YJ, Cho YJ, Park JS, Yoon HI, Lee CT, Lee JH. | Sci Rep | 10.1038/s41598-021-87197-9 | 2021 | | |
| Enzymology | Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in Japan. | Ito Y, Hirai T, Fujita K, Maekawa K, Niimi A, Ichiyama S, Mishima M. | J Infect Chemother | 10.1016/j.jiac.2015.01.004 | 2015 | |
| Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review. | Sayabovorn N, Chongtrakool P, Chayakulkeeree M. | BMC Infect Dis | 10.1186/s12879-020-05703-2 | 2021 | | |
| Cytopathological analysis of bronchoalveolar lavage fluid in patients with and without HIV infection. | Chen XM, Sun L, Yang K, Chen JM, Zhang L, Han XY, Zhou X, Ma ZY, Li M, Zhao HX, Qi LM, Wang P. | BMC Pulm Med | 10.1186/s12890-022-01851-0 | 2022 | | |
| Evaluation of the clinical impact of bone marrow cultures in current medical practice. | Sharvit G, Schwartz D, Heering G, Shulman A, Avigdor A, Rahav G, Toren A, Nagler A, Canaani J. | Sci Rep | 10.1038/s41598-022-14059-3 | 2022 | | |
| Genetics | Rifampicin Resistance Associated with rpoB Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020. | Schaeffer J, Lippert K, Pleininger S, Stoger A, Hasenberger P, Stadlbauer S, Heger F, Eigentler A, Geusau A, Indra A, Allerberger F, Ruppitsch W. | Microbiol Spectr | 10.1128/spectrum.02757-21 | 2022 | |
| Disseminated mycobacteriosis caused by Mycobacterium kansasii in a pot-bellied pig. | Schafbuch R, Tinkler S, Lim CK, Wolking R, Ramos-Vara J. | J Vet Diagn Invest | 10.1177/1040638718780189 | 2018 | | |
| Phylogeny | Strain variation amongst clinical and potable water isolates of M. kansasii using automated repetitive unit PCR. | Thomson R, Tolson C, Huygens F, Hargreaves M. | Int J Med Microbiol | 10.1016/j.ijmm.2014.02.004 | 2014 | |
| Enzymology | A photoelectrocatalytic process that disinfects water contaminated with Mycobacterium kansasii and Mycobacterium avium. | Brugnera MF, Miyata M, Zocolo GJ, Leite CQ, Zanoni MV. | Water Res | 10.1016/j.watres.2013.08.027 | 2013 | |
| Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study. | Augustynowicz-Kopec E, Siemion-Szczesniak I, Zabost A, Wyrostkiewicz D, Filipczak D, Oniszh K, Gawryluk D, Radzikowska E, Korzybski D, Szturmowicz M. | Pol J Microbiol | 10.21307/pjm-2019-002 | 2019 | | |
| Smoking is a Factor in Discordance Between QuantiFERONTB Gold Assay and Tuberculosis Etiology: Especially in Older Patients. | Liu L, Wu G, Wang J, Peng L, Xu X, Cai L. | Infect Drug Resist | 10.2147/idr.s412473 | 2023 | | |
| Molecular Identification of Non-tuberculous Mycobacteria in Suspected Tuberculosis Cases in Central India. | Dadheech M, Malhotra AG, Patel S, Singh J, Khadanga S, Khurana A, Purwar S, Biswas D, Singh S, Maurya AK. | Cureus | 10.7759/cureus.39992 | 2023 | | |
| Evaluation of the FluoroType Mycobacteria assay for identification of mycobacteria. | Luukinen B, Antikainen J, Aittoniemi J, Miikkulainen-Lahti T, Hyyrylainen H-L, Patari-Sampo A. | J Clin Microbiol | 10.1128/jcm.01054-23 | 2024 | | |
| Enzymology | Mastitis caused by Mycobacterium kansasii infection in a dog. | Murai A, Maruyama S, Nagata M, Yuki M. | Vet Clin Pathol | 10.1111/vcp.12056 | 2013 | |
| Silicosis Among Immigrant Engineered Stone (Quartz) Countertop Fabrication Workers in California. | Fazio JC, Gandhi SA, Flattery J, Heinzerling A, Kamangar N, Afif N, Cummings KJ, Harrison RJ. | JAMA Intern Med | 10.1001/jamainternmed.2023.3295 | 2023 | | |
| Cold Cas: reevaluating the occurrence of CRISPR/Cas systems in Mycobacteriaceae. | Brenner E, Sreevatsan S. | Front Microbiol | 10.3389/fmicb.2023.1204838 | 2023 | | |
| Enzymology | Pulmonary nontuberculous mycobacterial infections: presumptive diagnosis based on the international microbiological criteria adopted in the state of São Paulo, Brazil, 2011-2014. | Marques LRM, Ferrazoli L, Chimara E. | J Bras Pneumol | 10.1590/1806-3713/e20180278 | 2019 | |
| Pathogenicity | A Disseminated Mycobacterium Abscessus Infection in a Patient Affected by Pulmonary Graft versus Host Disease: Case Report with a Revision of Literature. | Bernardelli A, Schena A, Savoldi A, Colato C, Baretta V, D'Alessandro E, Zamboni G, Shoushtari Zadeh Naseri M, Favaro F, Peracchi M, Schena D, Andreini A, Cesaro S, Tecchio C. | J Clin Med | 10.3390/jcm11092410 | 2022 | |
| Crystal structure of a hemerythrin-like protein from Mycobacterium kansasii and homology model of the orthologous Rv2633c protein of M. tuberculosis. | Ma Z, Abendroth J, Buchko GW, Rohde KH, Davidson VL. | Biochem J | 10.1042/bcj20190827 | 2020 | | |
| Atypical mycobacterial cutaneous infections in Egyptians: a clinicopathological study. | El-Khalawany MA. | J Dermatol | 10.1111/1346-8138.12391 | 2014 | | |
| Pathogenicity | Investigation of the antimycobacterial activity of 8-hydroxyquinolines. | Cieslik W, Spaczynska E, Malarz K, Tabak D, Nevin E, O'Mahony J, Coffey A, Mrozek-Wilczkiewicz A, Jampilek J, Musiol R. | Med Chem | 10.2174/1573406410666150807111703 | 2015 | |
| Early acute rejection after lung transplantation mimicking viral pneumonia in the middle of COVID-19 pandemic: A case report. | Palleschi A, Rosso L, Morlacchi LC, Del Gobbo A, Ramondetta M, Gori A, Blasi F, Nosotti M. | Int J Surg Case Rep | 10.1016/j.ijscr.2020.10.105 | 2020 | | |
| Pathogenicity | Evaluation of the Efficacy of Novel Oxazolidinone Analogues against Nontuberculous Mycobacteria In Vitro. | Zhao W, Jiang Y, Bao P, Li Y, Tang L, Zhou Y, Zhao Y. | Jpn J Infect Dis | 10.7883/yoken.jjid.2014.498 | 2015 | |
| Enzymology | Utility of the MALDI-TOF MS method to identify nontuberculous mycobacteria. | Kodana M, Tarumoto N, Kawamura T, Saito T, Ohno H, Maesaki S, Ikebuchi K. | J Infect Chemother | 10.1016/j.jiac.2015.09.006 | 2016 | |
| Proteomics approach to understand reduced clearance of mycobacteria and high viral titers during HIV-mycobacteria co-infection. | Ganji R, Dhali S, Rizvi A, Sankati S, Vemula MH, Mahajan G, Rapole S, Banerjee S. | Cell Microbiol | 10.1111/cmi.12516 | 2016 | | |
| Nontuberculous Mycobacterial Tenosynovitis of the Hand: A 10-Year Experience at Two Centers in South Korea. | Kim DH, Park JY, Won HC, Park JS. | Clin Orthop Surg | 10.4055/cios22248 | 2023 | | |
| Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study. | Fong I, Low TB, Yii A. | Chron Respir Dis | 10.1177/14799731221098714 | 2022 | | |
| Identification of Nocardia and non-tuberculous Mycobacterium species by MALDI-TOF MS using the VITEK MS coupled to IVD and RUO databases. | Rodriguez-Temporal D, Zvezdanova ME, Benedi P, Marin M, Blazquez-Sanchez M, Ruiz-Serrano MJ, Munoz P, Rodriguez-Sanchez B. | Microb Biotechnol | 10.1111/1751-7915.14146 | 2023 | | |
| Non-tuberculous mycobacterial infections at San Francisco General Hospital. | Sheu LC, Tran TM, Jarlsberg LG, Marras TK, Daley CL, Nahid P. | Clin Respir J | 10.1111/crj.12159 | 2015 | | |
| Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates. | Kratky M, Volkova M, Novotna E, Trejtnar F, Stolarikova J, Vinsova J. | Bioorg Med Chem | 10.1016/j.bmc.2014.05.064 | 2014 | | |
| A Case of Pulmonary Mycobacterium kansasii Disease Complicated with Tension Pneumothorax. | Boo KY, Lee JH. | Tuberc Respir Dis (Seoul) | 10.4046/trd.2015.78.4.356 | 2015 | | |
| Profile of Nontuberculous Mycobacteria in Patients Suspected of Tuberculosis and Drug-Resistant Tuberculosis. | Sharma M, Malhotra B, Tiwari J, Bhargava S. | J Lab Physicians | 10.1055/s-0040-1721160 | 2020 | | |
| Mycobacterium chimaera as an Underestimated Cause of NTM Lung Diseases in Patients Hospitalized in Pulmonary Wards. | Zabost AT, Szturmowicz M, Brzezinska SA, Klatt MD, Augustynowicz-Kopec EM. | Pol J Microbiol | 10.33073/pjm-2021-028 | 2021 | | |
| Enzymology | Mycobacterium kansasii isolation from captive South American coati (Nasua nasua). | Rocha VC, Correa SH, Setzer AP, Catao-Dias JL, Ramos MC, Fiori W, Ikuta CY, Ferreira Neto JS. | J Zoo Wildl Med | 10.1638/1042-7260-44.1.167 | 2013 | |
| Pediatric Cutaneous Nontuberculous Mycobacterium Infections in Singapore. | Ng SS, Tay YK, Koh MJ, Thoon KC, Sng LH. | Pediatr Dermatol | 10.1111/pde.12575 | 2015 | | |
| Enzymology | Mycobacterium abscessus subsp. bolletii keratitis: rare case reported in Brazil. | Silva SC, Almeida IN, Ribeiro WC, Miranda SS, Rocha ACH. | Rev Inst Med Trop Sao Paulo | 10.1590/s1678-9946202062006 | 2020 | |
| Enzymology | A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient. | Chan A, Findlay A, Abeygunasekara S. | Transpl Infect Dis | 10.1111/j.1399-3062.2012.00768.x | 2012 | |
| Mycobacterium kansasii Pneumonia with Mediastinal Lymphadenitis in a Patient with Acute Myeloid Leukemia: Successful Treatment to Stem Cell Transplantation. | Choi YG, Cho SY, Lee DG, Yim E, Joo H, Ryu S, Choi JK, Kim HJ. | Infect Chemother | 10.3947/ic.2017.49.1.78 | 2017 | | |
| Complexity of Mycobacterium avium complex immune reconstitution inflammatory syndrome (MAC-IRIS) in a patient with HIV. | Xerri T, Borg J, Casha R, Fsadni C. | BMJ Case Rep | 10.1136/bcr-2021-241813 | 2021 | | |
| Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study. | Gommans EP, Even P, Linssen CF, van Dessel H, van Haren E, de Vries GJ, Dingemans AM, Kotz D, Rohde GG. | Respir Med | 10.1016/j.rmed.2014.10.013 | 2015 | | |
| Pathogenicity | In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran. | Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A. | Microb Drug Resist | 10.1089/mdr.2015.0134 | 2016 | |
| In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022. | Calado Nogueira de Moura V, Nguyen MH, Hunkins JJ, Daley CL, Khare R. | J Antimicrob Chemother | 10.1093/jac/dkad317 | 2023 | | |
| Enzymology | Septic subacromial bursitis caused by Mycobacterium kansasii in an immunocompromised host. | Mathew SD, Tully CC, Borra H, Berven MD, Arroyo R. | Mil Med | 10.7205/milmed-d-11-00236 | 2012 | |
| Enzymology | Mycobacterium kanasii flexor tenosynovitis of the finger. | Jing SS, Teare L, Iwuagwu F. | Hand Surg | 10.1142/s0218810414720204 | 2014 | |
| Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. | Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, Bottger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL. | Clin Infect Dis | 10.1093/cid/ciaa1125 | 2020 | | |
| Disseminated Mycobacterium kansasii in an HIV-negative patient. | Tabarsi P, Baghaei P, Kashani BS, Adimi P, Novin A, Mansouri D. | Int J Mycobacteriol | 10.1016/j.ijmyco.2012.01.008 | 2012 | | |
| Mycobacteriosis in slaughter pigs from South Africa from 1991 to 2002: Mycobacterium spp. diversity and Mycobacterium avium complex genotypes. | Gcebe N, Pierneef RE, Michel AL, Hlokwe MT. | Front Microbiol | 10.3389/fmicb.2023.1284906 | 2023 | | |
| Mycobacterium kansasii Subtype I Is Associated With Clarithromycin Resistance in China. | Li Y, Pang Y, Tong X, Zheng H, Zhao Y, Wang C. | Front Microbiol | 10.3389/fmicb.2016.02097 | 2016 | | |
| Enzymology | Pathological features of Mycobacterium kansasii infection in black bearded sakis (Chiropotes satanas). | Murai A, Murakami T, Inoue M, Ueda H, Shiihara S, Kimura J, Hirata A, Sakai H, Yanai T. | J Comp Pathol | 10.1016/j.jcpa.2012.02.006 | 2012 | |
| Genetics | Whole-genome sequencing reveals transmission pattern and drug resistance of Mycobacterium tuberculosis intra- or inter-hosts. | Ding F, Liu W, Wu C, Zhang W, Chen S, Lai W, Qu J, Lin Q, Lu S, Qu J. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1488547 | 2024 | |
| Diversity of Mycobacteriaceae from aquatic environment at the São Paulo Zoological Park Foundation in Brazil. | Romagnoli CL, Pellegrino KCM, Silva NM, Brianesi UA, Leao SC, Rabello MCDS, Viana-Niero C. | PLoS One | 10.1371/journal.pone.0227759 | 2020 | | |
| Pathogenicity | Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST. | Hombach M, Somoskovi A, Homke R, Ritter C, Bottger EC. | Int J Med Microbiol | 10.1016/j.ijmm.2013.04.003 | 2013 | |
| Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study. | Czaja CA, Levin AR, Cox CW, Vargas D, Daley CL, Cott GR. | Ann Am Thorac Soc | 10.1513/annalsats.201508-529oc | 2016 | | |
| Bursitis, Bacteremia, and Disseminated Infection of Mycobacteroides (Mycobacterium) abscessus subsp. massiliense. | Oka K, Morioka H, Eguchi M, Sato Y, Tetsuka N, Iguchi M, Kanematsu T, Fukano H, Hoshino Y, Kiyoi H, Yagi T. | Intern Med | 10.2169/internalmedicine.6189-20 | 2021 | | |
| Clinical and radiological features of Mycobacterium kansasii and other NTM infections. | Matveychuk A, Fuks L, Priess R, Hahim I, Shitrit D. | Respir Med | 10.1016/j.rmed.2012.06.023 | 2012 | | |
| CRISPR Interference-Based Inhibition of MAB_0055c Expression Alters Drug Sensitivity in Mycobacterium abscessus. | Nguyen TQ, Heo BE, Park Y, Jeon S, Choudhary A, Moon C, Jang J. | Microbiol Spectr | 10.1128/spectrum.00631-23 | 2023 | | |
| Pathogenicity | Clarithromycin-Rifampin-Based Treatment for Nontuberculous Mycobacteria Infections in Immunocompromised Patients who Require Concomitant CYP-Metabolized Medications. | Gonzalez-Bocco IH, Aleissa MM, Zhou E, Manne-Goehler J, Koo S, Cheng MP, Marty FM. | Open Forum Infect Dis | 10.1093/ofid/ofab582 | 2022 | |
| Functional characterization of a DNA-dependent AAA ATPase in a F-cluster mycobacteriophage. | Das R, Bajpai U. | Virus Res | 10.1016/j.virusres.2022.198957 | 2023 | | |
| Enzymology | [Identification of Mycobacterium spp. isolates using matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS)]. | Amlerova J, Studentova V, Hrabak J. | Epidemiol Mikrobiol Imunol | 2014 | | |
| Enzymology | Mycobacterium kansasii pericarditis in a kidney transplant recipient: a case report and comprehensive review of the literature. | Cho JH, Yu CH, Jin MK, Kwon O, Hong KD, Choi JY, Yoon SH, Park SH, Kim CD, Kim YL. | Transpl Infect Dis | 10.1111/j.1399-3062.2012.00767.x | 2012 | |
| Metabolism | NK cells kill mycobacteria directly by releasing perforin and granulysin. | Lu CC, Wu TS, Hsu YJ, Chang CJ, Lin CS, Chia JH, Wu TL, Huang TT, Martel J, Ojcius DM, Young JD, Lai HC. | J Leukoc Biol | 10.1189/jlb.4a0713-363rr | 2014 | |
| Enzymology | Mutations in the essential FAS II beta-hydroxyacyl ACP dehydratase complex confer resistance to thiacetazone in Mycobacterium tuberculosis and Mycobacterium kansasii. | Belardinelli JM, Morbidoni HR. | Mol Microbiol | 10.1111/mmi.12005 | 2012 | |
| Pathogenicity | Assessment of the Cepheid 3-gene Host Response Fingerstick Blood Test (MTB-HR) on rapid diagnosis of tuberculosis. | Wu X, Tan G, Ma J, Yang J, Guo Y, Lu H, Ke H, Li M, Tang YW, Sha W, Yu F. | Emerg Microbes Infect | 10.1080/22221751.2023.2261561 | 2023 | |
| Enzymology | Validation of MALDI-TOF MS devices in reanalysis of unidentified pathogenic bacteria detected in blood cultures. | Imai M, Kimura Y, Tanno D, Saito K, Honda M, Takano Y, Ohashi K, Toyokawa M, Ohana N, Yamadera Y, Shimura H. | Fukushima J Med Sci | 10.5387/fms.2020-09 | 2020 | |
| Abscess resulting from Mycobacterium kansasii in the left thigh of AIDS patient. | Lima CT, Magalhaes V. | An Bras Dermatol | 10.1590/abd1806-4841.20142741 | 2014 | | |
| Conformational folding of mycobacterial methoxy- and ketomycolic acids facilitated by alpha-methyl trans-cyclopropane groups rather than cis-cyclopropane units. | Villeneuve M, Kawai M, Horiuchi K, Watanabe M, Aoyagi Y, Hitotsuyanagi Y, Takeya K, Gouda H, Hirono S, Minnikin DE. | Microbiology (Reading) | 10.1099/mic.0.068866-0 | 2013 | | |
| Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates. | Kratky M, Bosze S, Baranyai Z, Szabo I, Stolarikova J, Paraskevopoulos G, Vinsova J. | Bioorg Med Chem | 10.1016/j.bmc.2014.12.019 | 2015 | | |
| Therapy for Mycobacterium kansasii Infection: Beyond 2018. | DeStefano MS, Shoen CM, Cynamon MH. | Front Microbiol | 10.3389/fmicb.2018.02271 | 2018 | | |
| Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019. | Yang C, Luo X, Fan L, Sha W, Xiao H, Cui H. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.571230 | 2020 | | |
| Single nucleotide variation catalog from clinical isolates mapped on tertiary and quaternary structures of ESX-1-related proteins reveals critical regions as putative Mtb therapeutic targets. | Tzfadia O, Gijsbers A, Vujkovic A, Snobre J, Vargas R, Dewaele K, Meehan CJ, Farhat M, Hakke S, Peters PJ, de Jong BC, Siroy A, Ravelli RBG. | Microbiol Spectr | 10.1128/spectrum.03816-23 | 2024 | | |
| Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency. | Lovell JP, Zerbe CS, Olivier KN, Claypool RJ, Frein C, Anderson VL, Freeman AF, Holland SM. | Ann Am Thorac Soc | 10.1513/annalsats.201603-207bc | 2016 | | |
| Distribution of non-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat shock protein 65 PCR-RFLP. | Nour-Neamatollahie A, Ebrahimzadeh N, Siadat SD, Vaziri F, Eslami M, Akhavan Sepahi A, Khanipour S, Masoumi M, Sakhaee F, Ghazanfari Jajin M, Bahrmand A, Fateh A. | Saudi J Biol Sci | 10.1016/j.sjbs.2016.02.001 | 2017 | | |
| 5-(3,5-Dinitrophenyl)-1,3,4-oxadiazol-2-amine derivatives, their precursors, and analogues: Synthesis and evaluation of novel highly potent antitubercular agent. | Pflegr V, Stolarikova J, Karabanovich G, Maixnerova J, Pal A, Kordulakova J, Sanderova Z, Liegertova M, Roh J, Trejtnar F, Vinsova J, Kratky M. | PLoS One | 10.1371/journal.pone.0324608 | 2025 | | |
| Analysis of pulmonary nodules caused by nontuberculous mycobacteriosis in 101 resected cases: multi-center retrospective study. | Ose N, Takeuchi Y, Kitahara N, Matumura A, Kodama K, Shiono H, Susaki Y, Funakoshi Y, Takabatake H, Shintani Y. | J Thorac Dis | 10.21037/jtd-20-3108 | 2021 | | |
| Synthesis and antimycobacterial evaluation of 5-alkylamino-N-phenylpyrazine-2-carboxamides. | Zitko J, Servusova B, Janoutova A, Paterova P, Mandikova J, Garaj V, Vejsova M, Marek J, Dolezal M, Dolezal M. | Bioorg Med Chem | 10.1016/j.bmc.2014.11.014 | 2015 | | |
| Pathogenicity | Heat-killed bacillus Calmette-Guérin and Mycobacterium kansasii antigen 85B combined vaccination ameliorates dermatitis in a mouse model of atopic dermatitis by inducing regulatory T cells. | Kakeda M, Yamanaka K, Kitagawa H, Tsuda K, Akeda T, Kurokawa I, Gabazza EC, Mizutani H. | Br J Dermatol | 10.1111/j.1365-2133.2011.10763.x | 2012 | |
| Genetics | MALDI Spectra Database for Rapid Discrimination and Subtyping of Mycobacterium kansasii. | Murugaiyan J, Lewin A, Kamal E, Bakula Z, van Ingen J, Ulmann V, Unzaga Baranano MJ, Humiecka J, Safianowska A, Roesler UH, Jagielski T. | Front Microbiol | 10.3389/fmicb.2018.00587 | 2018 | |
| The Value of 18F-FDG PET/CT in the Diagnosis of Tuberculous Pleurisy and in the Differential Diagnosis between Tuberculous Pleurisy and Pleural Metastasis from Lung Adenocarcinoma. | Du X, Zhu F, Yu C. | Contrast Media Mol Imaging | 10.1155/2022/4082291 | 2022 | | |
| Enzymology | Mycobacterium kansasii causing chronic monoarticular synovitis in a patient with HIV/AIDS. | Menashe L, Kerr LD, Hermann G. | J Radiol Case Rep | 10.3941/jrcr.v9i9.2542 | 2015 | |
| Enzymology | Vertebral osteomyelitis caused by non-tuberculous mycobacteria: case reports and review. | Shimizu H, Mizuno Y, Nakamura I, Fukushima S, Endo K, Matsumoto T. | J Infect Chemother | 10.1007/s10156-013-0550-8 | 2013 | |
| Submandibular lymphadenitis due to Mycobacterium malmoense: first reported case from Greece. | Mantadakis E, Soultanidis C, Christidou A, Maraki S. | BMJ Case Rep | 10.1136/bcr-2020-234657 | 2020 | | |
| Disseminated Mycobacterium kansasii infection with hepatic abscesses in a renal transplant recipient. | Kaur P, Fishman JA, Misdraji J, Varma MC, Kotton CN. | Transpl Infect Dis | 10.1111/j.1399-3062.2011.00633.x | 2011 | | |
| GATA2 variants in patients with non-tuberculous mycobacterial or fungal infections without known immunodeficiencies. | Mendes-de-Almeida DP, Andrade FG, Dos Santos-Bueno FV, Saraiva Freitas DF, Soares-Lima SC, Zancope-Oliveira RM, Pombo-de-Oliveira MS. | Hematol Transfus Cell Ther | 10.1016/j.htct.2022.01.014 | 2023 | | |
| The Epidemiology of Nontuberculous Mycobacteria in Cystic Fibrosis. | Sotiropoulou A, Loukou I, Vliora C, Douros K, Moustaki M. | Children (Basel) | 10.3390/children12091270 | 2025 | | |
| Pathogenicity | Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues. | Kozic J, Novotna E, Volkova M, Stolarikova J, Trejtnar F, Vinsova J. | Eur J Med Chem | 10.1016/j.ejmech.2012.07.044 | 2012 | |
| Phylogeny | hsp65 PCR-restriction analysis (PRA) with capillary electrophoresis for species identification and differentiation of Mycobacterium kansasii and Mycobacterium chelonae-Mycobacterium abscessus group. | Sajduda A, Martin A, Portaels F, Palomino JC. | Int J Infect Dis | 10.1016/j.ijid.2011.11.011 | 2012 | |
| A 14-year-old girl with thoracolumbar pain. | Haddadzadeh M. | Kardiochir Torakochirurgia Pol | 10.5114/kitp.2014.41939 | 2014 | | |
| Prevalence of latent tuberculosis infection (LTBI) in healthcare workers in Latin America and the Caribbean: systematic review and meta-analysis. | Meregildo-Rodriguez ED, Ortiz-Pizarro M, Asmat-Rubio MG, Rojas-Benites MJ, Vasquez-Tirado GA. | Infez Med | 10.53854/liim-3203-4 | 2024 | | |
| Evaluation of the Roche cobas MTB and MTB-RIF/INH Assays in Samples from Germany and Sierra Leone. | Nadarajan D, Hillemann D, Kamara R, Foray L, Conteh OS, Merker M, Niemann S, Lau J, Njoya M, Kranzer K, Somoskovi A, Maurer FP. | J Clin Microbiol | 10.1128/jcm.02983-20 | 2021 | | |
| [Present status of studies on epidemiology and molecular epidemiology of Mycobacterium kansasii, in special reference to its molecular epidemiology]. | Yoshida S, Saito H, Suzuki K. | Kekkaku | 2011 | | ||
| Metabolism | Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity). | Kuznetcova TI, Sauty A, Herbort CP. | Int Ophthalmol | 10.1007/s10792-012-9588-3 | 2012 | |
| Activity of combinations of bactericidal and bacteriostatic compounds in Mycobacterium abscessus-infected mice: an overview. | Lanni A, Iona E, Fattorini L, Giannoni F, Iacobino A. | Front Microbiol | 10.3389/fmicb.2025.1616149 | 2025 | | |
| Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London. | Davies BS, Roberts CH, Kaul S, Klein JL, Milburn HJ. | Scand J Infect Dis | 10.3109/00365548.2012.694469 | 2012 | | |
| Genetics | Mycobacterial Pathogenomics and Evolution. | Bottai D, Stinear TP, Supply P, Brosch R. | Microbiol Spectr | 10.1128/microbiolspec.mgm2-0025-2013 | 2014 | |
| Phylogeny | Mycobacterium kansasii infection in a bontebok (Damaliscus pygaragus dorcas) herd: diagnostic challenges in differentiating from the Mycobacterium tuberculosis complex. | Miller M, Terrell S, Lyashchenko K, Greenwald R, Harris B, Thomsen BV, Fontenot D, Stetter M, Neiffer D, Fleming G. | J Zoo Wildl Med | 10.1638/2010-0170.1 | 2011 | |
| [Present status of studies on epidemiology and molecular epidemiology of Mycobacterium kansasii, in special reference to its epidemiology]. | Yoshida S, Saito H, Suzuki K. | Kekkaku | 2011 | | ||
| Simultaneous detection and differentiation of Mycobacterium tuberculosis and nontuberculous mycobacteria in smear-negative sputum by a multiplex PCR assay: a clinical feasibility study. | Xie L, Cao J, Yang Y, Jiang S-L, Tan J-L, Zhang J, Ruan Z-F, Chen L, Xu D-Y, Chen Z, Huang M-X, Jiang X-W. | Microbiol Spectr | 10.1128/spectrum.02316-24 | 2025 | | |
| Pathogenicity | Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence. | van Ingen J, Ferro BE, Hoefsloot W, Boeree MJ, van Soolingen D. | Expert Rev Anti Infect Ther | 10.1586/14787210.2013.830413 | 2013 | |
| Effect of Mixed Infections with Mycobacterium tuberculosis and Nontuberculous Mycobacteria on Diagnosis of Multidrug-Resistant Tuberculosis: A Retrospective Multicentre Study in China. | Huang M, Tan Y, Zhang X, Wang Y, Su B, Xue Z, Wang J, Pang Y. | Infect Drug Resist | 10.2147/idr.s341817 | 2022 | | |
| Enzymology | Solitary pulmonary nodule due to Mycobacterium kansasii. | Abe M, Kobashi Y, Mouri K, Obase Y, Miyashita N, Nakata M, Oka M. | Intern Med | 10.2169/internalmedicine.50.4958 | 2011 | |
| Recurrent fluctuant mass of the wrist and forearm associated with chronic tenosynovitis by Mycobacterium kansasii. | Mazis GA, Sakellariou VI, Kontos F, Zerva L, Spyridonos SG. | Orthopedics | 10.3928/01477447-20110317-23 | 2011 | | |
| Pulmonary infection caused by Mycobacterium kansasii: findings on computed tomography of the chest. | Mogami R, Goldenberg T, de Marca PG, Mello FC, Lopes AJ. | Radiol Bras | 10.1590/0100-3984.2015.0078 | 2016 | | |
| Pathogenicity | Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity. | Vinsova J, Kozic J, Kratky M, Stolarikova J, Mandikova J, Trejtnar F, Buchta V. | Bioorg Med Chem | 10.1016/j.bmc.2013.12.016 | 2014 | |
| Genetics | A lung-specific mutational signature enables inference of viral and bacterial respiratory niche. | Ruis C, Peacock TP, Polo LM, Masone D, Alvarez MS, Hinrichs AS, Turakhia Y, Cheng Y, McBroome J, Corbett-Detig R, Parkhill J, Floto RA. | Microb Genom | 10.1099/mgen.0.001018 | 2023 | |
| New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species. | Pauk K, Zadrazilova I, Imramovsky A, Vinsova J, Pokorna M, Masarikova M, Cizek A, Jampilek J. | Bioorg Med Chem | 10.1016/j.bmc.2013.08.029 | 2013 | | |
| Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene. | Bakula Z, Safianowska A, Nowacka-Mazurek M, Bielecki J, Jagielski T. | Biomed Res Int | 10.1155/2013/178725 | 2013 | | |
| Pathogenicity | In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera. | Pidot SJ, Porter JL, Lister T, Stinear TP. | PLoS Negl Trop Dis | 10.1371/journal.pntd.0009636 | 2021 | |
| Ancient mycobacterial lipids: Key reference biomarkers in charting the evolution of tuberculosis. | Minnikin DE, Lee OY, Wu HH, Besra GS, Bhatt A, Nataraj V, Rothschild BM, Spigelman M, Donoghue HD. | Tuberculosis (Edinb) | 10.1016/j.tube.2015.02.009 | 2015 | | |
| Tuberculosis (T.B.) masquerading as tumor. An 8-year study on 25 cases of long bone tuberculosis presenting as tumors. | Wagh Y, Reddy R, Gundavda M, Agarwal M, Agashe VM, Bajwa S. | SICOT J | 10.1051/sicotj/2020011 | 2020 | | |
| Metabolism | Structural and Functional Characterization of Phosphatidylinositol-Phosphate Biosynthesis in Mycobacteria. | Belcher Dufrisne M, Jorge CD, Timoteo CG, Petrou VI, Ashraf KU, Banerjee S, Clarke OB, Santos H, Mancia F. | J Mol Biol | 10.1016/j.jmb.2020.04.028 | 2020 | |
| Clinical characteristics and risk factors of Talaromyces marneffei infection in human immunodeficiency virus-negative patients: A retrospective observational study. | Wei HY, Liang WJ, Li B, Wei LY, Jiang AQ, Chen WD, Guo PH, Xu J. | World J Emerg Med | 10.5847/wjem.j.1920-8642.2021.04.005 | 2021 | | |
| [Three cases of Mycobacterium kansasii pulmonary diseases in previously healthy young women]. | Ohnishi T, Kusumoto S, Yamaguchi S, Ohki Y, Satou M, Sugiyama T, Shirai T, Nakashima M, Yamaoka T, Okuda K, Hirose T, Adachi M. | Nihon Kokyuki Gakkai Zasshi | 2011 | | ||
| Risk factors for microbiological persistence after 6 months of treatment for Mycobacterium intracellulare and its impact on the drug-resistance profile. | Luo X, Zheng X, Fang Y, Yu F, Cui H, Sun Q, Sha W. | Microbiol Spectr | 10.1128/spectrum.00805-23 | 2023 | | |
| Disruption of nontuberculous mycobacteria biofilms induces a highly vulnerable to antibiotic killing phenotype. | Kurbatfinski N, Hill PJ, Tobin N, Kramer CN, Wickham J, Goodman SD, Hall-Stoodley L, Bakaletz LO. | Biofilm | 10.1016/j.bioflm.2023.100166 | 2023 | | |
| Current Updates on Mycobacterial Taxonomy, 2018 to 2019. | Armstrong DT, Parrish N. | J Clin Microbiol | 10.1128/jcm.01528-20 | 2021 | | |
| Pathogenicity | Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiST. | Lucke K, Hombach M, Friedel U, Ritter C, Bottger EC. | J Antimicrob Chemother | 10.1093/jac/dkr399 | 2012 | |
| Pathogenicity | Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles. | Zitko J, Jampilek J, Dobrovolny L, Svobodova M, Kunes J, Dolezal M, Dolezal M. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2011.12.129 | 2012 | |
| B Cell and Antibody Responses in Bovine Tuberculosis. | Klepp LI, Blanco FC, Bigi MM, Vazquez CL, Garcia EA, Sabio Y Garcia J, Bigi F. | Antibodies (Basel) | 10.3390/antib13040084 | 2024 | | |
| Improvement of Mycobacterium abscessus Pulmonary Disease after Nivolumab Administration in a Patient with Advanced Non-small Cell Lung Cancer. | Ishii S, Tamiya A, Taniguchi Y, Tanaka T, Abe Y, Isa SI, Tsuyuguchi K, Suzuki K, Atagi S. | Intern Med | 10.2169/internalmedicine.1195-18 | 2018 | | |
| Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in general and pneumologist practices in Germany. | Diel R, Obradovic M, Tyler S, Engelhard J, Kostev K. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2020.100178 | 2020 | | |
| Pathogenicity | New S-benzylisothiosemicarbazones with antimycobacterial activity. | Petrlikova E, Waisser K, Heinisch L, Stolarikova J. | Folia Microbiol (Praha) | 10.1007/s12223-011-0015-3 | 2011 | |
| Pathogenicity | New series of isoniazid hydrazones linked with electron-withdrawing substituents. | Vavrikova E, Polanc S, Kocevar M, Kosmrlj J, Horvati K, Bosze S, Stolarikova J, Imramovsky A, Vinsova J. | Eur J Med Chem | 10.1016/j.ejmech.2011.09.054 | 2011 | |
| Precise mycobacterial species and subspecies identification using the PEP-TORCH peptidome algorithm. | Bao D, Maity S, Zhan L, Seo S, Shu Q, Lyon CJ, Ning B, Zelazny A, Hu TY, Fan J. | EMBO Mol Med | 10.1038/s44321-025-00207-5 | 2025 | | |
| A Case of Mycobacterium kansasii Pulmonary Disease Presenting as Endobronchial Lesions in HIV-Infected Patient. | Kim MS, Han JW, Jin SS, Lee JM, Hah JH, Kim YJ, Kim SJ, Kang MW, Kang JY. | Tuberc Respir Dis (Seoul) | 10.4046/trd.2013.75.4.157 | 2013 | | |
| Analysis of alpha-1-antitrypsin (AAT)-regulated, glucocorticoid receptor-dependent genes in macrophages reveals a novel host defense function of AAT. | Bai X, Gao J, Guan X, Narum DE, Fornis LB, Griffith DE, Gao B, Sandhaus RA, Huang H, Chan ED. | Physiol Rep | 10.14814/phy2.16124 | 2024 | | |
| Enzymology | Incidence, Clinical Manifestation, Treatment Outcome, and Drug Susceptibility Pattern of Nontuberculous Mycobacteria in HIV Patients in Tehran, Iran. | Feysia SG, Hasan-Nejad M, Amini S, Hamzelou G, Kazemian H, Kardan-Yamchi J, Karami-Zarandi M, Feizabadi MM. | Ethiop J Health Sci | 10.4314/ejhs.v30i1.10 | 2020 | |
| Antimycobacterial and herbicidal activity of ring-substituted 1-hydroxynaphthalene-2-carboxanilides. | Gonec T, Kos J, Zadrazilova I, Pesko M, Keltosova S, Tengler J, Bobal P, Kollar P, Cizek A, Kralova K, Jampilek J. | Bioorg Med Chem | 10.1016/j.bmc.2013.08.030 | 2013 | | |
| Pathogenicity | Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase. | Kratky M, Vinsova J, Novotna E, Stolarikova J. | Eur J Pharm Sci | 10.1016/j.ejps.2013.12.001 | 2014 | |
| Risk Factors and Mental Health Status in Patients With Non-Tuberculous Mycobacterial Lung Disease: A Single Center Retrospective Study. | Zhao Z, Hu H, Wang M, Li F, Tang H. | Front Public Health | 10.3389/fpubh.2022.912651 | 2022 | | |
| Diagnostic performance of metagenomic next-generation sequencing in non-tuberculous mycobacterial pulmonary disease when applied to clinical practice. | Wei W, Cao J, Wu XC, Cheng LP, Shen XN, Sha W, Sun Q. | Infection | 10.1007/s15010-022-01890-z | 2023 | | |
| Enzymology | Potential biomarkers for identification of mycobacterial cultures by proton transfer reaction mass spectrometry analysis. | Crespo E, de Ronde H, Kuijper S, Pol A, Kolk AH, Cristescu SM, Anthony RM, Harren FJ. | Rapid Commun Mass Spectrom | 10.1002/rcm.6139 | 2012 | |
| The long non-coding RNA MALAT1 regulates intestine host-microbe interactions and polyposis. | Long T, Hernandez JE, Ma S, Steele S, Luo C, Li Y, Xie Q, Telese F, Zhou B, Huang WJM. | Front Cell Dev Biol | 10.3389/fcell.2023.1168693 | 2023 | | |
| A case of multidrug-resistant Mycobacterium simiae in an elderly woman. | Lotfi H, Aryan E, Sankian M, Meshkat Z, Khalifeh Soltani A, Alvandi AH, Farsiani H. | Respirol Case Rep | 10.1002/rcr2.715 | 2021 | | |
| A Series of Nontuberculous Mycobacterial Flexor Tenosynovitis Infections and Cost of Treatment. | Aryee JNA, Akinleye SD, Ugwu-Oju OC, Moore CC, Freilich AM. | J Wrist Surg | 10.1055/s-0041-1728801 | 2021 | | |
| Enzymology | The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China. | Wang MS, Wang JL, Wang XF. | BMC Pulm Med | 10.1186/s12890-016-0320-3 | 2016 | |
| Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections. | Wang G, Stapleton JT, Baker AW, Rouphael N, Creech CB, El Sahly HM, Stout JE, Jackson L, Charbek E, Leyva FJ, Tomashek KM, Tibbals M, Miller A, Frey S, Niemotka S, Wiemken TL, Beydoun N, Alaaeddine G, Turner N, Walter EB, Chamberland R, Abate G. | Open Forum Infect Dis | 10.1093/ofid/ofac375 | 2022 | | |
| Pathogenicity | New fluorine-containing hydrazones active against MDR-tuberculosis. | Vavrikova E, Polanc S, Kocevar M, Horvati K, Bosze S, Stolarikova J, Vavrova K, Vinsova J. | Eur J Med Chem | 10.1016/j.ejmech.2011.07.052 | 2011 | |
| Enzymology | Mycobacterium kansasii Isolated from Tuberculinpositive Rhesus Macaques (Macaca mulatta) in the Absence of Disease. | Shipley ST, Johnson DK, Roodgar M, Smith DG, Montgomery CA, Lloyd SM, Higgins JA, Kriel EH, Klein HJ, Porter WP, Nazareno JB, Houghton PW, Panda A, DeTolla LJ. | Comp Med | 2017 | | |
| Genetics | Association of Interferon-gamma Receptor-1 Gene Polymorphism with Nontuberculous Mycobacterial Lung Infection among Iranian Patients with Pulmonary Disease. | Farnia P, Ghanavi J, Saif S, Farnia P, Velayati AA. | Am J Trop Med Hyg | 10.4269/ajtmh.16-0905 | 2017 | |
| Aggressive mycobacterium abscessus on repeated exogenous lipoid pneumonia in the right middle lobe. | Gil BM, Chung MH, Kim YD, Kim YH, Kang HS, Kim IJ. | Ann Transl Med | 10.21037/atm.2019.04.02 | 2019 | | |
| Non-Tuberculosis Mycobacterium Periprosthetic Joint Infections Following Total Hip and Knee Arthroplasty: Case Series and Review of the Literature. | Maimaiti Z, Li Z, Xu C, Fu J, Hao L, Chen J, Li X, Chai W. | Orthop Surg | 10.1111/os.13661 | 2023 | | |
| Pulmonary Mycobacterium kansasii Infection Mimicking Malignancy on the (18)F-FDG PET Scan in a Patient Receiving Etanercept: A Case Report and Literature Review. | Min Z, Amlani M. | Case Rep Pulmonol | 10.1155/2014/973573 | 2014 | | |
| Metabolism | Effect and Mechanism of Mycobacterium tuberculosis Lipoprotein LpqH in NLRP3 Inflammasome Activation in Mouse Ana-1 Macrophage. | Liu L, Zhai K, Chen Y, Chen X, Wang G, Wu L. | Biomed Res Int | 10.1155/2021/8239135 | 2021 | |
| Pulmonary Cavitary Disease Secondary to Mycobacterium xenopi Complicated by Respiratory Failure. | Habib S, Rajdev K, Pervaiz S, Hasan Siddiqui A, Azam M, Chalhoub M. | Cureus | 10.7759/cureus.3512 | 2018 | | |
| Enzymology | Non-tuberculous mycobacteria infection: 75 cases. | Babalik A, Kuyucu T, Ordu EN, Ernam D, Partal M, Koksalan K. | Tuberk Toraks | 10.5578/tt.2543 | 2012 | |
| Animal Health Protection - Assessing Antimicrobial Activity of Veterinary Disinfectants and Antiseptics and Their Compliance with European Standards: A Narrative Review. | Tyski S, Bocian E, Laudy AE. | Pol J Microbiol | 10.33073/pjm-2024-043 | 2024 | | |
| Enzymology | Mycobacterium kansasii causing septic arthritis and osteomyelitis in a child. | Williams B, Neth O, Shingadia D, Dixon G, Jupp RS, Rosendahl K, Eastwood D, Klein N, Brogan P. | Pediatr Infect Dis J | 10.1097/inf.0b013e3181b78e8b | 2010 | |
| Highly Discriminative Genotyping of Mycobacterium abscessus Complex Using a Set of Variable Number Tandem Repeats in China. | Huang L, Li H, Ren W, Zhang X, Shang Y, Liu Y, Liu A, Pang Y. | Front Microbiol | 10.3389/fmicb.2021.802133 | 2021 | | |
| Genomic Detection of Mycobacterium avium subspecies paratuberculosis in Blood Samples of Patients with Inflammatory Bowel Disease in Southern Iran. | Amirizadehfard S, Mahzounieh M, Safarpour A, Nejabat M, Nazari N. | Iran J Med Sci | 10.30476/ijms.2020.72403.0 | 2020 | | |
| Enzymology | Multicentre study on the reproducibility of MALDI-TOF MS for nontuberculous mycobacteria identification. | Rodriguez-Temporal D, Alcaide F, Marekovic I, O'Connor JA, Gorton R, van Ingen J, Van den Bossche A, Hery-Arnaud G, Beauruelle C, Orth-Holler D, Palacios-Gutierrez JJ, Tudo G, Bou G, Ceyssens PJ, Garrigo M, Gonzalez-Martin J, Greub G, Hrabak J, Ingebretsen A, Mediavilla-Gradolph MC, Oviano M, Palop B, Pranada AB, Quiroga L, Ruiz-Serrano MJ, Rodriguez-Sanchez B. | Sci Rep | 10.1038/s41598-022-05315-7 | 2022 | |
| Pathogenicity | Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents. | Pang H, Jiang Y, Wan K. | Biomed Res Int | 10.1155/2017/1584658 | 2017 | |
| Nontuberculous mycobacterial infection after lung transplantation: a report of four cases. | Ose N, Minami M, Funaki S, Kanou T, Kanzaki R, Shintani Y. | Surg Case Rep | 10.1186/s40792-019-0565-1 | 2019 | | |
| Analysis of the diagnostic efficacy of the QuantiFERON-TB Gold In-Tube assay for preoperative differential diagnosis of spinal tuberculosis. | Hu X, Zhang H, Li Y, Zhang G, Tang B, Xu D, Tang M, Guo C, Liu S, Gao Q. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.983579 | 2022 | | |
| Enzymology | An AIDS patient with immune reconstitution inflammatory syndrome due to pulmonary Mycobacterium kansasii infection during antiretroviral therapy. | Ito M, Komatsu Y, Ushiki A, Yamazaki Y, Kubo K. | J Infect Chemother | 10.1007/s10156-009-0711-y | 2009 | |
| Repurposing Selamectin as an Antimicrobial Drug against Hospital-Acquired Staphylococcus aureus Infections. | Folliero V, Dell'Annunziata F, Santella B, Roscetto E, Zannella C, Capuano N, Perrella A, De Filippis A, Boccia G, Catania MR, Galdiero M, Franci G. | Microorganisms | 10.3390/microorganisms11092242 | 2023 | | |
| Phylogeny | A Novel Method That Allows SNP Discrimination with 160:1 Ratio for Biosensors Based on DNA-DNA Hybridization. | Nimse SB, Song KS, Warkad SD, Kim T. | Biosensors (Basel) | 10.3390/bios11080265 | 2021 | |
| Enzymology | Skin nontuberculous mycobacterial infection in systemic lupus erythematosus: an unusual skin infection mimicking lupus vasculitis. | Touma Z, Haddad A, Gladman DD, Uleryk EM, Urowitz MB. | Semin Arthritis Rheum | 10.1016/j.semarthrit.2012.08.002 | 2013 | |
| Pathogenicity | Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution. | Zitko J, Paterova P, Kubicek V, Mandikova J, Trejtnar F, Kunes J, Dolezal M, Dolezal M. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2012.11.052 | 2013 | |
| Enzymology | Sonographic findings in an alpaca with Mycobacterium kansasii infection. | Braun U, Previtali M, Gautschi A, Forster E, Steininger K, Irmer M, Reichle S, Sydler T, Wiederkehr D, Ruetten M, Hoelzle L. | Schweiz Arch Tierheilkd | 10.1024/0036-7281.151.6.287 | 2009 | |
| Enzymology | Mycobacterium kansasii. | Johnston JC, Chiang L, Elwood K. | Microbiol Spectr | 10.1128/microbiolspec.tnmi7-0011-2016 | 2017 | |
| Coexistence of oligo-articular gout and Mycobacterium kansasii joint and bursal infection in a patient with an orthotopic heart transplant. | Baker JF, Stonecypher M. | Clin Exp Rheumatol | 2009 | | ||
| Pathogenicity | Synthesis and in vitro antimycobacterial and isocitrate lyase inhibition properties of novel 2-methoxy-2'-hydroxybenzanilides, their thioxo analogues and benzoxazoles. | Kozic J, Novotna E, Volkova M, Stolarikova J, Trejtnar F, Wsol V, Vinsova J. | Eur J Med Chem | 10.1016/j.ejmech.2012.08.016 | 2012 | |
| The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands. | Schildkraut JA, Zweijpfenning SMH, Nap M, He K, Dacheva E, Overbeek J, Tostmann A, Wertheim HFL, Hoefsloot W, van Ingen J. | ERJ Open Res | 10.1183/23120541.00207-2021 | 2021 | | |
| Phylogeny | Pangenome databases improve host removal and mycobacteria classification from clinical metagenomic data. | Hall MB, Coin LJM. | Gigascience | 10.1093/gigascience/giae010 | 2024 | |
| Evaluation of MALDI Biotyper Mycobacteria Library for Identification of Nontuberculous Mycobacteria. | Toney NC, Zhu W, Jensen B, Gartin J, Anderson K, Lonsway D, Karlsson M, Rasheed JK. | J Clin Microbiol | 10.1128/jcm.00217-22 | 2022 | | |
| Pathogenicity | Highly active antimycobacterial derivatives of benzoxazine. | Petrlikova E, Waisser K, Divisova H, Husakova P, Vrabcova P, Kunes J, Kolar K, Stolarikova J. | Bioorg Med Chem | 10.1016/j.bmc.2010.10.017 | 2010 | |
| Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes. | Li Y, Zhang W, Zhao J, Lai W, Zhao Y, Li Y, Qu J. | Emerg Microbes Infect | 10.1080/22221751.2022.2103453 | 2022 | | |
| Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study. | Akrami S, Dokht Khosravi A, Hashemzadeh M. | Pathog Glob Health | 10.1080/20477724.2022.2049029 | 2023 | | |
| Diverse clinical presentations of tubercular parotitis in children: case series with review of literature. | Dhingra S, Juneja R. | Sudan J Paediatr | 10.24911/sjp.106-1588918898 | 2021 | | |
| Isolated Endobronchial Mycobacterium avium Disease Associated with Lobar Atelectasis in an Immunocompetent Young Adult: A Case Report and Literature Review. | Kim HI, Kim JW, Kim JY, Kim YN, Kim JH, Jeong BH, Chung MJ, Koh WJ. | Tuberc Respir Dis (Seoul) | 10.4046/trd.2015.78.4.412 | 2015 | | |
| Effect of substitution on the antimycobacterial activity of 2-(substituted benzyl)sulfanyl benzimidazoles, benzoxazoles, and benzothiazoles--a quantitative structure-activity relationship study. | Pytela O, Klimesova V. | Chem Pharm Bull (Tokyo) | 10.1248/cpb.59.179 | 2011 | | |
| Pathogenicity | Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. | van Ingen J, Boeree MJ, van Soolingen D, Mouton JW. | Drug Resist Updat | 10.1016/j.drup.2012.04.001 | 2012 | |
| Comparison of in vitro Susceptibility of Mycobacteria Against PA-824 to Identify Key Residues of Ddn, the Deazoflavin-Dependent Nitroreductase from Mycobacterium tuberculosis. | Zhang F, Li S, Wen S, Zhang T, Shang Y, Huo F, Xue Y, Li L, Pang Y. | Infect Drug Resist | 10.2147/idr.s240716 | 2020 | | |
| Disseminated Mycobacterium kansasii infection associated with hemophagocytic syndrome. | Chou YH, Hsu MS, Sheng WH, Chang SC. | Int J Infect Dis | 10.1016/j.ijid.2009.04.017 | 2010 | | |
| Evolution of Cytochrome P450 Enzymes and Their Redox Partners in Archaea. | Ngcobo PE, Nkosi BVZ, Chen W, Nelson DR, Syed K. | Int J Mol Sci | 10.3390/ijms24044161 | 2023 | | |
| Enzymology | Detection of Mycobacterium kansasii infection in a rhesus macaque (Macaca mulatta) using a modified QuantiFERON-TB Gold assay. | Parsons SD, de Villiers C, Gey van Pittius NC, Warren RM, van Helden PD. | Vet Immunol Immunopathol | 10.1016/j.vetimm.2010.03.020 | 2010 | |
| Mycobacterium shimoidei, a rare non-tuberculous mycobacteria pathogen identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | Nagano H. | Respirol Case Rep | 10.1002/rcr2.428 | 2019 | | |
| Induction of macrophage death by clinical strains of Mycobacterium kansasii. | Sohn H, Kim KW, Kang HB, Won CJ, Kim WS, Lee B, Kwon OJ, Koh WJ, Shin SJ, Kim HJ. | Microb Pathog | 10.1016/j.micpath.2010.02.005 | 2010 | | |
| Phylogeny | Mycobacterium talmoniae, a Potential Pulmonary Pathogen Isolated from Multiple Patients with Bronchiectasis in the United States, Including the First Case of Clinical Disease in a Patient with Cystic Fibrosis. | Vasireddy R, Vasireddy S, Brown-Elliott BA, Greninger AL, Davidson RM, Ard KL, Turenne CY, Wallace RJ. | J Clin Microbiol | 10.1128/jcm.00906-18 | 2019 | |
| Nontubercular Mycobacterial Infection in a Renal Allograft Recipient. | Anandh U, Jayanna K. | Indian J Nephrol | 10.4103/ijn.ijn_336_16 | 2017 | | |
| Clinical and Laboratory Characteristics of Patients with Nontuberculous Mycobacterium Bloodstream Infection in a Tertiary Referral Hospital in Beijing, China. | Bian SN, Zhang LF, Zhang YQ, Yang QW, Wang P, Xu YC, Shi XC, Liu XQ. | Chin Med J (Engl) | 10.4103/0366-6999.189920 | 2016 | | |
| Mycobacteria Intracellulare Spondylodiscitis Presenting as Progressive Consecutive Vertebral Sclerosis: A Case Report. | Shah K, Atodaria G, Patwardhan M, Nene A. | J Orthop Case Rep | 10.13107/jocr.2250-0685.964 | 2017 | | |
| [Mycobacterium kansasii infection after liver transplantation]. | Julian Gomez L, Garcia Pajares F, Alvarez Posadilla M, Sanchez Antolin G, Velicia Llames Mdel R, Caro-Paton Gomez A. | Gastroenterol Hepatol | 10.1016/j.gastrohep.2008.11.006 | 2009 | | |
| Pathogenicity | Antimicrobial activity of sulfonamides containing 5-chloro-2-hydroxybenzaldehyde and 5-chloro-2-hydroxybenzoic acid scaffold. | Kratky M, Vinsova J, Volkova M, Buchta V, Trejtnar F, Stolarikova J. | Eur J Med Chem | 10.1016/j.ejmech.2012.01.060 | 2012 | |
| A randomized prospective study to compare early versus delayed access to antiretroviral therapy over clinical and immunological sequel in HIV-positive adults. | Kumar V, Sharma A, Singh J, Singh H. | J Family Med Prim Care | 10.4103/jfmpc.jfmpc_493_22 | 2022 | | |
| Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease. | Malkin J, Shrimpton A, Wiselka M, Barer MR, Duddridge M, Perera N. | J Med Microbiol | 10.1099/jmm.0.006809-0 | 2009 | | |
| Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid. | Pflegr V, Maixnerova J, Stolarikova J, Pal A, Kordulakova J, Trejtnar F, Vinsova J, Kratky M. | Pharmaceuticals (Basel) | 10.3390/ph14121302 | 2021 | | |
| Phylogeny | A metabolomics approach to characterise and identify various Mycobacterium species. | Olivier I, Loots du T. | J Microbiol Methods | 10.1016/j.mimet.2012.01.012 | 2012 | |
| Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against Mycobacterium fortuitum and Mycobacterium abscessus. | Khosravi AD, Mirsaeidi M, Farahani A, Tabandeh MR, Mohajeri P, Shoja S, Hoseini Lar KhosroShahi SR. | Infect Drug Resist | 10.2147/idr.s187554 | 2018 | | |
| Application Value of SAT-TB Combined with Acid-Fast Staining in the Diagnosis and Treatment of Pulmonary Tuberculosis. | Qiu C, Pan N, Zhou Y, Ning H, Ye X, Liu S, Shi J. | Biomed Res Int | 10.1155/2020/3620425 | 2020 | | |
| Phylogeny | Nontuberculous mycobacteria isolated from specimens of pulmonary tuberculosis suspects, Northern Tunisia: 2002-2016. | Gharbi R, Mhenni B, Ben Fraj S, Mardassi H. | BMC Infect Dis | 10.1186/s12879-019-4441-1 | 2019 | |
| Use of the Human Granulysin Transgenic Mice To Evaluate the Role of Granulysin Expression by CD8 T Cells in Immunity To Mycobacterium tuberculosis. | Thakur P, Sutiwisesak R, Lu YJ, Behar SM. | mBio | 10.1128/mbio.03020-22 | 2022 | | |
| QuantiFERON-TB Gold PLUS versus QuantiFERON- TB Gold In-Tube test for diagnosing tuberculosis infection. | Kim SH, Jo KW, Shim TS. | Korean J Intern Med | 10.3904/kjim.2019.002 | 2020 | | |
| Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. | Santin M, Dorca J, Alcaide F, Gonzalez L, Casas S, Lopez M, Guerra MR. | Eur Respir J | 10.1183/09031936.00024008 | 2009 | | |
| Visible-Light-Driven Photocatalytic Inactivation of Bacteria, Bacteriophages, and Their Mixtures Using ZnO-Coated HDPE Beads as Floating Photocatalyst. | Urbonavicius M, Varnagiris S, Tuckute S, Sakalauskaite S, Demikyte E, Lelis M. | Materials (Basel) | 10.3390/ma15041318 | 2022 | | |
| Genetics | Genomic Insights Into the Mycobacterium kansasii Complex: An Update. | Jagielski T, Borowka P, Bakula Z, Lach J, Marciniak B, Brzostek A, Dziadek J, Dziurzynski M, Pennings L, van Ingen J, Zolnir-Dovc M, Strapagiel D. | Front Microbiol | 10.3389/fmicb.2019.02918 | 2019 | |
| Lung disease caused by nontuberculous mycobacteria. | Alvarez-Uria G. | Curr Opin Pulm Med | 10.1097/mcp.0b013e3283378fa3 | 2010 | | |
| Overview of Cutaneous Mycobacterial Infections. | Franco-Paredes C, Chastain DB, Allen L, Henao-Martinez AF. | Curr Trop Med Rep | 10.1007/s40475-018-0161-7 | 2018 | | |
| Cause Analysis of an Infection in Facelift Surgery Due to Mycobacterium chelonae. | Decalonne M, Lecorche E, Hau E, Petiteau A, Moreau C, Milan O, Lanotte P, Mereghetti L, Cambau E, van der Mee-Marquet N. | Front Med (Lausanne) | 10.3389/fmed.2019.00243 | 2019 | | |
| Enzymology | Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in Singapore. | Lim AYH, Chotirmall SH, Fok ETK, Verma A, De PP, Goh SK, Puah SH, Goh DEL, Abisheganaden JA. | BMC Pulm Med | 10.1186/s12890-018-0637-1 | 2018 | |
| Metabolism | Clinical usefulness of QuantiFERON TB-2G test for the early diagnosis of pulmonary Mycobacterium kansasii disease. | Kobashi Y, Mouri K, Miyashita N, Oka M. | Jpn J Infect Dis | 2009 | | |
| Mutational spectra are associated with bacterial niche. | Ruis C, Weimann A, Tonkin-Hill G, Pandurangan AP, Matuszewska M, Murray GGR, Levesque RC, Blundell TL, Floto RA, Parkhill J. | Nat Commun | 10.1038/s41467-023-42916-w | 2023 | | |
| Characteristics of pleural effusion with a high adenosine deaminase level: a case-control study. | Shimoda M, Hirata A, Tanaka Y, Morimoto K, Yoshiyama T, Yoshimori K, Saraya T, Ishii H, Ohta K. | BMC Pulm Med | 10.1186/s12890-022-02150-4 | 2022 | | |
| Phylogeny | Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan. | Wu TS, Leu HS, Chiu CH, Lee MH, Chiang PC, Wu TL, Chia JH, Su LH, Kuo AJ, Lai HC. | J Antimicrob Chemother | 10.1093/jac/dkp238 | 2009 | |
| Comparison of the RGM medium and the mycobacterial growth indicator tube automated system for isolation of non-tuberculous mycobacteria from sputum samples of cystic fibrosis patients in Belgium. | Scohy A, Gohy S, Mathys V, Sapriel G, Toussaint L, Bressant F, Zitouni A, Teylaert MN, Vander Meeren MC, Colmant A, Simon A, Perry JD, Lebecque P, Andre E. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2018.07.003 | 2018 | | |
| Pathogenicity | Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria. | Carroll J, Draper LA, O'Connor PM, Coffey A, Hill C, Ross RP, Cotter PD, O'Mahony J. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2010.03.029 | 2010 | |
| Phylogeny | Phylogenetic Analysis of Prevalent Tuberculosis and Non-Tuberculosis Mycobacteria in Isfahan, Iran, Based on a 360 bp Sequence of the rpoB Gene. | Nasr Esfahani B, Moghim S, Ghasemian Safaei H, Moghoofei M, Sedighi M, Hadifar S. | Jundishapur J Microbiol | 10.5812/jjm.30763 | 2016 | |
| Mycobacterium marinum Infection After Exposure to Coal Mine Water. | Huaman MA, Ribes JA, Lohr KM, Evans ME. | Open Forum Infect Dis | 10.1093/ofid/ofv205 | 2016 | | |
| Pulmonary infection with Mycobacterium szulgai: A case report. | Gido RDS, Wojciechowski AL, Bajwa RP. | SAGE Open Med Case Rep | 10.1177/2050313x18823448 | 2019 | | |
| Phylogeny | Evaluation of the Speed-oligo® Mycobacteria assay for identification of Mycobacterium spp. from fresh liquid and solid cultures of human clinical samples. | Quezel-Guerraz NM, Arriaza MM, Avila JA, Sanchez-Yebra Romera WE, Martinez-Lirola MJ, Indal-TB Group. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2010.06.006 | 2010 | |
| Isolation and Characterization of vB_MsmS_Celfi: A New Mycobacterium tuberculosis Bacteriophage. | Payaslian F, Gradaschi V, Rondon Salazar L, Dieterle ME, Urdaniz E, Di Paola M, Pena Carcamo J, Zon F, Sosa E, Fernandez Do Porto D, Dunne M, Goeller P, Klumpp J, Raya RR, Reyes A, Piuri M. | Phage (New Rochelle) | 10.1089/phage.2020.0030 | 2021 | | |
| A New Mouse Model of Chronic Myocarditis Induced by Recombinant Bacille Calmette-Guèrin Expressing a T-Cell Epitope of Cardiac Myosin Heavy Chain-alpha. | Tajiri K, Imanaka-Yoshida K, Tsujimura Y, Matsuo K, Hiroe M, Aonuma K, Ieda M, Yasutomi Y. | Int J Mol Sci | 10.3390/ijms22020794 | 2021 | | |
| Enzymology | Hoarseness due to Mycobacterium kansasii. | Wray D, Oko MO, Boldy DA, Butt MT. | J Laryngol Otol | 10.1017/s0022215108003393 | 2009 | |
| Correlation of Conservation of Sequence and Structures of Mycobacterial Hemerythrin-like Proteins with Evolutionary Relationship and Host Pathogenicity. | Ma Z, Caldas Nogueira ML, Marchi-Salvador DP, Davidson VL. | ACS Omega | 10.1021/acsomega.0c03338 | 2020 | | |
| Phylogenetic distribution of malonate semialdehyde decarboxylase (MSAD) genes among strains within the genus Mycobacterium: evidence of MSAD gene loss in the evolution of pathogenic mycobacteria. | Lee D, Kim DH, Seo H, Choi S, Kim BJ. | Front Microbiol | 10.3389/fmicb.2023.1275616 | 2023 | | |
| Rare case of pacemaker infection with Mycobacterium abscessus. | Radigan A, Jevert-Eichorn S. | BMJ Case Rep | 10.1136/bcr-2019-230100 | 2019 | | |
| Bronchopulmonary Kaposi's sarcoma. | Bashar N, Innes N, Orrell J. | Respir Med Case Rep | 10.1016/j.rmcr.2015.04.008 | 2015 | | |
| Fatal pulmonary cavitary disease secondary to Mycobacterium xenopi in a patient with sarcoidosis. | Abdulfattah O, Salhan D, Kandel S, Rahman EU, Dahal S, Alnafoosi Z, Schmidt F. | J Community Hosp Intern Med Perspect | 10.1080/20009666.2017.1407211 | 2017 | | |
| Diagnosis and management of sternoclavicular joint infections: a literature review. | Tasnim S, Shirafkan A, Okereke I. | J Thorac Dis | 10.21037/jtd-20-761 | 2020 | | |
| Enzymology | Characterization of non-tuberculous mycobacterium from humans and water in an Agropastoral area in Zambia. | Monde N, Munyeme M, Muwonge A, Muma JB, Malama S. | BMC Infect Dis | 10.1186/s12879-017-2939-y | 2018 | |
| Are we overlooking infections owing to non-tuberculous mycobacteria during routine conventional laboratory investigations? | Garima K, Varma-Basil M, Pathak R, Kumar S, Narang A, Rawat KS, Chaudhry A, Nair D, Ramachandran VG, Bose M. | Int J Mycobacteriol | 10.1016/j.ijmyco.2012.10.005 | 2012 | | |
| Mycobacteriophages in diagnosis and alternative treatment of mycobacterial infections. | Ouyang X, Li X, Song J, Wang H, Wang S, Fang R, Li Z, Song N. | Front Microbiol | 10.3389/fmicb.2023.1277178 | 2023 | | |
| The High Plasticity of Nonpathogenic Mycobacterium brumae Induces Rapid Changes in Its Lipid Profile during Pellicle Maturation: The Potential of This Bacterium as a Versatile Cell Factory for Lipid Compounds of Therapeutic Interest. | Campo-Perez V, Guallar-Garrido S, Luquin M, Sanchez-Chardi A, Julian E. | Int J Mol Sci | 10.3390/ijms232113609 | 2022 | | |
| Nontuberculous mycobacterial lung infections in patients with eating disorders: plausible mechanistic links in a case series. | Grayeb DE, Chan ED, Swanson LM, Gibson DG, Mehler PS. | AME Case Rep | 10.21037/acr-20-101 | 2021 | | |
| Enzymology | Isolation of novel mycobacteria contaminating an aquarium fish tank in a Japanese university hospital. | Marumo K, Nakamura H, Tazawa S, Kazumi Y, Kawano R, Shirata C, Taguchi K, Kikuchi T, Nagashima G. | J Appl Microbiol | 10.1111/j.1365-2672.2010.04680.x | 2010 | |
| Enzymology | An uncommon cause for a common complaint. | Rust PA, Bennett T. | Hand Surg | 10.1142/s0218810409004360 | 2009 | |
| DNA Methylation Profiling for the Diagnosis and Prognosis of Patients with Nontuberculous Mycobacterium Lung Disease. | Oh JY, Ko YK, Gim JA. | Curr Issues Mol Biol | 10.3390/cimb43020038 | 2021 | | |
| Mycobacterial bacteraemia in patients infected and not infected with human immunodeficiency virus, Taiwan. | Tan CK, Lai CC, Liao CH, Chou CH, Hsu HL, Huang YT, Hsueh PR. | Clin Microbiol Infect | 10.1111/j.1469-0691.2009.02939.x | 2010 | | |
| Enzymology | Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection. | Shitrit D, Peled N, Bishara J, Priess R, Pitlik S, Samra Z, Kramer MR. | Respir Med | 10.1016/j.rmed.2008.05.004 | 2008 | |
| Pathogenicity | [Evaluation of the mycobacterium efficacy of linezolid in vitro]. | Huang HR, Yu X, Jiang GL, Dai GM, Bi ZQ, Ma Y. | Zhonghua Jie He He Hu Xi Za Zhi | 2011 | | |
| Solitary pulmonary caseating granulomas: A 5-year retrospective single-center analysis. | Watanabe H, Uruma T, Seita I, Oishi T, Watanabe Y, Tsukimori A, Haga Y, Fukushima S, Sato A, Nakamura I, Matsumoto T. | Mol Clin Oncol | 10.3892/mco.2017.1244 | 2017 | | |
| Flexor Tenosynovitis of the Hand Caused by Mycobacterium tuberculosis. | Cohen-Tanugi S, Wright ML, Kadiyala RK. | J Am Acad Orthop Surg Glob Res Rev | 10.5435/jaaosglobal-d-17-00083 | 2018 | | |
| Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab. | Athni TS, Barmettler S. | Ann Allergy Asthma Immunol | 10.1016/j.anai.2023.01.018 | 2023 | | |
| Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy. | Deshpande D, Srivastava S, Pasipanodya JG, Gumbo T. | Front Pharmacol | 10.3389/fphar.2022.1024608 | 2022 | | |
| Phylogeny | Species identification and antimicrobial susceptibility testing of non-tuberculous mycobacteria isolated in Chongqing, Southwest China. | Zhang H, Luo M, Zhang K, Yang X, Hu K, Fu Z, Zhang L, Wu P, Wan D, Han M, Wang X. | Epidemiol Infect | 10.1017/s0950268820003088 | 2020 | |
| Pathogenicity | Clinical significance and antibiotic susceptibilities of nontuberculous mycobacteria from patients in Crete, Greece. | Gitti Z, Mantadakis E, Maraki S, Samonis G. | Future Microbiol | 10.2217/fmb.11.91 | 2011 | |
| In Vitro Effect of Three-Antibiotic Combinations plus Potential Antibiofilm Agents against Biofilm-Producing Mycobacterium avium and Mycobacterium intracellulare Clinical Isolates. | Batista S, Fernandez-Pittol M, Nicolas LS, Martinez D, Rubio M, Garrigo M, Vila J, Tudo G, Gonzalez-Martin J. | Antibiotics (Basel) | 10.3390/antibiotics12091409 | 2023 | | |
| Pathogenicity | N-benzylsalicylthioamides: highly active potential antituberculotics. | Dolezal R, Waisser K, Petrlikova E, Kunes J, Kubicova L, Machacek M, Kaustova J, Dahse HM. | Arch Pharm (Weinheim) | 10.1002/ardp.200800032 | 2009 | |
| Pathogenicity | In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China. | Pang Y, Zheng H, Tan Y, Song Y, Zhao Y. | Antimicrob Agents Chemother | 10.1128/aac.02627-16 | 2017 | |
| Septic arthritis of the wrist caused by Mycobacterium intracellulare: a case report. | Kawamura K, Yajima H, Omokawa S, Maegawa N, Shimizu T, Nakanishi Y, Kira T, Onishi T, Hayami N, Tanaka Y. | Case Reports Plast Surg Hand Surg | 10.1080/23320885.2016.1254561 | 2016 | | |
| Garvicin KS, a Broad-Spectrum Bacteriocin Protects Zebrafish Larvae against Lactococcus garvieae Infection. | Dubey S, Diep DB, Evensen O, Munang'andu HM. | Int J Mol Sci | 10.3390/ijms23052833 | 2022 | | |
| Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides. | Zitko J, Dolezal M, Dolezal M, Svobodova M, Vejsova M, Kunes J, Kucera R, Jilek P. | Bioorg Med Chem | 10.1016/j.bmc.2010.12.054 | 2011 | | |
| Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study. | Hirashima T, Nagai T, Shigeoka H, Tamura Y, Yoshida H, Kawahara K, Kondoh Y, Sakai K, Hashimoto S, Fujishima M, Shiroyama T, Tamiya M, Morishita N, Suzuki H, Okamoto N, Kawase I. | BMC Cancer | 10.1186/1471-2407-14-770 | 2014 | | |
| Mycobacteriophages and Their Applications. | Bonacorsi A, Ferretti C, Di Luca M, Rindi L. | Antibiotics (Basel) | 10.3390/antibiotics13100926 | 2024 | | |
| Pathogenicity | CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates. | Lee MR, Cheng A, Lee YC, Yang CY, Lai CC, Huang YT, Ho CC, Wang HC, Yu CJ, Hsueh PR. | J Antimicrob Chemother | 10.1093/jac/dkr420 | 2012 | |
| Enzymology | Identification of acid-fast bacilli using pyrosequencing analysis. | Bao JR, Master RN, Schwab DA, Clark RB. | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2010.02.022 | 2010 | |
| [Cervical adenitis caused by Mycobacterium kansasii: advantage of the INNO-LiPA V2 test in diagnosis of nontuberculous mycobacterial diseases]. | Salles Y, Fabre M, Guitterez MC, Chaudier B, Soler C. | Pathol Biol (Paris) | 10.1016/j.patbio.2007.08.008 | 2007 | | |
| Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State. | Ford ES, Horne DJ, Shah JA, Wallis CK, Fang FC, Hawn TR. | Ann Am Thorac Soc | 10.1513/annalsats.201609-731oc | 2017 | | |
| Non-tuberculous mycobacterial pulmonary disease: an Italian National survey. | Prato BD, Altieri AM, Carlucci B, Mori PA, Parrella R, Stainer A, Giacomi F, Pesci A, Faverio P, Gruppo di Studio AIPO "Patologie Infettive Respiratorie e Tubercolosi". | Sarcoidosis Vasc Diffuse Lung Dis | 10.36141/svdld.v35i1.6979 | 2018 | | |
| Simultaneous diagnosis of tuberculous and non-tuberculous mycobacterial diseases: Time for a better patient management. | Sarro YD, Kone B, Diarra B, Kumar A, Kodio O, Fofana DB, Achenbach CJ, Beavogui AH, Seydi M, Holl JL, Taiwo B, Diallo S, Doumbia S, Murphy RL, McFall SM, Maiga M. | Clin Microbiol Infect Dis | 10.15761/cmid.1000144 | 2018 | | |
| Development of multiplex PCR assays based on the 16S-23S rRNA internal transcribed spacer for the detection of clinically relevant nontuberculous mycobacteria. | Ngan GJ, Ng LM, Jureen R, Lin RT, Teo JW. | Lett Appl Microbiol | 10.1111/j.1472-765x.2011.03045.x | 2011 | | |
| Phylogeny | The Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease by Single Bacterial Isolation Plus Anti-GPL-Core IgA Antibody. | Kawasaki T, Kitada S, Fukushima K, Akiba E, Haduki K, Saito H, Nitta T, Kawano A, Miyazaki A, Nii T, Kuge T, Koba T, Matsuki T, Tsujino K, Miki K, Maekura R, Kida H. | Microbiol Spectr | 10.1128/spectrum.01406-21 | 2022 | |
| Evaluation of phytochemical composition, toxicity in Drosophila melanogaster and effects on antibiotics modulation of Plathymenia reticulata Benth extract. | Luna EM, Freitas TS, Campina FF, Costa MS, Rocha JE, Cruz RP, Sena Junior DL, Silveira ZS, Macedo NS, Pinheiro JCA, Pereira-Junior FN, Lisboa MAN, Cruz GV, Calixto Junior JT, Teixeira AMR, Coutinho HDM. | Toxicol Rep | 10.1016/j.toxrep.2021.03.020 | 2021 | | |
| A mixed-methods study on impact of silicosis on tuberculosis treatment outcomes and need for TB-silicosis collaborative activities in India. | Rupani MP. | Sci Rep | 10.1038/s41598-023-30012-4 | 2023 | | |
| Pathogenicity | Broncholithiasis in an immune compromised boy with disseminated Mycobacterium kansasii. | Cuppen I, de Lange WC, de Graaf SS, Mol SJ, Boetes C, Yntema JL. | Pediatr Pulmonol | 10.1002/ppul.20659 | 2007 | |
| Pathogenicity | Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents. | Kratky M, Stolarikova J, Vinsova J. | Molecules | 10.3390/molecules22040535 | 2017 | |
| Mycobacterium kansasii olecranon bursitis. | Barham GS, Hargreaves DG. | J Med Microbiol | 10.1099/jmm.0.46795-0 | 2006 | | |
| Enzymology | Mycobacterium kansasii infection diagnosed by pleural fluid cytology: a case report. | Domfeh AB, Nodit L, Gradowski JF, Bastacky S. | Acta Cytol | 10.1159/000325813 | 2007 | |
| Type 2 diabetes is associated with failure of non-operative treatment for sternoclavicular joint infection. | Reddy SB, Mizelle J, Sterbling HM, Lin B, Litle VR, Suzuki K. | J Thorac Dis | 10.21037/jtd-20-1897 | 2020 | | |
| Pathogenicity | Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains. | Ferriz JM, Vavrova K, Kunc F, Imramovsky A, Stolarikova J, Vavrikova E, Vinsova J. | Bioorg Med Chem | 10.1016/j.bmc.2009.12.055 | 2010 | |
| Enzymology | Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome. | Shitrit D, Priess R, Peled N, Bishara G, Shlomi D, Kramer MR. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-007-0331-3 | 2007 | |
| A note to the biological activity of benzoxazine derivatives containing the thioxo group. | Waisser K, Petrlikova E, Perina M, Klimesova V, Kunes J, Palat K, Kaustova J, Dahse HM, Mollmann U. | Eur J Med Chem | 10.1016/j.ejmech.2010.02.037 | 2010 | | |
| Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan. | Lin CY, Huang HY, Hsieh MH, Fang YF, Lo YL, Lin SM, Huang YT, Yeh CH, Wang CH, Lin HC. | Front Microbiol | 10.3389/fmicb.2022.868435 | 2022 | | |
| Enzymology | PCR-reverse blot hybridization assay in respiratory specimens for rapid detection and differentiation of mycobacteria in HIV-negative population. | Zhang Q, Xiao H, Yan L. | BMC Infect Dis | 10.1186/s12879-021-05934-x | 2021 | |
| A common but underreported entity of papulonecrotic tuberculid. | Sinha P, Sinha A, Baveja S, Sood A. | Med J Armed Forces India | 10.1016/j.mjafi.2014.04.018 | 2015 | | |
| Conformational Changes in a Macrolide Antibiotic Binding Protein From Mycobacterium smegmatis Upon ADP Binding. | Zhang Q, Liu X, Liu H, Zhang B, Yang H, Mi K, Guddat LW, Rao Z. | Front Microbiol | 10.3389/fmicb.2021.780954 | 2021 | | |
| [Radiographic findings of pulmonary nontuberculous mycobacteriosis other than Mycobacterium avium complex]. | Kurashima A. | Kekkaku | 2009 | | ||
| Extracellular Vesicles from Serum of Mycobacteria Patients Accelerate Expression of Apoptosis miRNAs and Facilitate THP-1 Monocyte Cell Death. | Javadi A, Shamaei M, Tabarsi P, Ainy E, Kazemi B. | Tanaffos | 2022 | | ||
| Phylogeny | Nontuberculous Mycobacteria-Overview. | Koh WJ. | Microbiol Spectr | 10.1128/microbiolspec.tnmi7-0024-2016 | 2017 | |
| Immunological and microbial shifts in the aging rhesus macaque lung during nontuberculous mycobacterial infection. | Cinco IR, Napier EG, Rhoades NS, Davies MH, Allison DB, Kohama SG, Bermudez L, Winthrop K, Fuss C, Spindel ER, Messaoudi I. | mBio | 10.1128/mbio.00829-24 | 2024 | | |
| [Clinical features of pneumothorax in patients with active nontuberculous mycobacterial lung disease]. | Hagiwara E, Shiihara J, Enomoto T, Tsuchiya N, Baba T, Shinohara T, Nishihira R, Kato T, Ogura T, Takahashi H. | Nihon Kokyuki Gakkai Zasshi | 2010 | | ||
| Phylogeny | Mycobacterium arupense flexor tenosynovitis: case report and review of antimicrobial susceptibility profiles for 40 clinical isolates. | Beam E, Vasoo S, Simner PJ, Rizzo M, Mason EL, Walker RC, Deml SM, Brown-Elliott BA, Wallace RJ, Wengenack NL, Sia IG. | J Clin Microbiol | 10.1128/jcm.00277-14 | 2014 | |
| A deceptive presentation of Tuberculosis hip as Staphylococcal infection, its successful management and literature review. | Dojode CMR, Joseph G, Shah NN. | BMJ Case Rep | 10.1136/bcr-2018-224558 | 2018 | | |
| Phylogeny | Diversity of Nontuberculous Mycobacteria in Kuwait: Rapid Identification and Differentiation of Mycobacterium Species by Multiplex PCR, INNO-LiPA Mycobacteria v2 Assay and PCR Sequencing of rDNA. | Ahmad S, Mokaddas E. | Med Princ Pract | 10.1159/000498910 | 2019 | |
| Differential conformational behaviors of alpha-mycolic acids in Langmuir monolayers and computer simulations. | Villeneuve M, Kawai M, Watanabe M, Aoyagi Y, Hitotsuyanagi Y, Takeya K, Gouda H, Hirono S, Minnikin DE, Nakahara H. | Chem Phys Lipids | 10.1016/j.chemphyslip.2010.04.010 | 2010 | | |
| Phylogeny | In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands. | van Ingen J, van der Laan T, Dekhuijzen R, Boeree M, van Soolingen D. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2009.09.023 | 2010 | |
| Comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube test in Bacillus Calmette-Guerin-vaccinated children. | Shah I, Kathwate J, Shetty NS. | Lung India | 10.4103/lungindia.lungindia_304_19 | 2020 | | |
| Enzymology | Restriction enzyme analysis of the hsp65 gene in clinical isolates from patients suspected of having pulmonary tuberculosis in Teresina, Brazil. | Bona Md, Leal MJ, Martins LM, Silva RN, Castro JA, Monte SJ. | J Bras Pneumol | 10.1590/s1806-37132011000500010 | 2011 | |
| Enzymology | Serodiagnosis of environmental mycobacterial infections. | Stavri H, Ulea I, Radu DL, Branaru MG, Moldovan O, Bogdan MA, Tudose C, Raileanu M, Duiculescu D, Ene L, Olar V, Ionita C, Popa GL, Popa MI, Brennan PJ. | J Microbiol Methods | 10.1016/j.mimet.2011.05.010 | 2011 | |
| A Review of the Biological Activity of Amidrazone Derivatives. | Paprocka R, Wiese-Szadkowska M, Kosmalski T, Frisch D, Ratajczak M, Modzelewska-Banachiewicz B, Studzinska R. | Pharmaceuticals (Basel) | 10.3390/ph15101219 | 2022 | | |
| Correlations Between Inflammatory Biomarkers in Tuberculosis-Associated Obstructive Pulmonary Disease Patients With Anxiety and Depression. | Katare S, Harsha A. | Cureus | 10.7759/cureus.22742 | 2022 | | |
| Immune Compromise in HIV-1/HTLV-1 Coinfection With Paradoxical Resolution of CD4 Lymphocytosis During Antiretroviral Therapy: A Case Report. | Rockwood N, Cook L, Kagdi H, Basnayake S, Bangham CRM, Pozniak AL, Taylor GP. | Medicine (Baltimore) | 10.1097/md.0000000000002275 | 2015 | | |
| Metabolism | Rapid Identification of Mycobacterium Leprae by Polymerase Chain Reaction-restriction Fragment Length Polymorphism Analysis of the Heat Shock Protein 65 Gene from Skin Specimens. | Zhao Z, Liu XW, Jia J, Cai L, Zhang JZ. | Chin Med J (Engl) | 10.4103/0366-6999.168076 | 2015 | |
| Mycobacteria that cause tuberculosis have retained ancestrally acquired genes for the biosynthesis of chemically diverse terpene nucleosides. | Mayfield JA, Raman S, Ramnarine AK, Mishra VK, Huang AD, Dudoit S, Buter J, Cheng TY, Young DC, Nair YM, Ouellet IG, Griebel BT, Ma S, Sherman DR, Mallet L, Rhee KY, Minnaard AJ, Branch Moody D. | PLoS Biol | 10.1371/journal.pbio.3002813 | 2024 | | |
| Pathogenicity | Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects. | Tompkins JC, Witzig RS. | Int J Tuberc Lung Dis | 2007 | | |
| Socio-Economic and Environmental Factors Related to Spatial Differences in Human Non-Tuberculous Mycobacterial Diseases in the Czech Republic. | Modra H, Ulmann V, Caha J, Hubelova D, Konecny O, Svobodova J, Weston RT, Pavlik I. | Int J Environ Res Public Health | 10.3390/ijerph16203969 | 2019 | | |
| The Neff strain of Acanthamoeba castellanii, a tool for testing the virulence of Mycobacterium kansasii. | Goy G, Thomas V, Rimann K, Jaton K, Prod'hom G, Greub G. | Res Microbiol | 10.1016/j.resmic.2007.01.003 | 2007 | | |
| Prevalence of Latent Tuberculous Infection in Patients With Nontuberculous Mycobacterial Lung Disease and Colonization: A Prospective Study in an Intermediate Tuberculosis Burden Country. | Lee HS, Wei YF, Tsai YJ, Wang PH, Chen CY, Pan SW, Shu CC. | Open Forum Infect Dis | 10.1093/ofid/ofac072 | 2022 | | |
| Enzymology | Current treatment of atypical mycobacteriosis. | Esteban J, Ortiz-Perez A. | Expert Opin Pharmacother | 10.1517/14656560903369363 | 2009 | |
| Pathogenicity | Mycobacterial lipomannan induces MAP kinase phosphatase-1 expression in macrophages. | Elass E, Coddeville B, Kremer L, Mortuaire M, Mazurier J, Guerardel Y. | FEBS Lett | 10.1016/j.febslet.2008.01.007 | 2008 | |
| Genetics | The Attenuation Mechanism and Live Vaccine Potential of a Low-Virulence Edwardsiella ictaluri Strain Obtained by Rifampicin Passaging Culture. | Wang S, Hao J, Yang J, Zhang Q, Li A. | J Microbiol Biotechnol | 10.4014/jmb.2210.10013 | 2023 | |
| [Detection of rpoB mutations in rifampicin-resistant Mycobacterium kansasii]. | Yoshida S, Suzuki K, Tsuyuguchi K, Iwamoto T, Tomita M, Okada M, Sakatani M. | Kekkaku | 2006 | | ||
| Metabolism | The role of hydrophobicity in tuberculosis evolution and pathogenicity. | Jankute M, Nataraj V, Lee OY, Wu HHT, Ridell M, Garton NJ, Barer MR, Minnikin DE, Bhatt A, Besra GS. | Sci Rep | 10.1038/s41598-017-01501-0 | 2017 | |
| [Molecular epidemiological analysis of Mycobacterium kansasii isolates]. | Yoshida S, Suzuki K, Tsuyuguchi K, Iwamoto T, Okada M, Sakatani M. | Kekkaku | 2007 | | ||
| Comparative genome analyses of mycobacteria give better insights into their evolution. | Wee WY, Dutta A, Choo SW. | PLoS One | 10.1371/journal.pone.0172831 | 2017 | | |
| Enzymology | Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation. | Balagopal A, Mills L, Shah A, Subramanian A. | Transpl Infect Dis | 10.1111/j.1399-3062.2009.00375.x | 2009 | |
| Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses. | Chapagain M, Pasipanodya JG, Athale S, Bernal C, Trammell R, Howe D, Gumbo T. | J Antimicrob Chemother | 10.1093/jac/dkac068 | 2022 | | |
| Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016. | Tan Y, Su B, Shu W, Cai X, Kuang S, Kuang H, Liu J, Pang Y. | BMC Pulm Med | 10.1186/s12890-018-0728-z | 2018 | | |
| Interleukin-1 contributes to an effective clearance of Mycobacterium kansasii from the respiratory tract. | Wieland CW, Florquin S, Pater JM, Weijer S, van der Poll T. | Microbes Infect | 10.1016/j.micinf.2006.05.002 | 2006 | | |
| Development of a new real-time PCR system for simultaneous detection of bacteria and fungi in pathological samples. | Fukumoto H, Sato Y, Hasegawa H, Saeki H, Katano H. | Int J Clin Exp Pathol | 2015 | | ||
| Antimicrobial Effect of Simira ecuadorensis Extracts and Their Impact on Improving Shelf Life in Chicken and Fish Products. | Reyes JF, Diez AM, Melero B, Rovira J, Jaime I. | Foods | 10.3390/foods11152352 | 2022 | | |
| Genetics | Applications and advances in molecular diagnostics: revolutionizing non-tuberculous mycobacteria species and subspecies identification. | Zhang H, Tang M, Li D, Xu M, Ao Y, Lin L. | Front Public Health | 10.3389/fpubh.2024.1410672 | 2024 | |
| Enzymology | Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens. | Moon SM, Park HY, Jeon K, Kim SY, Chung MJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Koh WJ. | PLoS One | 10.1371/journal.pone.0139621 | 2015 | |
| Enzymology | Descriptive study of the frequency of nontuberculous mycobacteria in the Baixada Santista region of the state of São Paulo, Brazil. | Zamarioli LA, Coelho AG, Pereira CM, Nascimento AC, Ueki SY, Chimara E. | J Bras Pneumol | 10.1590/s1806-37132008000800008 | 2008 | |
| Polysaccharide structural variability in mycobacteria: identification and characterization of phosphorylated mannan and arabinomannan. | Maes E, Coddeville B, Kremer L, Guerardel Y. | Glycoconj J | 10.1007/s10719-007-9036-1 | 2007 | | |
| Effect of adjusted cut-offs of interferon-gamma release assays on diagnosis of tuberculosis in patients with fever of unknown origin. | Shen Y, Qi X, Wu J, Gao Y, Shao L, Zhang W, Wang S. | J Clin Tuberc Other Mycobact Dis | 10.1016/j.jctube.2021.100290 | 2022 | | |
| Sequence and Structural Motifs Controlling the Broad Substrate Specificity of the Mycobacterial Hormone-Sensitive Lipase LipN. | Schemenauer DE, Pool EH, Raynor SN, Ruiz GP, Goehring LM, Koelper AJ, Wilson MA, Durand AJ, Kourtoglou EC, Larsen EM, Lavis LD, Esteb JJ, Hoops GC, Johnson RJ. | ACS Omega | 10.1021/acsomega.3c00534 | 2023 | | |
| [Cutaneous and soft skin infections due to non-tuberculous mycobacteria]. | Alcaide F, Esteban J. | Enferm Infecc Microbiol Clin | 10.1016/s0213-005x(10)70008-2 | 2010 | | |
| A non-HIV case with disseminated Mycobacterium kansasii disease associated with strong neutralizing autoantibody to interferon-gamma. | Nei T, Okabe M, Mikami I, Koizumi Y, Mase H, Matsuda K, Yamamoto T, Takeda S, Tanaka K, Dan K. | Respir Med Case Rep | 10.1016/j.rmcr.2012.11.003 | 2013 | | |
| Pathogenicity | New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains. | Imramovsky A, Vinsova J, Ferriz JM, Dolezal R, Jampilek J, Kaustova J, Kunc F. | Bioorg Med Chem | 10.1016/j.bmc.2009.04.008 | 2009 | |
| Nucleic Acid Amplification Testing and Sequencing Combined with Acid-Fast Staining in Needle Biopsy Lung Tissues for the Diagnosis of Smear-Negative Pulmonary Tuberculosis. | Jiang F, Huang W, Wang Y, Tian P, Chen X, Liang Z. | PLoS One | 10.1371/journal.pone.0167342 | 2016 | | |
| Phylogeny | Comparative study of two typing methods, hsp65 PRA and ITS sequencing, revealed a possible evolutionary link between Mycobacterium kansasii type I and II isolates. | Iwamoto T, Saito H. | FEMS Microbiol Lett | 10.1111/j.1574-6968.2005.00013.x | 2006 | |
| Genetics | Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary Disease. | Xu P, Yang K, Yang L, Wang Z, Jin F, Wang Y, Feng J. | Front Microbiol | 10.3389/fmicb.2022.898195 | 2022 | |
| The oriented development of antituberculotics: salicylanilides. | Waisser K, Matyk J, Divisova H, Husakova P, Kunes J, Klimesova V, Kaustova J, Mollmann U, Dahse HM, Miko M. | Arch Pharm (Weinheim) | 10.1002/ardp.200600093 | 2006 | | |
| Synthetic Phenolic Glycolipids for Application in Diagnostic Tests for Leprosy. | van Dijk JHM, van Hooij A, Groot LM, Geboers J, Moretti R, Verhard-Seymonsbergen E, de Jong D, van der Marel GA, Corstjens PLAM, Codee JDC, Geluk A. | Chembiochem | 10.1002/cbic.202000810 | 2021 | | |
| Pathogenicity | Biochemical Validation of a Third Guanidine Riboswitch Class in Bacteria. | Sherlock ME, Breaker RR. | Biochemistry | 10.1021/acs.biochem.6b01271 | 2017 | |
| Enzymology | Detection of nontuberculous mycobacteria from water buffalo raw milk in Brazil. | Jordao Junior CM, Lopes FC, David S, Farache Filho A, Leite CQ. | Food Microbiol | 10.1016/j.fm.2009.04.005 | 2009 | |
| Pathogenicity | New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis. | Barluenga J, Aznar F, Garcia AB, Cabal MP, Palacios JJ, Menendez MA. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2006.08.090 | 2006 | |
| The clinical course of a Mexican female with cystic fibrosis and the novel genotype S531P/S531P. | Laguna TA, Sagel SD, Sontag MK, Accurso FJ. | J Cyst Fibros | 10.1016/j.jcf.2008.03.008 | 2008 | | |
| Phylogeny | Evaluation of the GenoType Mycobacteria Direct assay for direct detection of the Mycobacterium tuberculosis complex obtained from sputum samples. | Kiraz N, Saglik I, Kiremitci A, Kasifoglu N, Akgun Y. | J Med Microbiol | 10.1099/jmm.0.013490-0 | 2010 | |
| Clinical, radiological, and laboratory predictors of a positive urine lipoarabinomannan test in sputum-scarce and sputum-negative patients with HIV-associated tuberculosis in two Johannesburg hospitals. | Chernick L, Kalla IS, Venter M. | South Afr J HIV Med | 10.4102/sajhivmed.v22i1.1234 | 2021 | | |
| Pathogenicity | QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors. | Dolezal R, Van Damme S, Bultinck P, Waisser K. | Eur J Med Chem | 10.1016/j.ejmech.2008.04.020 | 2009 | |
| Development and application of a rapid Mycobacterium tuberculosis detection technique using polymerase spiral reaction. | Liu W, Zou D, He X, Ao D, Su Y, Yang Z, Huang S, Zhao Q, Tang Y, Ma W, Lu Y, Wang J, Wang X, Huang L. | Sci Rep | 10.1038/s41598-018-21376-z | 2018 | | |
| Enzymology | Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient. | Manali ED, Tomford WJ, Liao DW, Farver C, Mehta AC. | Respiration | 10.1159/000085373 | 2005 | |
| Eating the brain - A multidisciplinary study provides new insights into the mechanisms underlying the cytopathogenicity of Naegleria fowleri. | Malych R, Folgosa F, Pilatova J, Mikes L, Dohnalek V, Mach J, Matejkova M, Kopecky V, Dolezal P, Sutak R. | PLoS Pathog | 10.1371/journal.ppat.1012995 | 2025 | | |
| [A rare case of disseminated Mycobacterium kansasii infection]. | Suzuki Y, Nozaki Y, Nakanishi K, Konoh T, Yoshimoto T, Nishiwaki K. | Kekkaku | 2005 | | ||
| Pathogenicity | The mimetics of antiadhesive peptides as the inhibitors of Mycobacterium kansasii phagocytosis. | Siemion IZ, Gawlowska M, Slepokura K, Biernat M, Wieczorek Z. | Peptides | 10.1016/j.peptides.2005.02.009 | 2005 | |
| Multiple nontuberculous scrofulodermas showing dramatic response to clarithromycin. | Parimalam K, Senthil G, Vinnarasan M, Arumugakani V, Amutha BM, Lalitha S, Swarna S. | Indian Dermatol Online J | 10.4103/2229-5178.148932 | 2015 | | |
| Promising Antimycobacterial Activities of Flavonoids against Mycobacterium sp. Drug Targets: A Comprehensive Review. | Rabaan AA, Alhumaid S, Albayat H, Alsaeed M, Alofi FS, Al-Howaidi MH, Turkistani SA, Alhajri SM, Alahmed HE, Alzahrani AB, Mashraqi MM, Alwarthan S, Alhajri M, Alshahrani FS, Almuthree SA, Alsubki RA, Abuzaid AA, Alfaresi M, Al Fares MA, Mutair AA. | Molecules | 10.3390/molecules27165335 | 2022 | | |
| Concomitant Presence of Aspergillus Species and Mycobacterium Species in the Respiratory Tract of Patients: Underestimated Co-occurrence? | Delliere S, Angebault C, Fihman V, Foulet F, Lepeule R, Maitre B, Schlemmer F, Botterel F. | Front Microbiol | 10.3389/fmicb.2019.02980 | 2019 | | |
| Septic monoarthritis of the first carpo-metacarpal joint caused by Mycobacterium kansasii. | Brutus JP, Lamraski G, Zirak C, Hauzeur JP, Thys JP, Schuind F. | Chir Main | 10.1016/j.main.2004.11.006 | 2005 | | |
| Pathogenicity | The role of the gut microbiota in tumor, immunity, and immunotherapy. | Xie Y, Liu F. | Front Immunol | 10.3389/fimmu.2024.1410928 | 2024 | |
| Enzymology | Development of a simple and low-cost real-time PCR method for the identification of commonly encountered mycobacteria in a high throughput laboratory. | Leung KL, Yip CW, Cheung WF, Lo AC, Ko WM, Kam KM. | J Appl Microbiol | 10.1111/j.1365-2672.2009.04324.x | 2009 | |
| Metabolism | Species Typing of Nontuberculous Mycobacteria by Use of Deoxyribozyme Sensors. | Wood HN, Sidders AE, Brumsey LE, Morozkin ES, Gerasimova YV, Rohde KH. | Clin Chem | 10.1373/clinchem.2018.295212 | 2019 | |
| A study of mycobacterial species causing lymphadenitis. | Reddy VC, Prasad CE, Aparna S, Gokhale S, Anjeneyulu. | Southeast Asian J Trop Med Public Health | 2008 | | ||
| Enzymology | Incidence of nontuberculous mycobacteria in four hot water systems using various types of disinfection. | Sebakova H, Kozisek F, Mudra R, Kaustova J, Fiedorova M, Hanslikova D, Nachtmannova H, Kubina J, Vraspir P, Sasek J. | Can J Microbiol | 10.1139/w08-080 | 2008 | |
| Enzymology | Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. | Borand L, de Lauzanne A, Nguyen NL, Cheng S, Pham TH, Eyangoh S, Ouedraogo AS, Ung V, Msellati P, Tejiokem M, Nacro B, Inghammar M, Dim B, Delacourt C, Godreuil S, Blanche S, Marcy O, Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group. | Clin Infect Dis | 10.1093/cid/ciy897 | 2019 | |
| Enzymology | Mycobacterium kansasii osteomyelitis in a patient with AIDS on highly active antiretroviral therapy. | Yano T, Okuda S, Kato K, Kato K, Kishimoto T. | Intern Med | 10.2169/internalmedicine.43.1084 | 2004 | |
| Pathogenicity | In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii. | Guna R, Munoz C, Dominguez V, Garcia-Garcia A, Galvez J, de Julian-Ortiz JV, Borras R. | J Antimicrob Chemother | 10.1093/jac/dki111 | 2005 | |
| Histoplasma capsulatum sinusitis: Possible way of revelation to the disseminated form of histoplasmosis in HIV patients: Case report and literature review. | Elansari R, Abada R, Rouadi S, Roubal M, Mahtar M. | Int J Surg Case Rep | 10.1016/j.ijscr.2016.03.010 | 2016 | | |
| Enzymology | Mycobacteriosis in a black-tailed deer (Odocoileus hemionus columbianus) caused by Mycobacterium kansasii. | Hall PB, Bender LC, Garner MM. | J Zoo Wildl Med | 10.1638/04-028 | 2005 | |
| Mycobacterial cavity on chest computed tomography: clinical implications and deep learning-based automatic detection with quantification. | Yoon I, Hong JH, Witanto JN, Yim JJ, Kwak N, Goo JM, Yoon SH. | Quant Imaging Med Surg | 10.21037/qims-22-620 | 2023 | | |
| Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea. | Lim DH, Kim YG, Shim TS, Jo KW, Ghang B, Ahn SM, Hong S, Lee CK, Yoo B. | Korean J Intern Med | 10.3904/kjim.2015.357 | 2017 | | |
| Lichenoid and granulomatous dermatitis associated with atypical mycobacterium infections. | S Breza T, Magro CM. | J Cutan Pathol | 10.1111/j.1600-0560.2006.00474.x | 2006 | | |
| Enzymology | Non-tuberculous mycobacteria pulmonary infection: management and follow-up of 31 infected patients. | Andrejak C, Lescure FX, Douadi Y, Laurans G, Smail A, Duhaut P, Jounieaux V, Schmit JL. | J Infect | 10.1016/j.jinf.2007.01.008 | 2007 | |
| Pathogenicity | Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates. | da Silva Telles MA, Chimara E, Ferrazoli L, Riley LW. | J Med Microbiol | 10.1099/jmm.0.45965-0 | 2005 | |
| Enzymology | [A case of pulmonary Mycobacterium kansasii infection complicated with pleural effusion]. | Kamiya H, Toyota E, Kobayashi N, Kudo K. | Kekkaku | 2004 | | |
| Genetics | Rapid Identification of Mycobacterium tuberculosis Complex Using Mass Spectrometry: A Proof of Concept. | Robinne S, Saad J, Morsli M, Hamidou ZH, Tazerart F, Drancourt M, Baron SA. | Front Microbiol | 10.3389/fmicb.2022.753969 | 2022 | |
| Characteristics of Nontuberculous Mycobacterial Infections at a Midwestern Tertiary Hospital: A Retrospective Study of 365 Patients. | Hannah CE, Ford BA, Chung J, Ince D, Wanat KA. | Open Forum Infect Dis | 10.1093/ofid/ofaa173 | 2020 | | |
| CD4+ cells play a limited role in murine lung infection with Mycobacterium kansasii. | Wieland CW, Florquin S, Pater JM, Weijer S, van der Poll T. | Am J Respir Cell Mol Biol | 10.1165/rcmb.2005-0198oc | 2006 | | |
| Clinical characteristics and treatment outcomes of Mycobacterium kansasii lung disease in Korea. | Park HK, Koh WJ, Shim TS, Kwon OJ. | Yonsei Med J | 10.3349/ymj.2010.51.4.552 | 2010 | | |
| Enzymology | [PFGE analysis of Mycobacterium kansasii isolates in Okayama Prefecture]. | Mimura K. | Kekkaku | 2005 | | |
| [Phenotypic and genotypic characteristics of Mycobacterium kansasii strains isolated in Spain (2000-2003)]. | Jimenez-Pajares MS, Herrera L, Valverde A, Saiz P, Saez-Nieto JA. | Enferm Infecc Microbiol Clin | 10.1157/13074964 | 2005 | | |
| Enzymology | [Clinical evaluation on isolation of Mycobacterium kansasii in our hospital]. | Inoue T, Tanaka E, Kato T, Sakuramoto M, Maeda Y, Maniwa K, Taguchi Y. | Kekkaku | 10.11400/kekkaku1923.79.431 | 2004 | |
| Pathogenicity | The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex. | Takei S, Ihara H, Togo S, Nakamura A, Fujimoto Y, Watanabe J, Kurokawa K, Shibayama K, Sumiyoshi I, Ochi Y, Iwai M, Okabe T, Chonan M, Misawa S, Ohsaka A, Takahashi K. | BMC Microbiol | 10.1186/s12866-020-02000-5 | 2020 | |
| Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study. | Manfredi R, Nanetti A, Valentini R, Ferri M, Morelli S, Calza L. | HIV Med | 10.1111/j.1468-1293.2004.00249.x | 2004 | | |
| MicroRNA-155 Modulates Macrophages' Response to Non-Tuberculous Mycobacteria through COX-2/PGE2 Signaling. | Yuan Z, Prasla Z, Lee FE, Bedi B, Sutliff RL, Sadikot RT. | Pathogens | 10.3390/pathogens10080920 | 2021 | | |
| Pathogenicity | Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes. | Cavicchioli M, Leite CQ, Sato DN, Massabni AC. | Arch Pharm (Weinheim) | 10.1002/ardp.200700040 | 2007 | |
| Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital. | Schiff HF, Jones S, Achaiah A, Pereira A, Stait G, Green B. | Sci Rep | 10.1038/s41598-018-37350-8 | 2019 | | |
| Enzymology | Mycobacteria mobility shift assay: a method for the rapid identification of Mycobacterium tuberculosis and nontuberculous mycobacteria. | Wildner LM, Bazzo ML, Liedke SC, Nogueira CL, Segat G, Senna SG, Schlindwein AD, Oliveira JG, Rovaris DB, Bonjardim CA, Kroon EG, Ferreira PC. | Mem Inst Oswaldo Cruz | 10.1590/0074-0276130458 | 2014 | |
| Latent tuberculosis among household contacts of pulmonary tuberculosis cases in Nairobi, Kenya. | Odera S, Mureithi M, Aballa A, Onyango N, Anzala O, Oyugi J. | Pan Afr Med J | 10.11604/pamj.2020.37.87.21102 | 2020 | | |
| Pathogenicity | Autophagy and Host Defense in Nontuberculous Mycobacterial Infection. | Silwal P, Kim IS, Jo EK. | Front Immunol | 10.3389/fimmu.2021.728742 | 2021 | |
| Septal perforation secondary to Mycobacterium kansasii infection. | Bennett AM, Patel N, Kotecha B, Al-Okati A. | J Laryngol Otol | 10.1258/002221503322683939 | 2003 | | |
| In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria. | Brown-Elliott BA, Wallace RJ. | Antimicrob Agents Chemother | 10.1128/aac.01947-20 | 2021 | | |
| Air pollution and airborne infection with mycobacterial bioaerosols: a potential attribution of soot. | Noda J, Tomizawa S, Takahashi K, Morimoto K, Mitarai S. | Int J Environ Sci Technol (Tehran) | 10.1007/s13762-021-03203-7 | 2022 | | |
| Enzymology | ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii. | Arend SM, de Haas P, Leyten E, Rosenkrands I, Rigouts L, Andersen P, Mijs W, van Dissel JT, van Soolingen D. | J Infect Dis | 10.1086/428950 | 2005 | |
| A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infection. | Marras TK, Daley CL. | J Acquir Immune Defic Syndr | 10.1097/00126334-200408010-00001 | 2004 | | |
| Metabolism | Mechanical Forces between Mycobacterial Antigen 85 Complex and Fibronectin. | Viljoen A, Alsteens D, Dufrene Y. | Cells | 10.3390/cells9030716 | 2020 | |
| Pathogenicity | In Vitro Susceptibility Testing of Tedizolid against Isolates of Nocardia. | Brown-Elliott BA, Wallace RJ. | Antimicrob Agents Chemother | 10.1128/aac.01537-17 | 2017 | |
| Metabolism | Administration of Ag85B showed therapeutic effects to Th2-type cytokine-mediated acute phase atopic dermatitis by inducing regulatory T cells. | Mori H, Yamanaka K, Matsuo K, Kurokawa I, Yasutomi Y, Mizutani H. | Arch Dermatol Res | 10.1007/s00403-008-0873-y | 2009 | |
| Molecular characterization of Mycobacterium kansasii isolates in the State of São Paulo between 1995-1998. | Chimara E, Giampaglia CM, Martins MC, Telles MA, Ueki SY, Ferrazoli L. | Mem Inst Oswaldo Cruz | 10.1590/s0074-02762004000700013 | 2004 | | |
| Pathogenicity | Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles. | Kazimierczuk Z, Andrzejewska M, Kaustova J, Klimesova V. | Eur J Med Chem | 10.1016/j.ejmech.2004.10.004 | 2005 | |
| Synthesis, X-ray structure and antimycobacterial activity of silver complexes with alpha-hydroxycarboxylic acids. | Cuin A, Massabni AC, Leite CQ, Sato DN, Neves A, Szpoganicz B, Silva MS, Bortoluzzi AJ. | J Inorg Biochem | 10.1016/j.jinorgbio.2006.10.001 | 2007 | | |
| B Cell-Based Vaccine Transduced With ESAT6-Expressing Vaccinia Virus and Presenting alpha-Galactosylceramide Is a Novel Vaccine Candidate Against ESAT6-Expressing Mycobacterial Diseases. | Kwon BE, Ahn JH, Park EK, Jeong H, Lee HJ, Jung YJ, Shin SJ, Jeong HS, Yoo JS, Shin E, Yeo SG, Chang SY, Ko HJ. | Front Immunol | 10.3389/fimmu.2019.02542 | 2019 | | |
| Metabolism | Tenosynovitis caused by Mycobacterium kansasii associated with a dog bite. | Southern PM. | Am J Med Sci | 10.1097/00000441-200405000-00023 | 2004 | |
| Disseminated Mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. | Goldschmidt N, Nusair S, Gural A, Amir G, Izhar U, Laxer U. | Am J Hematol | 10.1002/ajh.10410 | 2003 | | |
| Pathogenicity | In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. | Sohn H, Lee KS, Ko YK, Ryu JW, Woo JC, Koo DW, Shin SJ, Ahn SJ, Shin AR, Song CH, Jo EK, Park JK, Kim HJ. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2008.01.016 | 2008 | |
| Osteoarticular Infections in Pediatric Hospitals in Europe: A Prospective Cohort Study From the EUCLIDS Consortium. | Trobisch A, Schweintzger NA, Kohlfurst DS, Sagmeister MG, Sperl M, Grisold AJ, Feierl G, Herberg JA, Carrol ED, Paulus SC, Emonts M, van der Flier M, de Groot R, Cebey-Lopez M, Rivero-Calle I, Boeddha NP, Agapow PM, Secka F, Anderson ST, Behrends U, Wintergerst U, Reiter K, Martinon-Torres F, Levin M, Zenz W, EUCLIDS consortium. | Front Pediatr | 10.3389/fped.2022.744182 | 2022 | | |
| Enzymology | Evaluation of the GenoType Mycobacteria Direct assay for the simultaneous detection of the Mycobacterium tuberculosis complex and four atypical mycobacterial species in smear-positive respiratory specimens. | Seagar AL, Prendergast C, Emmanuel FX, Rayner A, Thomson S, Laurenson IF. | J Med Microbiol | 10.1099/jmm.0.47484-0 | 2008 | |
| Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis. | Hua JT, Zell-Baran L, Go LHT, Kramer MR, Van Bree JB, Chambers D, Deller D, Newbigin K, Matula M, Fireman E, Dahbash M, Martinez-Gonzalez C, Leon-Jimenez A, Sack C, Ferrer J, Villar A, Almberg KS, Cohen RA, Rose CS. | Occup Environ Med | 10.1136/oemed-2021-108190 | 2022 | | |
| Appendicitis in the HIV Era: a South African perspective. | Gigabhoy R, Cheddie S, Singh B. | Indian J Surg | 10.1007/s12262-016-1564-0 | 2018 | | |
| Enzymology | Septic arthritis caused by Mycobacterium kansasii in a prosthetic knee joint. | Neuberger A, Sprecher H, Oren I. | J Clin Microbiol | 10.1128/jcm.00087-06 | 2006 | |
| Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature. | Han SH, Kim KM, Chin BS, Choi SH, Lee HS, Kim MS, Jeong SJ, Choi HK, Kim CO, Choi JY, Song YG, Kim JM. | J Korean Med Sci | 10.3346/jkms.2010.25.2.304 | 2010 | | |
| A Case of Reactive Cervical Lymphadenopathy with Fat Necrosis Impinging on Adjacent Vascular Structures. | Han AY, Lentz JF, Kuan EC, Araya HH, Kamgar M. | Case Rep Otolaryngol | 10.1155/2016/6019501 | 2016 | | |
| Trends in the Prevalence and Antibiotic Resistance of Non-tuberculous Mycobacteria in Mainland China, 2000-2019: Systematic Review and Meta-Analysis. | Zhou L, Xu D, Liu H, Wan K, Wang R, Yang Z. | Front Public Health | 10.3389/fpubh.2020.00295 | 2020 | | |
| [A case of infected bulla caused by Mycobacterium kansasii]. | Minami S, Suzuki K, Tsuyuguchi K, Mawatari H, Suzuki M, Arai T, Inoue Y, Hayashi S, Sakatani N. | Nihon Kokyuki Gakkai Zasshi | 2004 | | ||
| Phylogeny | Mycobacterium kansasii, species or complex? Biomolecular and epidemiological insights. | Tortoli E. | Kekkaku | 2003 | | |
| Enzymology | Detection of Mycobacterium leprae by PCR testing of sputa from a patient with pulmonary cryptococcus coinfection in northern Australia. | Edwards LJ, Price RN, Krause VL, Huffam SE, Globan M, Fyfe J, Hajkowicz KM. | J Clin Microbiol | 10.1128/jcm.01060-14 | 2014 | |
| Synthesis of isomeric, oxathiolone fused chalcones, and comparison of their activity toward various microorganisms and human cancer cells line. | Konieczny MT, Konieczny W, Sabisz M, Skladanowski A, Wakiec R, Augustynowicz-Kopec E, Zwolska Z. | Chem Pharm Bull (Tokyo) | 10.1248/cpb.55.817 | 2007 | | |
| Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus. | Marras TK, Morris A, Gonzalez LC, Daley CL. | Am J Respir Crit Care Med | 10.1164/rccm.200402-162oc | 2004 | | |
| Incidence and molecular typing of Mycobacterium kansasii in a defined geographical area in Catalonia, Spain. | Santin M, Alcaide F, Benitez MA, Salazar A, Ardanuy C, Podzamczer D, Rufi G, Dorca J, Martin R, Gudiol F. | Epidemiol Infect | 10.1017/s095026880300150x | 2004 | | |
| Pathogenicity | Mycobactericidal and tuberculocidal activity of Korsolex AF, an amine detergent/disinfectant product. | Hernandez A, Martro E, Matas L, Jimenez A, Ausina V. | J Hosp Infect | 10.1016/j.jhin.2004.05.021 | 2005 | |
| Pathogenicity | Activity of clarithromycin alone and in combination in a murine model of Mycobacterium kansasii infection. | Cynamon MH, Elliott SA, DeStefano MS, Yeo AE. | J Antimicrob Chemother | 10.1093/jac/dkg323 | 2003 | |
| Pathogenicity | Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates. | Moraski GC, Oliver AG, Markley LD, Cho S, Franzblau SG, Miller MJ. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2014.05.062 | 2014 | |
| A Current Microbiological Picture of Mycobacterium Isolates from Istanbul, Turkey. | Sumbul B, Doymaz MZ. | Pol J Microbiol | 10.33073/pjm-2020-021 | 2020 | | |
| Enzymology | Characterization of mycobacteria in HIV/AIDS patients of Nepal. | Dhungana GP, Ghimire P, Sharma S, Rijal BP. | JNMA J Nepal Med Assoc | 10.31729/jnma.212 | 2008 | |
| Phylogeny | Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect. | Arend SM, Cerda de Palou E, de Haas P, Janssen R, Hoeve MA, Verhard EM, Ottenhoff TH, van Soolingen D, van Dissel JT. | Clin Microbiol Infect | 10.1111/j.1469-0691.2004.00898.x | 2004 | |
| Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis. | Alhumaid S, Rabaan AA, Dhama K, Yong SJ, Nainu F, Hajissa K, Dossary NA, Alajmi KK, Saggar AEA, AlHarbi FA, Aswany MB, Alshayee AA, Alrabiah SA, Saleh AM, Alqarni MA, Gharib FMA, Qattan SN, Almusabeh HM, AlGhatm HY, Almoraihel SA, Alzuwaid AS, Albaqshi MA, Khalaf MAA, Albaqshi YA, Brahim AHA, Al Mutared MM, Al-Helal H, Alghazal HA, Al Mutair A. | Vaccines (Basel) | 10.3390/vaccines10081289 | 2022 | | |
| Metabolism | Antiadhesive peptides as the inhibitors of Mycobacterium kansasii phagocytosis. | Siemion IZ, Wieczorek Z. | Peptides | 10.1016/s0196-9781(03)00101-3 | 2003 | |
| Nontuberculous Mycobacterium infection complicated with Haemophagocytic syndrome: a case report and literature review. | Shi W, Jiao Y. | BMC Infect Dis | 10.1186/s12879-019-4061-9 | 2019 | | |
| Atypical Mycobacterial Infections of the Upper Extremity: Becoming More Atypical? | Lopez M, Croley J, Murphy KD. | Hand (N Y) | 10.1177/1558944716642764 | 2017 | | |
| Non-tuberculous mycobacteria disease as a cause of hospitalization in HIV-infected subjects. | Miguez-Burbano MJ, Flores M, Ashkin D, Rodriguez A, Granada AM, Quintero N, Pitchenik A. | Int J Infect Dis | 10.1016/j.ijid.2004.11.005 | 2006 | | |
| Coinfection of disseminated Talaromyces marneffei and Mycobacteria kansasii in a patient with papillary thyroid cancer: A case report. | Zhang J, Huang X, Zhang X, Zhu Y, Liao K, Ma J, Wang G, Guo Y, Xie C. | Medicine (Baltimore) | 10.1097/md.0000000000009072 | 2017 | | |
| Pathogenicity | Drug susceptibility of the Mycobacterium genus: in vitro tests and clinical implications. | Rodriguez JC, Garcia-Pachon E, Ruiz M, Royo G. | Curr Clin Pharmacol | 10.2174/157488406778249361 | 2006 | |
| Monitoring and treatment of MDS in genetically susceptible persons. | Davies SM. | Hematology Am Soc Hematol Educ Program | 10.1182/hematology.2019000020 | 2019 | | |
| The role of endobronchial ultrasound-guided transbronchial needle aspiration in isolated intrathoracic lymphadenopathy in non-neoplastic patients: a common dilemma in clinical practice. | Santos LM, Figueiredo VR, Demarzo SE, Palomino ALM, Jacomelli M. | J Bras Pneumol | 10.36416/1806-3756/e20180183 | 2020 | | |
| Phylogeny | Utility of gas chromatography for rapid identification of mycobacterial species frequently encountered in clinical laboratory. | Mosca A, Russo F, Miragliotta L, Iodice MA, Miragliotta G. | J Microbiol Methods | 10.1016/j.mimet.2006.09.017 | 2007 | |
| Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. | Griffith DE, Brown-Elliott BA, Wallace RJ. | Clin Infect Dis | 10.1086/378742 | 2003 | | |
| Systemic Pulmonary Events Associated with Myelodysplastic Syndromes: A Retrospective Multicentre Study. | Scanvion Q, Pascal L, Sy T, Stervinou-Wemeau L, Lejeune AL, Deken V, Hachulla E, Quesnel B, Mekinian A, Launay D, Terriou L. | J Clin Med | 10.3390/jcm10061162 | 2021 | | |
| Enzymology | [Infection due to Mycobacterium kansasii in Elche, Spain]. | Rodriguez JC, Ayelo A, Ruiz M, Lopez M, Royo G. | Med Clin (Barc) | 10.1016/s0025-7753(03)73669-0 | 2003 | |
| Enzymology | A study of phage based diagnostic technique for tuberculosis. | Barman P, Gadre D. | Indian J Tuberc | 2007 | | |
| Enzymology | [A case of idiopathic bronchiolitis obliterans accompanied with pneumothorax and pulmonary atypical mycobacteriosis]. | Ogata Y, Mori Y, Koga H, Awai K, Arakawa Y, Nakanishi N, Kataoka M, Kohi F. | Nihon Kokyuki Gakkai Zasshi | 2004 | | |
| [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain]. | Leal Arranz MV, Gaafar A, Unzaga Baranano MJ, Crespo Notario JA, Cisterna Cancer R, Garcia Cebrian F. | Arch Bronconeumol | 10.1016/s1579-2129(06)60424-2 | 2005 | | |
| Antioxidant and antimycobacterial activities of Tabernaemontana catharinensis extracts obtained by supercritical CO2 + cosolvent. | Pereira CG, Leal PF, Sato DN, Meireles MA. | J Med Food | 10.1089/jmf.2005.8.533 | 2005 | | |
| Smooth Tubercle Bacilli: Neglected Opportunistic Tropical Pathogens. | Aboubaker Osman D, Bouzid F, Canaan S, Drancourt M. | Front Public Health | 10.3389/fpubh.2015.00283 | 2015 | | |
| Species-Specific Interferon-Gamma Release Assay for the Diagnosis of Mycobacterium abscessus Complex Infection. | Steindor M, Stehling F, Olivier M, Kehrmann J, Diricks M, Maurer FP, Horn PA, Strassburg S, Welsner M, Sutharsan S, Lindemann M. | Front Microbiol | 10.3389/fmicb.2021.692395 | 2021 | | |
| Pathogenicity | Analogs of RGDVY and GRGD peptides inhibit Mycobacterium kansasii phagocytosis. | Siemion IZ, Gawlowska M, Krajewski K, Strug I, Wieczorek Z. | Peptides | 10.1016/j.peptides.2003.07.002 | 2003 | |
| Enzymology | Atypical mycobacterial infection among HIV seronegative patients in Pondicherry. | Sivasankari P, Khyriem AB, Venkatesh K, Parija SC. | Indian J Chest Dis Allied Sci | 2006 | | |
| Pathogenicity | Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains. | Kratky M, Vinsova J, Stolarikova J. | Molecules | 10.3390/molecules171112812 | 2012 | |
| Nutrition and Markers of Disease Severity in Patients With Bronchiectasis. | Despotes KA, Choate R, Addrizzo-Harris D, Aksamit TR, Barker A, Basavaraj A, Daley CL, Eden E, DiMango A, Fennelly K, Philley J, Johnson MM, McShane PJ, Metersky ML, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Knowles MR, Daniels MLA, Noone PG. | Chronic Obstr Pulm Dis | 10.15326/jcopdf.7.4.2020.0178 | 2020 | | |
| Clinical/pathologic correlations in 553 patients with primary centrilobular findings on high-resolution CT scan of the thorax. | Okada F, Ando Y, Yoshitake S, Ono A, Tanoue S, Matsumoto S, Wakisaka M, Maeda T, Mori H. | Chest | 10.1378/chest.07-0482 | 2007 | | |
| Metabolism | Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol. | Kremer L, de Chastellier C, Dobson G, Gibson KJ, Bifani P, Balor S, Gorvel JP, Locht C, Minnikin DE, Besra GS. | Mol Microbiol | 10.1111/j.1365-2958.2005.04717.x | 2005 | |
| Enzymology | Mycobacterium paraffinicum causing symptomatic pulmonary infection. | Chan AW, Kabbani S, Staton G, Kraft CS. | J Clin Microbiol | 10.1128/jcm.03107-13 | 2014 | |
| Current status of nontuberculous mycobacterial surgery in Japan: analysis of data from the annual survey by the Japanese Association for Thoracic Surgery. | Shiraishi Y. | Gen Thorac Cardiovasc Surg | 10.1007/s11748-015-0594-z | 2016 | | |
| Evaluation of Three Commercial Interferon-gamma Assays in a Bovine Tuberculosis Free Population. | Ghielmetti G, Landolt P, Friedel U, Morach M, Hartnack S, Stephan R, Schmitt S. | Front Vet Sci | 10.3389/fvets.2021.682466 | 2021 | | |
| Hypersensitivity reaction and tolerance induction to ethambutol. | Cernadas JR, Santos N, Pinto C, Mota PC, Castells M. | Case Rep Med | 10.1155/2013/208797 | 2013 | | |
| Non-tuberculous mycobacterial lung disease due to multiple "minor" risk factors: an illustrative case and a review of these "lesser elements". | Moon P, Guillaumin E, Chan ED. | J Thorac Dis | 10.21037/jtd-20-986 | 2020 | | |
| [Four cases of Mycobacterium xenopi pulmonary disease]. | Minami S, Suzuki K, Tsuyuguchi K, Sakatani M. | Kekkaku | 10.11400/kekkaku1923.79.313 | 2004 | | |
| Pulmonary Manifestations of GATA2 Deficiency. | Marciano BE, Olivier KN, Folio LR, Zerbe CS, Hsu AP, Freeman AF, Filie AC, Spinner MA, Sanchez LA, Lovell JP, Parta M, Cuellar-Rodriguez JM, Hickstein DD, Holland SM. | Chest | 10.1016/j.chest.2021.05.046 | 2021 | | |
| Hemophagocytic lymphohistiocytosis: An unusual complication in disseminated Mycobacterium tuberculosis. | Padhi S, Ravichandran K, Sahoo J, Varghese RG, Basheer A. | Lung India | 10.4103/0970-2113.168100 | 2015 | | |
| Non-tuberculous mycobacteria mimic of MDR-TB infection in Pott's disease. | Kumar M, Verma S, Dhole TN, Kumar R. | BMJ Case Rep | 10.1136/bcr-2016-215265 | 2016 | | |
| Management of disease due to Mycobacterium kansasii. | Griffith DE. | Clin Chest Med | 10.1016/s0272-5231(02)00016-3 | 2002 | | |
| Virulence-Associated Secretion in Mycobacterium abscessus. | Bar-Oz M, Meir M, Barkan D. | Front Immunol | 10.3389/fimmu.2022.938895 | 2022 | | |
| Computed tomographic findings of macrolide-resistant Mycobacterium massiliense pulmonary disease and changes after antibiotic treatment. | Yoon HJ, Chung MJ, Koh WJ, Jhun BW, Moon SM. | Medicine (Baltimore) | 10.1097/md.0000000000016826 | 2019 | | |
| [Mycobacterium kansasii lung infection and synchronous bronchopulmonary carcinoma]. | Sancho Chinesta J, Carrion Valero F. | An Med Interna | 10.4321/s0212-71992002000400007 | 2002 | | |
| Diagnostic Efficacy of T-SPOT.TB for Active Tuberculosis in Adult: A Retrospective Study. | Sun Y, Yao X, Ni Y, Peng Y, Shi G. | Infect Drug Resist | 10.2147/idr.s388568 | 2022 | | |
| Synthesis, Crystal Structures, Lipophilic Properties and Antimicrobial Activity of 5-Pyridylmethylidene-3-rhodanine-carboxyalkyl Acids Derivatives. | Zeslawska E, Zakrzewski R, Nowicki A, Korona-Glowniak I, Lycka A, Kania A, Zborowski KK, Suder P, Skorska-Stania A, Tejchman W. | Molecules | 10.3390/molecules27133975 | 2022 | | |
| Enzymology | Mycobacterium avium Complex: Addressing Gaps in Diagnosis and Management. | Daley CL, Winthrop KL. | J Infect Dis | 10.1093/infdis/jiaa354 | 2020 | |
| Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study. | Canueto-Quintero J, Caballero-Granado FJ, Herrero-Romero M, Dominguez-Castellano A, Martin-Rico P, Verdu EV, Santamaria DS, Cerquera RC, Torres-Tortosa M, Grupo Andaluz para el Estudio de las Esfermedades Infecciosas. | Clin Infect Dis | 10.1086/376987 | 2003 | | |
| The IS6110 repetitive DNA element of Mycobacterium tuberculosis is not detected in exhaled breath condensate of patients with active pulmonary tuberculosis. | Jain R, Schriever CA, Danziger LH, Cho SH, Rubinstein I. | Respiration | 10.1159/000101786 | 2007 | | |
| Enzymology | Distribution of mycobacteria in clinically healthy ornamental fish and their aquarium environment. | Beran V, Matlova L, Dvorska L, Svastova P, Pavlik I. | J Fish Dis | 10.1111/j.1365-2761.2006.00729.x | 2006 | |
| Enzymology | Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome. | Smith MB, Molina CP, Schnadig VJ, Boyars MC, Aronson JF. | Arch Pathol Lab Med | 10.5858/2003-127-0554-pfomki | 2003 | |
| Enzymology | Cutaneous and mediastinal lymphadenitis due to Mycobacterium kansasii. | Kotb R, Dhote R, Garcia-Ricart F, Permal S, Carlotti A, Arfi C, Christoforov B. | J Infect | 10.1053/jinf.2000.0800 | 2001 | |
| Metabolism | Diaryl azo derivatives as anti-diabetic and antimicrobial agents: synthesis, in vitro, kinetic and docking studies. | Tahir T, Shahzad MI, Tabassum R, Rafiq M, Ashfaq M, Hassan M, Kotwica-Mojzych K, Mojzych M. | J Enzyme Inhib Med Chem | 10.1080/14756366.2021.1929949 | 2021 | |
| [Differentiation of infection with Mycobacterium tuberculosis by recombinant Mycobacterium tuberculosis 11000 protein]. | Xu M, Luo YA, Li YL, Chen BW, Shen XB, Su C, Wang GZ. | Zhonghua Jie He He Hu Xi Za Zhi | 2006 | | ||
| Enzymology | Microscopic morphology in smears prepared from MGIT broth medium for rapid presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex and Mycobacterium kansasii. | Tu HZ, Chang SH, Huaug TS, Huaug WK, Liu YC, Lee SS. | Ann Clin Lab Sci | 2003 | | |
| Mycobacterium kansasii causing carpal tunnel syndrome with concomitant pulmonary Mycobacterium tuberculosis infection. | Blue ML, Payne WG, Mannari RI, Moffitt MR, Walusimbi MG, Robson MC. | South Med J | 10.1097/00007611-200209000-00039 | 2002 | | |
| Enzymology | Mycobacterium kansasii arthritis of the foot in a patient with systemic lupus erythematosus. | Nakamura T, Yamamura Y, Tsuruta T, Tomoda K, Sakaguchi M, Tsukano M. | Intern Med | 10.2169/internalmedicine.40.1045 | 2001 | |
| Pathogenicity | Antimycobacterial activity of basic ethyl esters of alkoxy-substituted phenylcarbamic acids. | Waisser K, Drazkova K, Cizmarik J, Kaustova J. | Folia Microbiol (Praha) | 10.1007/bf02931274 | 2003 | |
| Heterocyclic isosters of antimycobacterial salicylanilides. | Matyk J, Waisser K, Drazkova K, Kunes J, Klimesova V, Palat K, Kaustova J. | Farmaco | 10.1016/j.farmac.2005.02.002 | 2005 | | |
| Metabolism | Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. | Vignal C, Guerardel Y, Kremer L, Masson M, Legrand D, Mazurier J, Elass E. | J Immunol | 10.4049/jimmunol.171.4.2014 | 2003 | |
| [Endemic incidence of Mycobacterium kansasii infection in Karvina District 1968-1999; overview of the descriptive characteristics]. | Martinkova I, Sebakova H, Pelikan M, Zatloukal O. | Epidemiol Mikrobiol Imunol | 2001 | | ||
| Pathogenicity | In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria. | Brown-Elliott BA, Rubio A, Wallace RJ. | Antimicrob Agents Chemother | 10.1128/aac.01503-18 | 2018 | |
| Treatment alternatives for Mycobacterium kansasii. | Graybill JR, Bocanegra R. | J Antimicrob Chemother | 10.1093/jac/47.4.417 | 2001 | | |
| Tuberculin skin testing is useful in the screening for nontuberculous mycobacterial cervicofacial lymphadenitis in children. | Lindeboom JA, Kuijper EJ, Prins JM, Bruijnesteijn van Coppenraet ES, Lindeboom R. | Clin Infect Dis | 10.1086/509326 | 2006 | | |
| Disseminated cutaneous infection with Mycobacterium kansasii: genotyping versus phenotyping. | Tzen CY, Chen TL, Wu TY, Yong DI, Lee HC. | J Am Acad Dermatol | 10.1067/mjd.2001.114745 | 2001 | | |
| Enzymology | High prevalence of non-tuberculous mycobacterial disease among non-HIV infected individuals in a TB endemic country--experience from a tertiary center in Delhi, India. | Jain S, Sankar MM, Sharma N, Singh S, Chugh TD. | Pathog Glob Health | 10.1179/2047773214y.0000000133 | 2014 | |
| Identification of New Mycobacterium bovis antigens and development of a multiplexed serological bead-immunoassay for the diagnosis of bovine tuberculosis in cattle. | Moens C, Filee P, Boes A, Alie C, Dufrasne F, Andre E, Marche S, Fretin D. | PLoS One | 10.1371/journal.pone.0292590 | 2023 | | |
| Genetics | Metagenomic next-generation sequencing to identify pathogens and cancer in lung biopsy tissue. | Guo Y, Li H, Chen H, Li Z, Ding W, Wang J, Yin Y, Jin L, Sun S, Jing C, Wang H. | EBioMedicine | 10.1016/j.ebiom.2021.103639 | 2021 | |
| Enzymology | Isolation and identification of Mycobacterium kansasii from pleural fluid of a dog with persistent pleural effusion. | Pressler BM, Hardie EM, Pitulle C, Hopwood RM, Sontakke S, Breitschwerdt EB. | J Am Vet Med Assoc | 10.2460/javma.2002.220.1336 | 2002 | |
| Metabolism | Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. | Guerardel Y, Maes E, Briken V, Chirat F, Leroy Y, Locht C, Strecker G, Kremer L. | J Biol Chem | 10.1074/jbc.m305427200 | 2003 | |
| [New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones]. | Waisser K, Holy P, Bures O, Kunes J, Kaustova J. | Ceska Slov Farm | 2003 | | ||
| Microbiological aspects of peritonitis in patients on continuous ambulatory peritoneal dialysis. | Vikrant S, Guleria RC, Kanga A, Verma BS, Singh D, Dheer SK. | Indian J Nephrol | 10.4103/0971-4065.107188 | 2013 | | |
| Mycobacterium avium-intracellulare brain abscess in HIV-positive patient. | Karne SS, Sangle SA, Kiyawat DS, Dharmashale SN, Kadam DB, Bhardwaj RS. | Ann Indian Acad Neurol | 10.4103/0972-2327.93282 | 2012 | | |
| Enzymology | Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali. | Kone B, Sarro YS, Maiga M, Sanogo M, Somboro AM, Diarra B, Togo ACG, Coulibaly N, Dembele BPP, Goita D, Baya B, Kone A, Diabate S, Polis MA, Belson M, Dao S, Orsega S, Achenbach CJ, Murphy RL, Diallo S, Siddiqui S. | Epidemiol Infect | 10.1017/s0950268817003090 | 2018 | |
| [Clinical investigation of pulmonary Mycobacterium kansasii infection in our hospital]. | Tao Y, Ninomiya K, Miyazaki M, Aizawa H. | Kekkaku | 2002 | | ||
| Congenital unilateral pulmonary artery agenesis and aspergilloma. | Kadir IS, Thekudan J, Dheodar A, Jones MT, Carroll KB. | Ann Thorac Surg | 10.1016/s0003-4975(02)03979-6 | 2002 | | |
| [Mycobacterium kansasii skin infection at insulin injection sites]. | Domergue Than Trong E, Descamps V, Larger E, Grossin M, Belaich S, Crickx B. | Ann Dermatol Venereol | 2001 | | ||
| The Effect of Detectable HIV Viral Load among HIV-Infected Children during Antiretroviral Treatment: A Cross-Sectional Study. | Moolasart V, Chottanapund S, Ausavapipit J, Likanonsakul S, Uttayamakul S, Changsom D, Lerdsamran H, Puthavathana P. | Children (Basel) | 10.3390/children5010006 | 2018 | | |
| Metabolism | N-Alkyl-2-[4-(trifluoromethyl)benzoyl]hydrazine-1-carboxamides and Their Analogues: Synthesis and Multitarget Biological Activity. | Kratky M, Baranyai Z, Stepankova S, Svrckova K, Svarcova M, Stolarikova J, Horvath L, Bosze S, Vinsova J. | Molecules | 10.3390/molecules25102268 | 2020 | |
| Activation of host nucleic acid sensors by Mycobacterium: good for us or good for them? | Schorey JS, Vecchio J, McManus WR, Ongalo J, Webber K. | Crit Rev Microbiol | 10.1080/1040841x.2023.2294904 | 2024 | | |
| A Clinical-Epidemiological and Geospatial Study of Tuberculosis in a Neglected Area in the Amazonian Region Highlights the Urgent Need for Control Measures. | Mesquita CR, Conceicao EC, Monteiro LHMT, da Silva OM, Lima LNGC, de Oliveira RAC, de Brito AC, Guimaraes RJPSE, Lima KVB. | Int J Environ Res Public Health | 10.3390/ijerph18031335 | 2021 | | |
| Environmental mycobacteria from alpine and subalpine habitats. | Thorel MF, Falkinham JO, Moreau RG. | FEMS Microbiol Ecol | 10.1016/j.femsec.2004.04.016 | 2004 | | |
| Enzymology | Cutaneous infection due to Mycobacterium kansasii. | Razavi B, Cleveland MG. | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(00)00195-4 | 2000 | |
| Enzymology | Emergence of Mycobacterium simiae in respiratory specimens. | Samra Z, Kaufman L, Pitlik S, Shalit I, Bishara J. | Scand J Infect Dis | 10.1080/00365540500264712 | 2005 | |
| Correlation of cytomorphological patterns and acid-fast Bacilli positivity in tuberculous lymphadenitis in a rural population of southern India. | Masilamani S, Arul P, Akshatha C. | J Nat Sci Biol Med | 10.4103/0976-9668.166121 | 2015 | | |
| Enzymology | Mycobacterium kansasii pericarditis as a presentation of AIDS. | Pintado V, Fortun J, Casado JL, Gomez-Mampaso E. | Infection | 10.1007/s15010-001-0061-x | 2001 | |
| [A new group of potential antitubercular agents: antimycobacterial N-benzylsalicylamides]. | Waisser K, Perina M, Boudova I, Kunes J, Kaustova J. | Ceska Slov Farm | 2003 | | ||
| Characteristics of Mycobacterium avium complex (MAC) pulmonary disease in previously treated lung cancer patients. | Meier E, Pennington K, Gallo de Moraes A, Escalante P. | Respir Med Case Rep | 10.1016/j.rmcr.2017.06.012 | 2017 | | |
| Nanoscale clustering of mycobacterial ligands and DC-SIGN host receptors are key determinants for pathogen recognition. | Viljoen A, Vercellone A, Chimen M, Gaibelet G, Mazeres S, Nigou J, Dufrene YF. | Sci Adv | 10.1126/sciadv.adf9498 | 2023 | | |
| Enzymology | Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. | Rindi L, Garzelli C. | BMC Infect Dis | 10.1186/s12879-016-1380-y | 2016 | |
| Pathogenicity | Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides. | Waisser K, Drazkova K, Kunes J, Klimesova V, Kaustova J. | Farmaco | 10.1016/j.farmac.2004.02.003 | 2004 | |
| [Prevalence of mycobacteriosis and tuberculosis in a reference hospital, Cordoba province]. | Barnes AI, Rojo S, Moretto H. | Rev Argent Microbiol | 2004 | | ||
| Mutant prevention concentration: a new tool for choosing treatment in nontuberculous mycobacterial infections. | Rodriguez JC, Cebrian L, Lopez M, Ruiz M, Royo G. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2004.03.026 | 2004 | | |
| On the relationship between the substitution pattern of thiobenzanilides and their antimycobacterial activity. | Kunes J, Balsanek V, Pour M, Waisser K, Kaustova J. | Farmaco | 10.1016/s0014-827x(02)01285-5 | 2002 | | |
| Metabolism | Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection. | Chen CC, Tsai SH, Lu CC, Hu ST, Wu TS, Huang TT, Said-Sadier N, Ojcius DM, Lai HC. | PLoS One | 10.1371/journal.pone.0036292 | 2012 | |
| Contemporary Pharmacotherapies for Nontuberculosis Mycobacterial Infections: A Narrative Review. | Johnson TM, Byrd TF, Drummond WK, Childs-Kean LM, Mahoney MV, Pearson JC, Rivera CG. | Infect Dis Ther | 10.1007/s40121-022-00750-5 | 2023 | | |
| Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis. | Mirsaeidi M, Sadikot RT. | Int J Mycobacteriol | 10.1016/j.ijmyco.2015.05.002 | 2015 | | |
| [A case report of pulmonary Mycobacterium kansasii infection found regular medical examination in our medical college of nursing]. | Inatomi K. | Kekkaku | 2000 | | ||
| [Pulmonary Mycobacterium Kansasii infection in the southern area of Fukuoka prefecture]. | Kitahara Y, Ochiai S, Harada Y, Kajiki A, Mitsuyama T, Ikedo Y, Wakamatsu K, Nagata N, Harada S, Takamoto M. | Kekkaku | 2001 | | ||
| Latent tuberculosis testing through the ages: the search for a sleeping killer. | Kestler B, Tyler SK. | Am J Physiol Lung Cell Mol Physiol | 10.1152/ajplung.00217.2021 | 2022 | | |
| Incidence of nontuberculous mycobacterial disease and coinfection with tuberculosis in a tuberculosis-endemic region: A population-based retrospective cohort study. | Lin CK, Yang YH, Lu ML, Tsai YH, Hsieh MJ, Lee YC, Wang TN, Chen YL, Chen VC. | Medicine (Baltimore) | 10.1097/md.0000000000023775 | 2020 | | |
| Metabolism | Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. | Quesniaux VJ, Nicolle DM, Torres D, Kremer L, Guerardel Y, Nigou J, Puzo G, Erard F, Ryffel B. | J Immunol | 10.4049/jimmunol.172.7.4425 | 2004 | |
| Enzymology | Mycobacterium kansasii infections in patients with cancer. | Jacobson KL, Teira R, Libshitz HI, Raad I, Rolston KV, Terrand J, Whimbey E. | Clin Infect Dis | 10.1086/313967 | 2000 | |
| Phylogeny | Evaluation of the RT-LAMP and LAMP methods for detection of Mycobacterium tuberculosis. | Wu D, Kang J, Li B, Sun D. | J Clin Lab Anal | 10.1002/jcla.22326 | 2018 | |
| Enzymology | [Clinical importance of Mycobacterium kansasii and evaluation of the need to identify nontuberculous mycobacteria]. | Etxebarrieta M, Rodrigo A, Martin C, Ojer M, Ruz A, Dorronsoro I. | Enferm Infecc Microbiol Clin | 10.1016/s0213-005x(02)72760-2 | 2002 | |
| The combination of real-time PCR and HPLC for the identification of non-tuberculous mycobacteria. | Park JS, Choi JI, Lim JH, Ahn JJ, Jegal Y, Seo KW, Ra SW, Jeon JB, Lee SH, Kim SR, Jeong J. | Ann Lab Med | 10.3343/alm.2013.33.5.349 | 2013 | | |
| Enzymology | Endobronchial carcinoid tumor combined with pulmonary non-tuberculous mycobacterial infection: report of two cases. | Nakamura Y, Okada Y, Endo C, Aikawa H, Sakurada A, Sato M, Kondo T. | Lung Cancer | 10.1016/s0169-5002(02)00450-6 | 2003 | |
| Multiplex Real-Time PCR-shortTUB Assay for Detection of the Mycobacterium tuberculosis Complex in Smear-Negative Clinical Samples with Low Mycobacterial Loads. | Alcaide F, Trastoy R, Moure R, Gonzalez-Bardanca M, Ambroa A, Lopez M, Bleriot I, Blasco L, Fernandez-Garcia L, Tato M, Bou G, Tomas M, Mycobacterial and GEMARA SEIMC/REIPI Bacterial Clinical Adaptation Study Group. | J Clin Microbiol | 10.1128/jcm.00733-19 | 2019 | | |
| Nontuberculous Mycobacteria, Macrophages, and Host Innate Immune Response. | Shamaei M, Mirsaeidi M. | Infect Immun | 10.1128/iai.00812-20 | 2021 | | |
| Pathogenicity | Localized primary cutaneous Mycobacterium kansasii infection in an immunocompromised patient. | Stengem J, Grande KK, Hsu S. | J Am Acad Dermatol | 10.1016/s0190-9622(99)70344-0 | 1999 | |
| Enzymology | Atypical mycobacterial infection in a patient with hairy cell leukemia. | Trizna Z, Tschen J, Natelson EA. | Cutis | 2001 | | |
| Pathogenicity | 3-Benzyl-2H-1,3-benzoxazine-2,4(3H)-diones, a new group of antimycobacterial compounds against potentially pathogenic strains. | Waisser K, Perina M, Kunes J, Klimesova V, Kaustova J. | Farmaco | 10.1016/j.farmac.2003.07.004 | 2003 | |
| Emergence of disseminated infections due to nontuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan. | Lai CC, Lee LN, Ding LW, Yu CJ, Hsueh PR, Yang PC. | J Infect | 10.1016/j.jinf.2005.10.009 | 2006 | | |
| Glycopeptidolipid of Mycobacterium smegmatis J15cs Affects Morphology and Survival in Host Cells. | Fujiwara N, Ohara N, Ogawa M, Maeda S, Naka T, Taniguchi H, Yamamoto S, Ayata M. | PLoS One | 10.1371/journal.pone.0126813 | 2015 | | |
| [Pulmonary disease caused by Mycobacterium kansasii. Analysis of 39 cases]. | Garros Garay J, Garcia Cebrian F, Martin Saco G, Lorza Blasco JJ, Ruiz de Gordejuela E. | Arch Bronconeumol | 10.1016/s0300-2896(01)75004-1 | 2001 | | |
| Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease. | Lee SH, Lee JH, Chang JH, Kim SJ, Yoon HY, Shim SS, Kim MU, Choi SY, Ryu YJ. | BMC Pulm Med | 10.1186/s12890-019-0881-z | 2019 | | |
| Metabolism | Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. | Le Cabec V, Carreno S, Moisand A, Bordier C, Maridonneau-Parini I. | J Immunol | 10.4049/jimmunol.169.4.2003 | 2002 | |
| Clinical features of eleven cases of Mycobacterium avium-intracellulare complex pulmonary disease associated with pneumoconiosis. | Fujita J, Kishimoto T, Ohtsuki Y, Shigeto E, Ohnishi T, Shiode M, Yamaji Y, Suemitsu I, Yamadori I, Bandoh S, Nishimura K, Matsushima T, Ishida T. | Respir Med | 10.1016/j.rmed.2004.02.011 | 2004 | | |
| Hospital costs in the US for pulmonary mycobacterial diseases. | Mirsaeidi M, Allen MB, Ebrahimi G, Schraufnagel D. | Int J Mycobacteriol | 10.1016/j.ijmyco.2015.05.003 | 2015 | | |
| Metabolism | Mycobacterium abscessus-Bronchial Epithelial Cells Cross-Talk Through Type I Interferon Signaling. | Zhang C, Asif H, Holt GE, Griswold AJ, Campos M, Bejarano P, Fregien NL, Mirsaeidi M. | Front Immunol | 10.3389/fimmu.2019.02888 | 2019 | |
| Enzymology | Molecular analyses of mycobacteria other than the M. tuberculosis complex isolated from Northern Ireland cattle. | Hughes MS, Ball NW, McCarroll J, Erskine M, Taylor MJ, Pollock JM, Skuce RA, Neill SD. | Vet Microbiol | 10.1016/j.vetmic.2005.03.001 | 2005 | |
| [Molecular identification of mycobacteria and detection of antibiotic resistance]. | Cattoir V. | Ann Biol Clin (Paris) | 2004 | | ||
| Enzymology | Presumed choroidal atypical tuberculosis superinfected with cytomegalovirus retinitis in an acquired immunodeficiency syndrome patient: a case report. | Lai LJ, Chen SN, Kuo YH, Ho JD, Ho CL. | Jpn J Ophthalmol | 10.1016/s0021-5155(02)00500-2 | 2002 | |
| Evaluation of Mycobacterium tuberculosis Early Secreted Antigenic Target 6 Recombinant Protein as a Diagnostic Marker in Skin Test. | Moradi J, Mosavari N, Ebrahimi M, Arefpajohi R, Tebianian M. | Osong Public Health Res Perspect | 10.1016/j.phrp.2014.12.002 | 2015 | | |
| Mycobacterium kansaii flexor tenosynovitis presenting as carpal tunnel syndrome. | Wada A, Nomura S, Ihara F. | J Hand Surg Br | 10.1054/jhsb.2000.0387 | 2000 | | |
| Development of an inexpensive matrix-assisted laser desorption-time of flight mass spectrometry method for the identification of endophytes and rhizobacteria cultured from the microbiome associated with maize. | LaMontagne MG, Tran PL, Benavidez A, Morano LD. | PeerJ | 10.7717/peerj.11359 | 2021 | | |
| A low incidence of nontuberculous mycobacterial infections in pediatric hematopoietic stem cell transplantation recipients. | Unal E, Yen C, Saiman L, George D, Della-Latta P, van de Ven C, Morris E, Bradley MB, Del Toro G, Garvin J, Bhatia M, Schwartz J, Satwani P, Roman E, Cooney E, Wolownik K, Hawks R, Foley S, Cairo MS. | Biol Blood Marrow Transplant | 10.1016/j.bbmt.2006.07.006 | 2006 | | |
| Necrotizing Cervical Lymphadenitis Caused by Mycobacterium simiae in an HIV-Positive Patient: Imaging with (18)F-FDG PET/CT. | Makis W, Rush C. | Nucl Med Mol Imaging | 10.1007/s13139-011-0088-6 | 2011 | | |
| Pathogenicity | In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. | Rodriguez Diaz JC, Lopez M, Ruiz M, Royo G. | Int J Antimicrob Agents | 10.1016/s0924-8579(03)00048-7 | 2003 | |
| Enzymology | Nontubercular mycobacterial pulmonary infection in immunocompetent men. | Kanathur N, Shantaveerapa HN, Byrd RP, Mehta JB, Roy TM. | South Med J | 10.1097/00007611-200107000-00018 | 2001 | |
| Metabolism | Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins. | Peyron P, Bordier C, N'Diaye EN, Maridonneau-Parini I. | J Immunol | 10.4049/jimmunol.165.9.5186 | 2000 | |
| Phylogeny | Intact molecular characterization of cord factor (trehalose 6,6'-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. | Fujita Y, Naka T, McNeil MR, Yano I. | Microbiology (Reading) | 10.1099/mic.0.28158-0 | 2005 | |
| Archival influenza virus genomes from Europe reveal genomic variability during the 1918 pandemic. | Patrono LV, Vrancken B, Budt M, Dux A, Lequime S, Boral S, Gilbert MTP, Gogarten JF, Hoffmann L, Horst D, Merkel K, Morens D, Prepoint B, Schlotterbeck J, Schuenemann VJ, Suchard MA, Taubenberger JK, Tenkhoff L, Urban C, Widulin N, Winter E, Worobey M, Schnalke T, Wolff T, Lemey P, Calvignac-Spencer S. | Nat Commun | 10.1038/s41467-022-29614-9 | 2022 | | |
| Pathogenicity | Antimycobacterial 3-aryl-2H-1,3-benzoxazine-2,4(3H)-diones. | Waisser K, Bures O, Holy P, Kunes J, Oswald R, Jiraskova L, Pour M, Klimesova V, Palat K, Kaustova J, Danse HM, Mollmann U. | Pharmazie | 2003 | | |
| Pathogenicity | An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease. | Srivastava S, Pasipanodya JG, Heysell SK, Boorgula GD, Gumbo T, McShane PJ, Philley JV | J Glob Antimicrob Resist | 10.1016/j.jgar.2021.12.010 | 2021 | |
| A Murine Model of Mycobacterium kansasii Infection Reproducing Necrotic Lung Pathology Reveals Considerable Heterogeneity in Virulence of Clinical Isolates. | Mussi VO, Simao TLBV, Almeida FM, Machado E, de Carvalho LD, Calixto SD, Sales GAM, Carvalho ECQ, Vasconcellos SEG, Catanho M, Suffys PN, Lasunskaia EB | Front Microbiol | 10.3389/fmicb.2021.718477 | 2021 | | |
| Enzymology | Molecular typing of Mycobacterium kansasii using pulsed-field gel electrophoresis and a newly designed variable-number tandem repeat analysis. | Bakula Z, Brzostek A, Borowka P, Zaczek A, Szulc-Kielbik I, Podpora A, Parniewski P, Strapagiel D, Dziadek J, Proboszcz M, Bielecki J, van Ingen J, Jagielski T | Sci Rep | 10.1038/s41598-018-21562-z | 2018 | |
| The Structure-Antimicrobial Activity Relationships of a Promising Class of the Compounds Containing the N-Arylpiperazine Scaffold. | Malik I, Csollei J, Jampilek J, Stanzel L, Zadrazilova I, Hosek J, Pospisilova S, Cizek A, Coffey A, O'Mahony J | Molecules | 10.3390/molecules21101274 | 2016 | | |
| Genetics | Comparative Genomics and Proteomic Analysis of Four Non-tuberculous Mycobacterium Species and Mycobacterium tuberculosis Complex: Occurrence of Shared Immunogenic Proteins. | Gcebe N, Michel A, Gey van Pittius NC, Rutten V | Front Microbiol | 10.3389/fmicb.2016.00795 | 2016 | |
| Metabolism | MKAN27435 is required for the biosynthesis of higher subclasses of lipooligosaccharides in Mycobacterium kansasii. | Nataraj V, Pang PC, Haslam SM, Veerapen N, Minnikin DE, Dell A, Besra GS, Bhatt A | PLoS One | 10.1371/journal.pone.0122804 | 2015 | |
| Genetics | Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii. | Wang J, McIntosh F, Radomski N, Dewar K, Simeone R, Enninga J, Brosch R, Rocha EP, Veyrier FJ, Behr MA | Genome Biol Evol | 10.1093/gbe/evv035 | 2015 | |
| Metabolism | Mycobacterium kansasii-induced death of murine macrophages involves endoplasmic reticulum stress responses mediated by reactive oxygen species generation or calpain activation. | Lim YJ, Choi HH, Choi JA, Jeong JA, Cho SN, Lee JH, Park JB, Kim HJ, Song CH | Apoptosis | 10.1007/s10495-012-0792-4 | 2013 | |
| Enzymology | Multicenter evaluation of mycobacteria identification by PCR restriction enzyme analysis in laboratories from Latin America and the Caribbean. | Leao SC, Bernardelli A, Cataldi A, Zumarraga M, Robledo J, Realpe T, Mejia GI, da Silva Telles MA, Chimara E, Velazco M, Fernandez J, Rodrigues PA, Guerrero MI, Leon CI, Porras TB, Rastogi N, Goh KS, Suffys P, da Silva Rocha A, dos Santos Netto D, Ritacco V, Lopez B, Barrera L, Palomino JC, Martin A, Portaels F | J Microbiol Methods | 10.1016/j.mimet.2004.11.015 | 2004 | |
| Cultivation | Characterization of the susceptibility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and characterization of the individual components of PANTA in the presence of C18-carboxypropylbetaine. | Thornton CG, MacLellan KM, Brink TL, Passen S | J Microbiol Methods | 10.1016/j.mimet.2003.10.020 | 2004 | |
| Phylogeny | Large-restriction-fragment analysis of Mycobacterium kansasii genomic DNA and its application in molecular typing. | Iinuma Y, Ichiyama S, Hasegawa Y, Shimokata K, Kawahara S, Matsushima T | J Clin Microbiol | 10.1128/jcm.35.3.596-599.1997 | 1997 | |
| Phylogeny | Demonstration of Mycobacterium kansasii species heterogeneity by the amplification of the 16S-23S spacer region. | Abed Y, Bollet C, De Micco P | J Med Microbiol | 10.1099/00222615-43-2-156 | 1995 | |
| Pathogenicity | Omadacycline Pharmacokinetics/Pharmacodynamics in the Hollow Fiber System Model and Potential Combination Regimen for Short Course Treatment of Mycobacterium kansasii Pulmonary Disease. | Singh S, Gumbo T, Boorgula GD, Shankar P, Heysell SK, Srivastava S | Antimicrob Agents Chemother | 10.1128/aac.00687-22 | 2022 | |
| Phylogeny | Phylogenomics reveal that Mycobacterium kansasii subtypes are species-level lineages. Description of Mycobacterium pseudokansasii sp. nov., Mycobacterium innocens sp. nov. and Mycobacterium attenuatum sp. nov. | Tagini F, Aeby S, Bertelli C, Droz S, Casanova C, Prod'hom G, Jaton K, Greub G. | Int J Syst Evol Microbiol | 10.1099/ijsem.0.003378 | 2019 | |
| Mycobacterium hainanense sp. nov. represents an emerging nontuberculous Mycobacterium associated with chronic pulmonary disease | Kuang D, Liu F, Liu W, Li J, Tian S, Wang Y, Zhong Y, Li H, Pei H, Huang H, Xia Q. | Sci Rep | 2025 | | ||
| Phylogeny | Mycobacterium persicum sp. nov., a novel species closely related to Mycobacterium kansasii and Mycobacterium gastri. | Shahraki AH, Trovato A, Mirsaeidi M, Borroni E, Heidarieh P, Hashemzadeh M, Shahbazi N, Cirillo DM, Tortoli E. | Int J Syst Evol Microbiol | 10.1099/ijsem.0.001862 | 2017 | |
| Phylogeny | Mycobacterium nebraskense sp. nov., a novel slowly growing scotochromogenic species. | Mohamed AM, Iwen PC, Tarantolo S, Hinrichs SH. | Int J Syst Evol Microbiol | 10.1099/ijs.0.63126-0 | 2004 | |
| Phylogeny | Mycobacterium shinjukuense sp. nov., a slowly growing, non-chromogenic species isolated from human clinical specimens. | Saito H, Iwamoto T, Ohkusu K, Otsuka Y, Akiyama Y, Sato S, Taguchi O, Sueyasu Y, Kawabe Y, Fujimoto H, Ezaki T, Butler R | Int J Syst Evol Microbiol | 10.1099/ijs.0.025478-0 | 2010 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive8393.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License